The dopamine motive system: implications for drug and food addiction

Key Points The motivation to eat, like the motivation to take addictive drugs, activates the forebrain dopamine systems. Excessive activation of this system strengthens the specific habits that precede the activation, sensitizing the animal's responsiveness to the specific conditions that elici...

Full description

Saved in:

Bibliographic Details
Published in	Nature reviews. Neuroscience Vol. 18; no. 12; pp. 741 - 752
Main Authors	Volkow, Nora D., Wise, Roy A., Baler, Ruben
Format	Journal Article
Language	English
Published	London Nature Publishing Group UK 01.12.2017 Nature Publishing Group
Subjects	59/36 631/378/1488/393 631/378/1689/5 631/378/2629/1788 692/699/317 692/699/476/5 Addiction Addictions Analysis Animal Genetics and Genomics Animals Behavior, Addictive - drug therapy Behavior, Addictive - physiopathology Behavioral Sciences Biological Techniques Biomedicine Brain research Dopamine Dopamine - metabolism Dopamine - pharmacology Dopamine receptors Dopaminergic mechanisms Drug addiction Food Food Addiction - drug therapy Health aspects Humans Motivation Motivation (Psychology) Motivation - drug effects Neostriatum Neural Pathways - drug effects Neurobiology Neurosciences Obesity Psychological aspects Reinforcement (Psychology) review-article Risk factors
Online Access	Get full text
ISSN	1471-003X 1471-0048 1471-0048 1469-3178
DOI	10.1038/nrn.2017.130

Cover

Loading…

Abstract	Key Points The motivation to eat, like the motivation to take addictive drugs, activates the forebrain dopamine systems. Excessive activation of this system strengthens the specific habits that precede the activation, sensitizing the animal's responsiveness to the specific conditions that elicit those habits. At the same time, overactivation of the dopamine system downregulates the dopamine receptors, leaving the subject less interested in other activities. The repeated intake of high-impact foods or addictive drugs thus makes food consumption or drug taking more habitual and decreases the importance of stimuli calling for alternatives. Repeated drug use erodes the function of brain networks necessary for self-regulation, thereby facilitating impulsive, inflexible and compulsive actions. The dopamine motive system, which integrates reinforcement and motivation, is influenced by obesogenic foods and addictive drugs. In this Review, Volkow and colleagues highlight how these stimuli sensitize the subject's motivation towards them while desensitizing the subject's motivation towards alternative reinforcers. Behaviours such as eating, copulating, defending oneself or taking addictive drugs begin with a motivation to initiate the behaviour. Both this motivational drive and the behaviours that follow are influenced by past and present experience with the reinforcing stimuli (such as drugs or energy-rich foods) that increase the likelihood and/or strength of the behavioural response (such as drug taking or overeating). At a cellular and circuit level, motivational drive is dependent on the concentration of extrasynaptic dopamine present in specific brain areas such as the striatum. Cues that predict a reinforcing stimulus also modulate extrasynaptic dopamine concentrations, energizing motivation. Repeated administration of the reinforcer (drugs, energy-rich foods) generates conditioned associations between the reinforcer and the predicting cues, which is accompanied by downregulated dopaminergic response to other incentives and downregulated capacity for top-down self-regulation, facilitating the emergence of impulsive and compulsive responses to food or drug cues. Thus, dopamine contributes to addiction and obesity through its differentiated roles in reinforcement, motivation and self-regulation, referred to here as the 'dopamine motive system', which, if compromised, can result in increased, habitual and inflexible responding. Thus, interventions to rebalance the dopamine motive system might have therapeutic potential for obesity and addiction.
AbstractList	Behaviours such as eating, copulating, defending oneself or taking addictive drugs begin with a motivation to initiate the behaviour. Both this motivational drive and the behaviours that follow are influenced by past and present experience with the reinforcing stimuli (such as drugs or energy-rich foods) that increase the likelihood and/or strength of the behavioural response (such as drug taking or overeating). At a cellular and circuit level, motivational drive is dependent on the concentration of extrasynaptic dopamine present in specific brain areas such as the striatum. Cues that predict a reinforcing stimulus also modulate extrasynaptic dopamine concentrations, energizing motivation. Repeated administration of the reinforcer (drugs, energy-rich foods) generates conditioned associations between the reinforcer and the predicting cues, which is accompanied by downregulated dopaminergic response to other incentives and downregulated capacity for top-down self-regulation, facilitating the emergence of impulsive and compulsive responses to food or drug cues. Thus, dopamine contributes to addiction and obesity through its differentiated roles in reinforcement, motivation and self-regulation, referred to here as the 'dopamine motive system', which, if compromised, can result in increased, habitual and inflexible responding. Thus, interventions to rebalance the dopamine motive system might have therapeutic potential for obesity and addiction. Behaviours such as eating, copulating, defending oneself or taking addictive drugs begin with a motivation to initiate the behaviour. Both this motivational drive and the behaviours that follow are influenced by past and present experience with the reinforcing stimuli (such as drugs or energy-rich foods) that increase the likelihood and/or strength of the behavioural response (such as drug taking or overeating). At a cellular and circuit level, motivational drive is dependent on the concentration of extrasynaptic dopamine present in specific brain areas such as the striatum. Cues that predict a reinforcing stimulus also modulate extrasynaptic dopamine concentrations, energizing motivation. Repeated administration of the reinforcer (drugs, energy-rich foods) generates conditioned associations between the reinforcer and the predicting cues, which is accompanied by downregulated dopaminergic response to other incentives and downregulated capacity for top-down self-regulation, facilitating the emergence of impulsive and compulsive responses to food or drug cues. Thus, dopamine contributes to addiction and obesity through its differentiated roles in reinforcement, motivation and self-regulation, referred to here as the 'dopamine motive system', which, if compromised, can result in increased, habitual and inflexible responding. Thus, interventions to rebalance the dopamine motive system might have therapeutic potential for obesity and addiction.Behaviours such as eating, copulating, defending oneself or taking addictive drugs begin with a motivation to initiate the behaviour. Both this motivational drive and the behaviours that follow are influenced by past and present experience with the reinforcing stimuli (such as drugs or energy-rich foods) that increase the likelihood and/or strength of the behavioural response (such as drug taking or overeating). At a cellular and circuit level, motivational drive is dependent on the concentration of extrasynaptic dopamine present in specific brain areas such as the striatum. Cues that predict a reinforcing stimulus also modulate extrasynaptic dopamine concentrations, energizing motivation. Repeated administration of the reinforcer (drugs, energy-rich foods) generates conditioned associations between the reinforcer and the predicting cues, which is accompanied by downregulated dopaminergic response to other incentives and downregulated capacity for top-down self-regulation, facilitating the emergence of impulsive and compulsive responses to food or drug cues. Thus, dopamine contributes to addiction and obesity through its differentiated roles in reinforcement, motivation and self-regulation, referred to here as the 'dopamine motive system', which, if compromised, can result in increased, habitual and inflexible responding. Thus, interventions to rebalance the dopamine motive system might have therapeutic potential for obesity and addiction. Key Points The motivation to eat, like the motivation to take addictive drugs, activates the forebrain dopamine systems. Excessive activation of this system strengthens the specific habits that precede the activation, sensitizing the animal's responsiveness to the specific conditions that elicit those habits. At the same time, overactivation of the dopamine system downregulates the dopamine receptors, leaving the subject less interested in other activities. The repeated intake of high-impact foods or addictive drugs thus makes food consumption or drug taking more habitual and decreases the importance of stimuli calling for alternatives. Repeated drug use erodes the function of brain networks necessary for self-regulation, thereby facilitating impulsive, inflexible and compulsive actions. The dopamine motive system, which integrates reinforcement and motivation, is influenced by obesogenic foods and addictive drugs. In this Review, Volkow and colleagues highlight how these stimuli sensitize the subject's motivation towards them while desensitizing the subject's motivation towards alternative reinforcers. Behaviours such as eating, copulating, defending oneself or taking addictive drugs begin with a motivation to initiate the behaviour. Both this motivational drive and the behaviours that follow are influenced by past and present experience with the reinforcing stimuli (such as drugs or energy-rich foods) that increase the likelihood and/or strength of the behavioural response (such as drug taking or overeating). At a cellular and circuit level, motivational drive is dependent on the concentration of extrasynaptic dopamine present in specific brain areas such as the striatum. Cues that predict a reinforcing stimulus also modulate extrasynaptic dopamine concentrations, energizing motivation. Repeated administration of the reinforcer (drugs, energy-rich foods) generates conditioned associations between the reinforcer and the predicting cues, which is accompanied by downregulated dopaminergic response to other incentives and downregulated capacity for top-down self-regulation, facilitating the emergence of impulsive and compulsive responses to food or drug cues. Thus, dopamine contributes to addiction and obesity through its differentiated roles in reinforcement, motivation and self-regulation, referred to here as the 'dopamine motive system', which, if compromised, can result in increased, habitual and inflexible responding. Thus, interventions to rebalance the dopamine motive system might have therapeutic potential for obesity and addiction.
Audience	Academic
Author	Volkow, Nora D. Baler, Ruben Wise, Roy A.
Author_xml	– sequence: 1 givenname: Nora D. surname: Volkow fullname: Volkow, Nora D. email: nvolkow@nida.nih.gov organization: National Institute on Drug Abuse, National Institutes of Health – sequence: 2 givenname: Roy A. surname: Wise fullname: Wise, Roy A. organization: National Institute on Drug Abuse, National Institutes of Health – sequence: 3 givenname: Ruben surname: Baler fullname: Baler, Ruben organization: National Institute on Drug Abuse, National Institutes of Health
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/29142296$$D View this record in MEDLINE/PubMed
BookMark	eNp1kU1P3DAQhq0K1IUtt56rSL30QBaP48RJbwhoi4TEhUrcLK892Rol9tZOkPbf12EpX1rkgz32MzOv5z0ke847JOQz0AXQoj5xwS0YBbGAgn4gB8AF5JTyeu_pXNzOyGGMd5RCBaL6SGasAc5YUx2Q85s_mBm_Vr11mPV-sPeYxU0csP-e2X7dWa0G613MWh8yE8ZVppxJgTeZMsbq6fET2W9VF_HocZ-T3z8ubs5-5VfXPy_PTq9yzUs65EsuKFMV6AIawRRXGjSlqihR17pFthQ0iaWN4K3Ry5pxhqZUJskuaK0YK-bk27buOvi_I8ZB9jZq7Drl0I9RQlOVLLWqyoR-fYPe-TG4pC5RouaclTU8UyvVobSu9UNQeioqT0vgpYBaTG0XO6i0DPZWJzdam-5fJXx5bD4uezRyHWyvwkb-H3sCjreADj7GgO0TAlROrsrkqpxclenvCWdvcG2HB1uSENu9l5Rvk2Kq7VYYXkxgF_8Pzc-wqQ
CitedBy_id	crossref_primary_10_1016_j_appet_2022_106075 crossref_primary_10_1016_j_phymed_2021_153594 crossref_primary_10_1093_alcalc_agy048 crossref_primary_10_1016_j_jpsychires_2020_07_044 crossref_primary_10_3390_biomedicines10051126 crossref_primary_10_3758_s13415_019_00725_z crossref_primary_10_1007_s40263_020_00721_9 crossref_primary_10_3390_ijms22105279 crossref_primary_10_1111_dom_16178 crossref_primary_10_3390_nu12020294 crossref_primary_10_1016_j_pharmthera_2022_108215 crossref_primary_10_1016_j_neuroimage_2019_06_036 crossref_primary_10_1016_j_heliyon_2023_e15525 crossref_primary_10_3390_metabo12121247 crossref_primary_10_2174_2589977513666210518160924 crossref_primary_10_1016_j_jaac_2018_06_039 crossref_primary_10_1021_acssensors_8b00368 crossref_primary_10_1038_s41380_023_01942_2 crossref_primary_10_1007_s11033_023_08610_2 crossref_primary_10_1016_j_neubiorev_2018_03_020 crossref_primary_10_1016_j_cub_2020_04_037 crossref_primary_10_1016_j_neuroscience_2022_06_033 crossref_primary_10_1016_j_pnpbp_2021_110265 crossref_primary_10_3389_fpsyt_2023_1237163 crossref_primary_10_1007_s00702_018_1957_2 crossref_primary_10_1523_ENEURO_0393_20_2020 crossref_primary_10_1016_j_molmet_2023_101764 crossref_primary_10_1007_s00415_023_12100_7 crossref_primary_10_3390_nu11030687 crossref_primary_10_1038_s41380_021_01294_9 crossref_primary_10_1186_s11671_019_3203_8 crossref_primary_10_1007_s11682_019_00048_0 crossref_primary_10_1093_jn_nxab068 crossref_primary_10_1177_0269881119895521 crossref_primary_10_1016_j_brainresbull_2019_07_002 crossref_primary_10_1002_osp4_363 crossref_primary_10_1002_hbm_25454 crossref_primary_10_1038_s41386_018_0287_2 crossref_primary_10_3390_ijerph19042201 crossref_primary_10_1038_s41398_024_03112_6 crossref_primary_10_1007_s40429_019_00268_w crossref_primary_10_56083_RCV4N7_207 crossref_primary_10_1016_j_neuroscience_2021_12_016 crossref_primary_10_1111_adb_12750 crossref_primary_10_1016_j_jns_2020_116763 crossref_primary_10_1111_adb_12877 crossref_primary_10_1111_ijpo_13042 crossref_primary_10_1038_s41366_020_00685_2 crossref_primary_10_3390_cells14010024 crossref_primary_10_12688_f1000research_20829_1 crossref_primary_10_1016_j_diabet_2025_101612 crossref_primary_10_1007_s11682_019_00200_w crossref_primary_10_3390_brainsci10080487 crossref_primary_10_1038_s41598_022_15833_z crossref_primary_10_3390_brainsci14121245 crossref_primary_10_1016_j_neuropsychologia_2018_09_002 crossref_primary_10_1016_j_bbr_2021_113660 crossref_primary_10_1016_j_yhbeh_2023_105374 crossref_primary_10_1016_j_appet_2021_105834 crossref_primary_10_1016_j_physbeh_2019_03_026 crossref_primary_10_1007_s12529_018_9750_z crossref_primary_10_1016_j_cobeha_2018_06_012 crossref_primary_10_1177_02698811241261022 crossref_primary_10_3390_nu16070949 crossref_primary_10_26559_mersinsbd_687364 crossref_primary_10_1038_s41386_021_01052_z crossref_primary_10_1038_s41467_020_16882_6 crossref_primary_10_1016_j_bbr_2019_01_007 crossref_primary_10_1097_FBP_0000000000000553 crossref_primary_10_1021_acschemneuro_8b00601 crossref_primary_10_1111_adb_12735 crossref_primary_10_23736_S1824_4785_19_03216_3 crossref_primary_10_1016_j_appet_2024_107768 crossref_primary_10_1016_j_rechem_2024_101489 crossref_primary_10_3390_nu12113563 crossref_primary_10_3390_cells11203262 crossref_primary_10_1021_acs_biochem_1c00656 crossref_primary_10_1002_kjm2_12454 crossref_primary_10_1038_s41574_023_00871_y crossref_primary_10_1371_journal_pone_0259860 crossref_primary_10_3390_app12147240 crossref_primary_10_1021_acssensors_3c02042 crossref_primary_10_1080_09540261_2023_2189951 crossref_primary_10_1007_s11154_021_09701_w crossref_primary_10_1016_j_neubiorev_2021_02_033 crossref_primary_10_3280_PU2022_003001 crossref_primary_10_3389_fimmu_2024_1423263 crossref_primary_10_1002_brb3_1222 crossref_primary_10_1111_adb_12967 crossref_primary_10_1007_s00213_024_06570_4 crossref_primary_10_1016_j_molmet_2021_101163 crossref_primary_10_1002_jcpy_1221 crossref_primary_10_1016_j_neuropharm_2025_110320 crossref_primary_10_3390_medicina61010017 crossref_primary_10_1007_s11154_022_09711_2 crossref_primary_10_1016_j_addicn_2023_100126 crossref_primary_10_1016_j_pharmthera_2019_107417 crossref_primary_10_1038_s41386_021_01249_2 crossref_primary_10_1002_cne_24572 crossref_primary_10_1038_s41467_020_20041_2 crossref_primary_10_1038_s41598_020_78083_x crossref_primary_10_1016_j_physbeh_2022_114049 crossref_primary_10_1113_JP283915 crossref_primary_10_1016_j_brs_2024_02_001 crossref_primary_10_1016_j_physbeh_2024_114523 crossref_primary_10_1016_j_crphys_2024_100125 crossref_primary_10_1038_s41583_021_00465_5 crossref_primary_10_1021_acschemneuro_0c00336 crossref_primary_10_1016_j_electacta_2020_137013 crossref_primary_10_3389_fpsyg_2018_02639 crossref_primary_10_1016_j_neubiorev_2022_104821 crossref_primary_10_3390_ijms23147503 crossref_primary_10_1016_j_physbeh_2018_07_016 crossref_primary_10_1016_j_physbeh_2023_114111 crossref_primary_10_1017_S003329171900312X crossref_primary_10_1016_j_neubiorev_2019_04_023 crossref_primary_10_1093_ijnp_pyad056 crossref_primary_10_1016_j_bbr_2021_113613 crossref_primary_10_1111_adb_12826 crossref_primary_10_1016_j_neubiorev_2021_02_018 crossref_primary_10_1038_s41593_022_01228_w crossref_primary_10_1111_add_15062 crossref_primary_10_3389_fpsyt_2022_813507 crossref_primary_10_1016_j_phyplu_2020_100007 crossref_primary_10_1016_j_pnpbp_2023_110806 crossref_primary_10_1017_S2040174421000039 crossref_primary_10_3389_fpsyg_2018_02523 crossref_primary_10_1017_S0140525X23002753 crossref_primary_10_1016_j_jns_2020_116733 crossref_primary_10_3389_fnbeh_2021_821680 crossref_primary_10_1016_j_cogsys_2022_11_001 crossref_primary_10_1214_21_AOAS1574 crossref_primary_10_1016_j_neuron_2024_06_004 crossref_primary_10_3390_healthcare10091659 crossref_primary_10_1007_s11356_023_31093_4 crossref_primary_10_54108_10086 crossref_primary_10_1017_S003329172000402X crossref_primary_10_54108_10085 crossref_primary_10_1017_S0140525X22002047 crossref_primary_10_1038_s41398_022_01807_2 crossref_primary_10_1111_bph_17325 crossref_primary_10_7554_eLife_89766 crossref_primary_10_1186_s40337_024_01170_1 crossref_primary_10_1038_s41398_021_01548_8 crossref_primary_10_3389_fnmol_2022_874080 crossref_primary_10_3389_fnins_2020_594818 crossref_primary_10_1016_j_neuropharm_2018_01_035 crossref_primary_10_1016_j_lfs_2024_123290 crossref_primary_10_3390_nu11092086 crossref_primary_10_1007_s00702_024_02766_2 crossref_primary_10_1016_j_carbon_2022_07_007 crossref_primary_10_12688_f1000research_18883_1 crossref_primary_10_1007_s40429_022_00443_6 crossref_primary_10_1007_s11064_024_04256_z crossref_primary_10_1016_S2352_4642_19_30404_3 crossref_primary_10_3390_ijerph182111529 crossref_primary_10_1016_j_molmet_2021_101366 crossref_primary_10_1016_j_pneurobio_2024_102630 crossref_primary_10_1111_jnc_15141 crossref_primary_10_3390_ijms24119574 crossref_primary_10_1016_j_appet_2018_07_034 crossref_primary_10_3389_fphar_2022_819470 crossref_primary_10_1021_acschemneuro_4c00297 crossref_primary_10_1360_TB_2024_0576 crossref_primary_10_1038_s41598_019_38846_7 crossref_primary_10_1007_s40263_018_0596_3 crossref_primary_10_1111_bcpt_13776 crossref_primary_10_1007_s00702_023_02713_7 crossref_primary_10_1007_s40429_020_00312_0 crossref_primary_10_1016_j_alcohol_2021_02_004 crossref_primary_10_1007_s12640_022_00545_z crossref_primary_10_3389_fncir_2021_752420 crossref_primary_10_3389_fphar_2020_608887 crossref_primary_10_1111_adb_13201 crossref_primary_10_1038_s41380_023_02025_y crossref_primary_10_2174_1570159X23666241107160840 crossref_primary_10_3389_fncel_2021_798464 crossref_primary_10_54033_cadpedv22n5_049 crossref_primary_10_3389_fphar_2020_00057 crossref_primary_10_1097_NMD_0000000000000860 crossref_primary_10_3389_fpsyt_2020_609874 crossref_primary_10_1016_j_appet_2022_106146 crossref_primary_10_1016_j_neulet_2018_09_043 crossref_primary_10_1186_s40337_022_00531_y crossref_primary_10_1038_s42003_023_04545_3 crossref_primary_10_1016_j_drugalcdep_2020_108063 crossref_primary_10_1016_j_pnpbp_2025_111295 crossref_primary_10_1016_j_neuropharm_2018_01_013 crossref_primary_10_1007_s11481_020_09963_2 crossref_primary_10_1016_j_elecom_2021_107089 crossref_primary_10_3390_jpm12122015 crossref_primary_10_1186_s12889_021_10160_w crossref_primary_10_2174_1385272824666200204121746 crossref_primary_10_3390_brainsci12091212 crossref_primary_10_1016_j_cobeha_2018_12_002 crossref_primary_10_1007_s11910_022_01218_2 crossref_primary_10_1016_j_rmr_2018_12_001 crossref_primary_10_1038_s41467_023_41972_6 crossref_primary_10_1111_ajad_13210 crossref_primary_10_3389_fpsyt_2019_00626 crossref_primary_10_1172_jci_insight_126283 crossref_primary_10_7759_cureus_61643 crossref_primary_10_1016_j_pharmthera_2018_11_005 crossref_primary_10_1016_j_conctc_2024_101414 crossref_primary_10_1021_acs_inorgchem_3c03189 crossref_primary_10_3389_fpsyt_2023_1148993 crossref_primary_10_1210_clinem_dgac043 crossref_primary_10_3390_ijms22052728 crossref_primary_10_1093_ijnp_pyab049 crossref_primary_10_1111_jne_12812 crossref_primary_10_1016_j_bbr_2019_112348 crossref_primary_10_1038_s42255_022_00557_1 crossref_primary_10_1016_j_psyneuen_2021_105148 crossref_primary_10_1111_ppc_13082 crossref_primary_10_1016_j_psyneuen_2022_105667 crossref_primary_10_1016_j_cej_2024_155715 crossref_primary_10_17714_gumusfenbil_562555 crossref_primary_10_3389_fnhum_2019_00044 crossref_primary_10_1017_S003329172100430X crossref_primary_10_1038_s41467_021_26209_8 crossref_primary_10_3390_brainsci13091259 crossref_primary_10_1038_s41380_021_01273_0 crossref_primary_10_1038_s42003_025_07837_y crossref_primary_10_3389_fpsyt_2018_00545 crossref_primary_10_1016_j_abrep_2025_100596 crossref_primary_10_1016_j_celrep_2023_113669 crossref_primary_10_1186_s40168_023_01526_w crossref_primary_10_1038_s41380_023_02131_x crossref_primary_10_3389_fpsyg_2024_1441184 crossref_primary_10_1038_s41598_019_52062_3 crossref_primary_10_1016_j_physbeh_2019_112730 crossref_primary_10_1152_physiol_00043_2020 crossref_primary_10_1590_2237_6089_2018_0089 crossref_primary_10_3390_ijms25105293 crossref_primary_10_1016_j_neurol_2024_09_004 crossref_primary_10_1016_j_jemermed_2020_04_025 crossref_primary_10_1038_s41398_019_0449_y crossref_primary_10_3390_ijms24119773 crossref_primary_10_1148_radiol_2019181012 crossref_primary_10_1007_s00148_025_01077_4 crossref_primary_10_1016_j_bbr_2024_115401 crossref_primary_10_1016_j_gene_2020_144569 crossref_primary_10_1016_j_ijlp_2024_102034 crossref_primary_10_1007_s00213_021_05890_z crossref_primary_10_1007_s40263_019_00664_w crossref_primary_10_4103_NRR_NRR_D_24_00607 crossref_primary_10_1007_s00278_020_00483_1 crossref_primary_10_1016_j_neubiorev_2022_104757 crossref_primary_10_1111_obr_13392 crossref_primary_10_22201_fpsi_20074719e_2018_3_02 crossref_primary_10_1111_adb_12682 crossref_primary_10_3389_fpsyt_2020_00531 crossref_primary_10_3390_nu14245248 crossref_primary_10_7554_eLife_86183 crossref_primary_10_1016_j_neulet_2022_136588 crossref_primary_10_1111_ejn_14648 crossref_primary_10_1523_JNEUROSCI_0848_23_2023 crossref_primary_10_1371_journal_pone_0307967 crossref_primary_10_1097_NMD_0000000000001644 crossref_primary_10_21706_ptt_25_4_302 crossref_primary_10_1007_s11481_019_09843_4 crossref_primary_10_1080_14659891_2024_2413844 crossref_primary_10_1556_2006_2020_00073 crossref_primary_10_1016_j_neuroscience_2021_05_022 crossref_primary_10_1371_journal_pcbi_1009371 crossref_primary_10_1186_s40359_021_00712_5 crossref_primary_10_1016_j_ebiom_2020_103066 crossref_primary_10_1016_j_neuron_2021_09_041 crossref_primary_10_1038_s41467_019_11399_z crossref_primary_10_1007_s43440_023_00472_6 crossref_primary_10_1016_j_neuroscience_2023_08_019 crossref_primary_10_3390_nu12102937 crossref_primary_10_1038_s41593_022_01246_8 crossref_primary_10_3390_molecules25132998 crossref_primary_10_3390_nu15061416 crossref_primary_10_1016_j_ibneur_2022_05_002 crossref_primary_10_1016_j_pnpbp_2023_110768 crossref_primary_10_1080_00952990_2020_1841784 crossref_primary_10_3389_fpsyt_2023_1231760 crossref_primary_10_1186_s40795_023_00717_w crossref_primary_10_1021_jacs_3c08256 crossref_primary_10_3389_fnbeh_2018_00206 crossref_primary_10_1038_s41398_021_01414_7 crossref_primary_10_1007_s11682_018_9929_6 crossref_primary_10_1016_j_bbr_2022_114055 crossref_primary_10_1016_j_celrep_2023_112553 crossref_primary_10_3389_fpsyg_2024_1346839 crossref_primary_10_1016_j_jhepr_2024_101250 crossref_primary_10_1038_s41431_020_00726_4 crossref_primary_10_1016_j_physbeh_2022_113896 crossref_primary_10_3389_fnsyn_2021_660218 crossref_primary_10_1039_C8NR05046E crossref_primary_10_1016_j_neulet_2019_134367 crossref_primary_10_1007_s11695_024_07214_4 crossref_primary_10_1016_j_brs_2021_10_386 crossref_primary_10_1016_j_nlm_2023_107865 crossref_primary_10_1016_j_appet_2019_104553 crossref_primary_10_1002_prp2_855 crossref_primary_10_1111_jcpp_13961 crossref_primary_10_1038_s41366_021_00918_y crossref_primary_10_1111_jnc_15309 crossref_primary_10_1016_j_neuropharm_2021_108725 crossref_primary_10_1177_0361684320987126 crossref_primary_10_1093_psyrad_kkac021 crossref_primary_10_3389_fnbeh_2021_725856 crossref_primary_10_1002_ar_24732 crossref_primary_10_1016_j_neuropharm_2020_108350 crossref_primary_10_1038_s41386_021_01090_7 crossref_primary_10_1038_s41467_024_54819_5 crossref_primary_10_1177_14550725231206011 crossref_primary_10_1124_jpet_119_258004 crossref_primary_10_1016_j_bbr_2023_114612 crossref_primary_10_1007_s13668_019_0269_y crossref_primary_10_1002_oby_23978 crossref_primary_10_3389_fnbeh_2021_674169 crossref_primary_10_1016_j_neuropharm_2021_108518 crossref_primary_10_4158_EP_2018_0316 crossref_primary_10_1111_add_16626 crossref_primary_10_1038_s41598_020_79929_0 crossref_primary_10_1038_s41598_021_88363_9 crossref_primary_10_3390_nu15051095 crossref_primary_10_1016_j_bbr_2023_114841 crossref_primary_10_1038_s41380_022_01438_5 crossref_primary_10_1038_s41386_024_01803_8 crossref_primary_10_1080_13548506_2023_2190990 crossref_primary_10_1016_j_foodres_2023_113206 crossref_primary_10_1007_s40429_024_00588_6 crossref_primary_10_20964_2019_10_32 crossref_primary_10_1101_sqb_2018_83_037457 crossref_primary_10_1111_bcpt_70004 crossref_primary_10_1007_s00702_021_02450_9 crossref_primary_10_1007_s12272_024_01491_4 crossref_primary_10_1016_j_neuron_2019_05_050 crossref_primary_10_30773_pi_2024_0122 crossref_primary_10_1016_j_addbeh_2022_107599 crossref_primary_10_3390_ijms24054346 crossref_primary_10_1371_journal_pone_0233915 crossref_primary_10_1007_s00702_018_1840_1 crossref_primary_10_1016_j_lfs_2022_120633 crossref_primary_10_1124_jpet_118_255976 crossref_primary_10_1016_j_appet_2022_106308 crossref_primary_10_1016_j_nut_2018_09_004 crossref_primary_10_3390_bs11100128 crossref_primary_10_1016_S2215_0366_20_30264_9 crossref_primary_10_1016_j_jand_2022_04_015 crossref_primary_10_1038_s41598_021_99456_w crossref_primary_10_1111_bph_15677 crossref_primary_10_1016_j_yhbeh_2025_105697 crossref_primary_10_1007_s00213_024_06576_y crossref_primary_10_1080_1028415X_2019_1651104 crossref_primary_10_1093_brain_awac445 crossref_primary_10_1002_oby_23834 crossref_primary_10_1186_s13041_021_00739_0 crossref_primary_10_1124_jpet_119_259390 crossref_primary_10_1007_s40429_020_00293_0 crossref_primary_10_1016_j_dadr_2021_100008 crossref_primary_10_1038_s41598_019_56125_3 crossref_primary_10_3389_fnbeh_2023_1240748 crossref_primary_10_1128_cmr_00045_23 crossref_primary_10_1007_s00394_021_02613_0 crossref_primary_10_1007_s11356_019_05977_3 crossref_primary_10_1017_SJP_2024_16 crossref_primary_10_52965_001c_125273 crossref_primary_10_1016_j_appet_2018_10_009 crossref_primary_10_1038_s41398_019_0421_x crossref_primary_10_3389_fnins_2021_701919 crossref_primary_10_1371_journal_pone_0234601 crossref_primary_10_1016_j_neuropharm_2024_109866 crossref_primary_10_1016_j_neuroimage_2018_09_058 crossref_primary_10_1111_ejn_14581 crossref_primary_10_1016_j_biopsych_2018_09_010 crossref_primary_10_1124_jpet_119_258699 crossref_primary_10_1016_j_jacc_2019_04_043 crossref_primary_10_1017_S0954579419000671 crossref_primary_10_1111_adb_13264 crossref_primary_10_1007_s13738_022_02711_8 crossref_primary_10_1016_j_physbeh_2020_113183 crossref_primary_10_1016_j_neuropharm_2022_108948 crossref_primary_10_1101_cshperspect_a039255 crossref_primary_10_3389_fendo_2022_877647 crossref_primary_10_1021_acsmedchemlett_9b00050 crossref_primary_10_1177_00048674231165201 crossref_primary_10_1523_ENEURO_0394_19_2019 crossref_primary_10_1111_ejn_14352 crossref_primary_10_3389_fnut_2022_964491 crossref_primary_10_1016_j_neubiorev_2018_07_003 crossref_primary_10_1093_ijnp_pyz044 crossref_primary_10_1523_JNEUROSCI_1918_20_2021 crossref_primary_10_1523_JNEUROSCI_0894_20_2020 crossref_primary_10_3389_fpubh_2024_1414110 crossref_primary_10_1002_oby_23418 crossref_primary_10_1149_1945_7111_aba159 crossref_primary_10_1016_j_euroneuro_2019_02_001 crossref_primary_10_1139_cjpp_2021_0318 crossref_primary_10_1016_j_celrep_2024_114509 crossref_primary_10_1016_j_neubiorev_2020_11_004 crossref_primary_10_4062_biomolther_2020_123 crossref_primary_10_1016_j_neubiorev_2020_11_003 crossref_primary_10_3389_fpsyt_2018_00475 crossref_primary_10_3390_brainsci10050262 crossref_primary_10_1523_JNEUROSCI_2550_20_2021 crossref_primary_10_1016_j_neuropharm_2024_109971 crossref_primary_10_1038_s41366_024_01685_2 crossref_primary_10_1016_j_physbeh_2020_113152 crossref_primary_10_1016_j_neuropharm_2023_109457 crossref_primary_10_1523_ENEURO_0461_19_2020 crossref_primary_10_1016_j_appet_2021_105248 crossref_primary_10_1111_obr_12799 crossref_primary_10_1155_2018_8061389 crossref_primary_10_1016_j_cmet_2018_12_006 crossref_primary_10_1111_acer_70041 crossref_primary_10_3389_fpsyt_2018_00369 crossref_primary_10_7717_peerj_13500 crossref_primary_10_1016_j_neubiorev_2021_07_035 crossref_primary_10_1038_s41598_021_83116_0 crossref_primary_10_1038_s41398_022_01988_w crossref_primary_10_1016_j_neuropharm_2020_108005 crossref_primary_10_1016_j_neuropharm_2020_108368 crossref_primary_10_1021_acs_inorgchem_2c02810 crossref_primary_10_1093_cercor_bhab190 crossref_primary_10_1080_1354750X_2022_2087002 crossref_primary_10_3389_fphys_2022_882176 crossref_primary_10_1111_ejn_15223 crossref_primary_10_26599_SAB_2020_9060009 crossref_primary_10_47836_mjmhs_20_6_21 crossref_primary_10_1002_arcp_1098 crossref_primary_10_1038_s41598_024_53076_2 crossref_primary_10_1016_j_jnutbio_2024_109784 crossref_primary_10_1016_j_neuropharm_2020_108374 crossref_primary_10_1016_j_appet_2021_105115 crossref_primary_10_1007_s40519_020_00858_y crossref_primary_10_1016_j_appet_2021_105597 crossref_primary_10_1111_add_15869 crossref_primary_10_1038_s41467_021_22430_7 crossref_primary_10_1016_j_cub_2023_12_046 crossref_primary_10_1152_physrev_00014_2018 crossref_primary_10_1016_j_mcn_2018_04_001 crossref_primary_10_1016_j_nicl_2021_102825 crossref_primary_10_17816_RCF20129_54 crossref_primary_10_3389_fphys_2019_00421 crossref_primary_10_1016_j_physbeh_2020_113014 crossref_primary_10_1177_0269881120965912 crossref_primary_10_1016_j_neuint_2020_104882 crossref_primary_10_3389_fnins_2021_675061 crossref_primary_10_1007_s40429_022_00417_8 crossref_primary_10_1016_S1636_5410_20_44305_3 crossref_primary_10_3390_nu13041234 crossref_primary_10_1016_j_appet_2019_05_015 crossref_primary_10_3389_fnbeh_2020_601111 crossref_primary_10_1007_s11469_022_00934_7 crossref_primary_10_1016_j_physbeh_2022_113804 crossref_primary_10_1016_j_tics_2023_02_003 crossref_primary_10_1126_sciadv_abo1440 crossref_primary_10_1016_j_ypmed_2020_106176 crossref_primary_10_3390_brainsci13101480 crossref_primary_10_1016_j_cub_2020_09_011 crossref_primary_10_1021_acschemneuro_9b00109 crossref_primary_10_1016_j_compbiomed_2019_103466 crossref_primary_10_3389_fphys_2019_00555 crossref_primary_10_1016_j_diamond_2024_111540 crossref_primary_10_1016_j_addbeh_2021_106941 crossref_primary_10_1016_j_brainres_2019_146441 crossref_primary_10_1172_JCI185102 crossref_primary_10_1109_TSMC_2021_3073216 crossref_primary_10_1073_pnas_2106648118 crossref_primary_10_1126_sciadv_adq5652 crossref_primary_10_1016_j_physbeh_2020_113018 crossref_primary_10_1016_j_neures_2020_07_002 crossref_primary_10_1016_S1634_7358_21_45047_3 crossref_primary_10_1080_23808993_2021_1994186 crossref_primary_10_1016_j_euroneuro_2019_09_708 crossref_primary_10_1080_17405629_2020_1816166 crossref_primary_10_1007_s10865_023_00453_3 crossref_primary_10_3389_fnut_2022_838177 crossref_primary_10_1155_2024_2298306 crossref_primary_10_3389_fnhum_2024_1308549 crossref_primary_10_3390_genes14122113 crossref_primary_10_1007_s12640_019_00146_3 crossref_primary_10_1016_j_bbi_2021_11_003 crossref_primary_10_1016_j_jshs_2019_07_004 crossref_primary_10_1017_S0140525X23002960 crossref_primary_10_1016_j_physbeh_2024_114562 crossref_primary_10_3390_biomedicines11112993 crossref_primary_10_1525_collabra_150 crossref_primary_10_1111_ner_13348 crossref_primary_10_1016_j_expneurol_2022_114230 crossref_primary_10_1016_j_tem_2019_03_001 crossref_primary_10_1111_ejn_14163 crossref_primary_10_3389_fncir_2020_00039 crossref_primary_10_3390_cancers12113232 crossref_primary_10_1002_oby_22358 crossref_primary_10_1111_ejn_14160 crossref_primary_10_3390_brainsci12040486 crossref_primary_10_1007_s40429_019_00240_8 crossref_primary_10_3390_bs11050060 crossref_primary_10_1038_s41467_024_45035_2 crossref_primary_10_3389_fpsyt_2023_1307732 crossref_primary_10_1177_00030651211057041 crossref_primary_10_1038_s41386_022_01422_1 crossref_primary_10_1016_j_neuroimage_2023_120421 crossref_primary_10_1097_FBP_0000000000000424 crossref_primary_10_1016_j_bbr_2021_113139 crossref_primary_10_1016_j_neuroscience_2019_11_002 crossref_primary_10_1038_s41386_019_0457_x crossref_primary_10_1038_s41386_020_0686_z crossref_primary_10_1038_s41593_021_00828_2 crossref_primary_10_3389_fpsyt_2022_1014447 crossref_primary_10_1038_s41598_021_98590_9 crossref_primary_10_3389_fanim_2023_1127575 crossref_primary_10_3389_fnins_2021_782786 crossref_primary_10_1007_s11695_019_03822_7 crossref_primary_10_1016_j_pnpbp_2019_01_017 crossref_primary_10_1038_s41598_021_90266_8 crossref_primary_10_1088_2043_6262_ac5d44 crossref_primary_10_1016_j_cobeha_2021_04_021 crossref_primary_10_1097_FBP_0000000000000538 crossref_primary_10_1016_j_chemosphere_2021_132640 crossref_primary_10_1038_s42255_024_01157_x crossref_primary_10_1038_s44319_023_00024_2 crossref_primary_10_2139_ssrn_4590938 crossref_primary_10_1172_JCI164799 crossref_primary_10_1002_jeab_747 crossref_primary_10_3174_ajnr_A7707 crossref_primary_10_1002_wcs_1562 crossref_primary_10_1038_s41366_019_0360_x crossref_primary_10_1016_j_nicl_2021_102870 crossref_primary_10_1016_j_nicl_2020_102350 crossref_primary_10_1080_1354750X_2022_2049367 crossref_primary_10_53394_akd_1059563 crossref_primary_10_1016_j_cobeha_2018_01_025 crossref_primary_10_1016_j_biopsych_2022_09_033 crossref_primary_10_1002_erv_2621 crossref_primary_10_1172_jci_insight_181339 crossref_primary_10_1007_s12264_021_00756_y crossref_primary_10_1038_s41467_024_48780_6 crossref_primary_10_1021_acschemneuro_8b00437 crossref_primary_10_1242_dmm_042200 crossref_primary_10_3390_ijerph18020615 crossref_primary_10_1111_jfbc_12731 crossref_primary_10_3390_brainsci9110300 crossref_primary_10_46813_2019_121_053 crossref_primary_10_1016_j_pbb_2019_06_005 crossref_primary_10_1007_s00213_019_05370_5 crossref_primary_10_1016_j_cobeha_2022_101224 crossref_primary_10_1016_j_neubiorev_2019_12_025 crossref_primary_10_1124_pharmrev_120_000144 crossref_primary_10_3390_brainsci12070913 crossref_primary_10_1080_15622975_2022_2039408 crossref_primary_10_1016_j_jneumeth_2020_108968 crossref_primary_10_3389_fpsyg_2024_1387288 crossref_primary_10_1038_s41366_021_00929_9 crossref_primary_10_1002_erv_2652 crossref_primary_10_3390_jcm12134296 crossref_primary_10_1016_j_jbiotec_2020_07_016 crossref_primary_10_47115_jshs_1016105 crossref_primary_10_3390_molecules25051175 crossref_primary_10_1016_j_pscychresns_2021_111430 crossref_primary_10_3389_fnmol_2018_00175 crossref_primary_10_1002_erv_2645 crossref_primary_10_1038_s41386_018_0243_1 crossref_primary_10_1080_1028415X_2019_1639306 crossref_primary_10_3390_nu17030369 crossref_primary_10_1002_lim2_54 crossref_primary_10_1016_j_celrep_2022_110500 crossref_primary_10_1159_000530804 crossref_primary_10_3390_ani13213368 crossref_primary_10_1097_FBP_0000000000000740 crossref_primary_10_1016_j_neulet_2021_135984 crossref_primary_10_1002_ana_25581 crossref_primary_10_1371_journal_pone_0190206 crossref_primary_10_3389_fnut_2024_1437526 crossref_primary_10_3389_fpsyg_2024_1416222 crossref_primary_10_1002_wps_21073 crossref_primary_10_1007_s00213_019_05318_9 crossref_primary_10_1016_j_brs_2019_12_028 crossref_primary_10_1016_j_drugalcdep_2020_107854 crossref_primary_10_1016_j_addbeh_2020_106534 crossref_primary_10_1016_j_addbeh_2021_106956 crossref_primary_10_1002_mds_29334 crossref_primary_10_1016_j_neuroscience_2024_11_005 crossref_primary_10_1038_s41593_024_01819_9 crossref_primary_10_1007_s00204_021_02980_x crossref_primary_10_1007_s11481_020_09927_6 crossref_primary_10_1007_s12144_023_04384_9 crossref_primary_10_1016_j_neuroscience_2021_09_016
Cites_doi	10.1523/JNEUROSCI.3133-07.2007 10.1016/j.brs.2012.06.008 10.1007/s00213-013-3041-9 10.1055/s-0036-1582055 10.1016/j.conb.2012.11.012 10.1111/adb.12401 10.1038/nn1105-1442 10.1016/j.molmet.2013.10.001 10.1176/appi.ajp.160.6.1078 10.1016/j.neuroscience.2014.04.026 10.1007/s00213-016-4409-4 10.1111/ejn.13117 10.1523/JNEUROSCI.0694-08.2008 10.1080/13556210500314527 10.1038/npp.2016.19 10.1038/nn1103 10.1186/2191-219X-1-37 10.1111/cob.12183 10.1523/JNEUROSCI.2588-12.2013 10.1523/JNEUROSCI.2344-15.2015 10.1038/mp.2016.44 10.1007/978-3-540-88955-7_13 10.1016/0014-2999(77)90070-X 10.1016/j.tins.2007.03.003 10.1038/npp.2014.149 10.1002/syn.21809 10.1016/0195-6663(91)90021-J 10.1111/j.1471-4159.1992.tb09298.x 10.1016/j.neuropharm.2013.04.025 10.1016/j.neuron.2008.01.032 10.1038/nn.4173 10.1016/j.neuroscience.2014.07.034 10.1111/j.1369-1600.2004.tb00535.x 10.1038/ijo.2009.73 10.1016/S0893-133X(96)00184-4 10.1080/08870446.2012.751106 10.1016/S0006-8993(02)04087-8 10.1016/j.neuron.2006.08.023 10.1016/j.biopsych.2010.03.026 10.1016/j.neuron.2016.04.035 10.1523/JNEUROSCI.0809-13.2013 10.1111/j.1749-6632.1998.tb08222.x 10.1146/annurev-neuro-061010-113641 10.1016/j.euroneuro.2015.11.011 10.1016/j.neuroimage.2014.12.073 10.1523/JNEUROSCI.23-28-09395.2003 10.1073/pnas.1010076108 10.1126/science.1239275 10.1177/0269881114531664 10.1016/j.bbr.2016.11.020 10.1016/j.physbeh.2014.04.017 10.1176/appi.ajp.158.12.2015 10.1038/nn.2519 10.1016/j.brainres.2005.08.053 10.1038/npp.2011.303 10.1007/s00429-013-0601-z 10.1038/npp.2008.235 10.1021/acschemneuro.6b00413 10.1093/brain/124.9.1720 10.1016/j.ebiom.2016.09.029 10.1002/cpt.402 10.1038/nn.3100 10.1016/j.neulet.2017.01.055 10.3389/fpsyt.2011.00023 10.1016/j.addbeh.2009.10.017 10.1016/j.tips.2015.01.002 10.1016/j.conb.2013.01.002 10.12688/f1000research.9180.1 10.1101/lm.043539.116 10.1523/JNEUROSCI.1894-10.2010 10.1038/nn.4068 10.1152/jn.1998.80.1.1 10.3389/fpsyt.2016.00133 10.1001/archpsyc.63.9.999 10.1037/a0013600 10.1038/srep35455 10.1002/erv.2256 10.1007/s00213-016-4231-z 10.1515/RNS.2011.055 10.1016/j.neuropharm.2013.03.019 10.1038/mp.2013.57 10.1016/S0006-3223(01)01081-2 10.1016/j.neuron.2010.05.011 10.1038/nrn2234 10.1073/pnas.1605548113 10.1016/j.physbeh.2017.03.019 10.3389/fnhum.2016.00514 10.1001/jama.2013.278344 10.1113/JP271946 10.1523/JNEUROSCI.4153-14.2015 10.1038/npp.2015.230 10.1016/j.biopsych.2013.01.032 10.1210/en.2005-0973 10.1111/bph.12639 10.1016/j.neuron.2009.05.011 10.1038/ijo.2016.163 10.1523/JNEUROSCI.0955-05.2005 10.1016/j.euroneuro.2012.04.009 10.1002/oby.20397 10.1111/adb.12314 10.1007/s11011-016-9917-8 10.1016/j.psyneuen.2009.09.005 10.1111/acer.13199 10.1016/j.neuroscience.2015.06.033 10.1016/j.cmet.2011.06.016 10.1007/BF02246140 10.1016/j.physbeh.2011.04.041 10.1016/j.neuroscience.2010.03.034 10.1523/JNEUROSCI.19-14-06102.1999 10.1016/j.neuroscience.2011.02.016 10.1016/j.psyneuen.2014.07.018 10.1016/j.neuron.2010.11.022 10.1016/j.coph.2009.09.008 10.1088/1741-2560/13/4/041002 10.1038/nature11270 10.1038/mp.2014.58 10.1124/jpet.115.228833 10.1111/j.1530-0277.2010.01339.x 10.1046/j.1471-4159.2002.01005.x 10.1016/j.tics.2015.06.007 10.1038/nature11552 10.1523/JNEUROSCI.2338-16.2016 10.1016/j.pharmthera.2016.10.015 10.1111/adb.12295 10.1038/nn.3321 10.1093/brain/awu277 10.1038/tp.2016.14 10.1038/nrn.2016.165 10.1002/syn.20755 10.1038/nature11846 10.1016/S0896-6273(01)00319-1 10.1523/JNEUROSCI.0045-12.2012 10.1210/me.2005-0084 10.1371/journal.pone.0083741 10.1016/j.neuron.2011.10.019 10.1111/j.1460-9568.2008.06397.x 10.1002/erv.2399 10.1016/j.mcn.2014.08.001 10.1056/NEJMra1511480 10.1126/science.1188472 10.1016/j.pbb.2010.10.004 10.1016/j.neuroimage.2008.06.002 10.1038/oby.2002.66 10.1159/000338163 10.1016/S0092-8674(00)80949-6 10.1016/j.neuropharm.2013.05.024 10.1016/j.brainresbull.2015.08.003 10.4088/PCC.v07n0305 10.1021/ac200143v 10.1098/rstb.2008.0107 10.1016/j.tins.2004.06.006 10.1016/j.tins.2009.06.004 10.1523/JNEUROSCI.0925-05.2005 10.1523/JNEUROSCI.14-10-06084.1994 10.1016/j.bandc.2016.04.004 10.1016/j.neuroimage.2012.10.035 10.1002/syn.890140210 10.1016/j.physbeh.2015.06.013 10.1016/j.biopsych.2010.08.002 10.1016/j.neuron.2005.04.036 10.1007/s40263-014-0178-y 10.1002/syn.21501 10.1016/j.physbeh.2011.04.063 10.1016/j.nicl.2015.03.016 10.1016/j.neuron.2011.10.038 10.1007/s11695-009-0015-4 10.1093/cercor/10.3.318 10.1007/s11481-016-9680-y 10.1196/annals.1417.003 10.1016/j.bbr.2011.03.064 10.1016/j.molmet.2012.07.003 10.1523/JNEUROSCI.4861-12.2014 10.1038/nn1455 10.1016/S0140-6736(00)03643-6 10.1371/journal.pone.0101350 10.1038/npp.2015.358 10.1080/09595230601036960 10.1016/j.neuron.2017.02.029 10.3389/fendo.2012.00169 10.1080/08039488.2016.1176252 10.1038/nn.3743 10.1038/nature06995 10.1073/pnas.1404323111 10.1523/JNEUROSCI.2369-11.2011 10.1176/appi.ajp.162.8.1414 10.1038/385165a0 10.1016/j.cell.2015.07.046 10.1016/j.cmet.2015.10.009 10.1016/j.tins.2006.08.002 10.1016/j.yfrne.2015.07.001 10.1016/j.cub.2016.02.036 10.1523/JNEUROSCI.4461-11.2012 10.3945/ajcn.113.075481 10.1111/adb.12287 10.1002/syn.10000 10.1038/tp.2016.223 10.1038/nrendo.2016.150 10.1016/j.tips.2013.08.001 10.1007/s40263-016-0373-0 10.1371/journal.pone.0101585 10.1007/s12640-010-9176-0 10.1139/cjpp-2014-0188 10.1038/ijo.2012.128 10.3390/brainsci6030021 10.1016/j.celrep.2015.06.062 10.1002/syn.10075 10.1002/hbm.22617 10.1523/JNEUROSCI.1935-13.2013 10.1038/nrn1406 10.1523/JNEUROSCI.4744-14.2015 10.1523/JNEUROSCI.2105-10.2010 10.1038/oby.2011.57 10.1001/jama.2012.6147 10.1038/mp.2010.97 10.3389/fnbeh.2016.00066 10.1124/pr.114.009514 10.1016/0306-4522(89)90168-1 10.1073/pnas.0813415106 10.1016/j.brainresrev.2010.02.002 10.1098/rstb.2008.0089 10.1016/j.jpsychires.2004.11.005 10.3389/fcimb.2016.00015 10.1038/tp.2016.86 10.1038/nn.4313 10.3109/10409238.2012.735642 10.1016/j.neuint.2013.10.003 10.1016/j.pneurobio.2009.05.003 10.1016/j.tins.2015.04.002 10.2337/dc11-2250 10.1038/nrn4004 10.1038/npp.2017.126
ContentType	Journal Article
Copyright	Springer Nature Limited 2017 COPYRIGHT 2017 Nature Publishing Group Copyright Nature Publishing Group Dec 2017
Copyright_xml	– notice: Springer Nature Limited 2017 – notice: COPYRIGHT 2017 Nature Publishing Group – notice: Copyright Nature Publishing Group Dec 2017
DBID	AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QG 7QP 7QR 7RV 7TK 7TM 7X7 7XB 88E 88G 8AO 8FD 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ HCIFZ K9. KB0 LK8 M0S M1P M2M M7P NAPCQ P64 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PSYQQ Q9U RC3 7X8
DOI	10.1038/nrn.2017.130
DatabaseName	CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Animal Behavior Abstracts Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Nursing & Allied Health Database Neurosciences Abstracts Nucleic Acids Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Psychology Database (Alumni) ProQuest Pharma Collection Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection Proquest Central Natural Science Collection ProQuest One Community College ProQuest Central Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Biological Sciences ProQuest Health & Medical Collection PML(ProQuest Medical Library) Psychology Database Biological Science Database Nursing & Allied Health Premium Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic Genetics Abstracts MEDLINE - Academic
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Psychology ProQuest Central Student ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China ProQuest One Applied & Life Sciences Health Research Premium Collection Natural Science Collection Health & Medical Research Collection Biological Science Collection Chemoreception Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) Technology Research Database ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Central Basic ProQuest Nursing & Allied Health Source ProQuest Psychology Journals (Alumni) ProQuest SciTech Collection ProQuest Medical Library ProQuest Psychology Journals Animal Behavior Abstracts ProQuest Central (Alumni) MEDLINE - Academic
DatabaseTitleList	MEDLINE - Academic ProQuest One Psychology MEDLINE
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	1471-0048 1469-3178
EndPage	752
ExternalDocumentID	A514571872 29142296 10_1038_nrn_2017_130
Genre	Journal Article Review
GroupedDBID	--- .55 0R~ 123 29M 36B 39C 3V. 4.4 53G 70F 7RV 7X7 88E 8AO 8FI 8FJ 8R4 8R5 AAEEF AARCD AAWYQ AAYZH AAZLF ABAWZ ABDBF ABIVO ABJNI ABLJU ABNNU ABUWG ACGFS ACIWK ACPRK ACRPL ACUHS ADBBV ADNMO AENEX AFBBN AFKRA AFSHS AGAYW AGGDT AGHTU AHBCP AHMBA AHOSX AHSBF AIBTJ AIYXT ALFFA ALIPV ALMA_UNASSIGNED_HOLDINGS ARMCB ASPBG AVWKF AXYYD AZFZN AZQEC B0M BBNVY BENPR BHPHI BKEYQ BKKNO BPHCQ BVXVI CCPQU CS3 DB5 DU5 DWQXO EAD EAP EBS EE. EJD EMB EMK EMOBN EPL EPS ESX EX3 EXGXG F5P FEDTE FQGFK FSGXE FYUFA GNUQQ HCIFZ HMCUK HVGLF HZ~ IAO IGS IHR INH INR IPY ITC L-9 M1P M2M M7P N9A NAPCQ NNMJJ O9- ODYON P2P PQQKQ PROAC PSQYO PSYQQ Q2X RIG RNR RNT RNTTT SHXYY SIXXV SNYQT SOJ SV3 TAOOD TBHMF TDRGL TSG TUS UKHRP WOW X7M ~8M AAYXX ACSTC AETEA AFANA ALPWD ATHPR CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM PMFND 7QG 7QP 7QR 7TK 7TM 7XB 8FD 8FE 8FH 8FK FR3 K9. LK8 P64 PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS Q9U RC3 7X8
ID	FETCH-LOGICAL-c450t-b4702a61c31972a4ac1c00a35ec8cfe2b700030974fdcb8242ed5ad001308a223
IEDL.DBID	7X7
ISSN	1471-003X 1471-0048
IngestDate	Fri Jul 11 11:31:25 EDT 2025 Fri Jul 25 09:00:33 EDT 2025 Tue Jun 17 21:48:53 EDT 2025 Tue Jun 10 20:42:18 EDT 2025 Thu Apr 03 07:02:14 EDT 2025 Tue Jul 01 00:42:04 EDT 2025 Thu Apr 24 22:54:33 EDT 2025 Fri Feb 21 02:38:37 EST 2025
IsPeerReviewed	true
IsScholarly	true
Issue	12
Language	English
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c450t-b4702a61c31972a4ac1c00a35ec8cfe2b700030974fdcb8242ed5ad001308a223
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23
PMID	29142296
PQID	1978442581
PQPubID	44265
PageCount	12
ParticipantIDs	proquest_miscellaneous_1965245065 proquest_journals_1978442581 gale_infotracmisc_A514571872 gale_infotracacademiconefile_A514571872 pubmed_primary_29142296 crossref_primary_10_1038_nrn_2017_130 crossref_citationtrail_10_1038_nrn_2017_130 springer_journals_10_1038_nrn_2017_130
ProviderPackageCode	CITATION AAYXX
PublicationCentury	2000
PublicationDate	2017-12-01
PublicationDateYYYYMMDD	2017-12-01
PublicationDate_xml	– month: 12 year: 2017 text: 2017-12-01 day: 01
PublicationDecade	2010
PublicationPlace	London
PublicationPlace_xml	– name: London – name: England
PublicationTitle	Nature reviews. Neuroscience
PublicationTitleAbbrev	Nat Rev Neurosci
PublicationTitleAlternate	Nat Rev Neurosci
PublicationYear	2017
Publisher	Nature Publishing Group UK Nature Publishing Group
Publisher_xml	– name: Nature Publishing Group UK – name: Nature Publishing Group
References	Rapuano (CR128) 2017; 114 Justinova, Panlilio, Goldberg (CR149) 2009; 1 Volkow (CR107) 1993; 14 Koob, Everitt, Robbins (CR51) 2008 Lobo (CR216) 2010; 330 Hnasko, Sotak, Palmiter (CR14) 2007; 27 Guiraud (CR165) 2016; 13 Rothman, Elmer, Shippenberg, Rea, Baumann (CR226) 1998; 844 Wightman, Robinson (CR59) 2002; 82 Kiraly (CR177) 2016; 6 Yager, Garcia, Wunsch, Ferguson (CR15) 2015; 301 Epel (CR96) 2014; 9 Dunn (CR109) 2012; 35 Befort (CR81) 2015; 6 Higgins, Sellers, Fletcher (CR227) 2013; 34 Vo, Rutledge, Chatterjee, Kable (CR19) 2014; 137 Wang (CR67) 2005; 25 Mooney (CR145) 2016; 100 Higgins (CR143) 2012; 37 Shen, Jiang, Liu, Wang, Ma (CR201) 2016; 6 al'Absi, Lemieux, Nakajima (CR209) 2014; 49 de Araujo (CR139) 2008; 57 Hyman (CR63) 2005; 162 Johnson, Kenny (CR89) 2010; 13 Cosgrove, Veldhuizen, Sandiego, Morris, Small (CR116) 2015; 69 Wang (CR131) 1997; 16 Volkow (CR171) 2012; 32 Wiers (CR173) 2016; 6 Ball, Combs, Beyer (CR84) 2011; 222 Stuber, Wightman, Carelli (CR2) 2005; 46 van de Giessen, Celik, Schweitzer, van den Brink, Booij (CR103) 2014; 28 Gramsch, Blasig, Herz (CR130) 1977; 44 Pfaffly (CR203) 2010; 64 Ren (CR78) 2010; 168 Franco (CR163) 2016; 6 Sorensen (CR207) 2015; 149 Svensson (CR151) 2013; 21 Gilbert-Diamond (CR127) 2017; 41 Carelli, West (CR119) 2014; 76 Bonnavion, Mickelsen, Fujita, de Lecea, Jackson (CR185) 2016; 594 Sinha, Jastreboff (CR137) 2013; 73 Skibicka, Hansson, Alvarez-Crespo, Friberg, Dickson (CR183) 2011; 180 Hong (CR225) 2016; 233 Howard, Li, Geddes, Jin (CR17) 2017; 93 Sinha, Li (CR112) 2007; 26 Wise (CR62) 1995; 120 Val-Laillet (CR157) 2015; 8 Cansell, Denis, Joly-Amado, Castel, Luquet (CR196) 2012; 3 Madhavan, Argilli, Bonci, Whistler (CR66) 2013; 33 Weygandt (CR113) 2015; 109 Verwey, Dhir, Amir (CR172) 2016; 5 Bromberg-Martin, Matsumoto, Hikosaka (CR23) 2010; 68 Jayasinghe, Chiavaroli, Holland, Cutfield, O'Sullivan (CR175) 2016; 6 Zweifel (CR27) 2009; 106 Billes, Simonds, Cowley (CR86) 2012; 1 Wang (CR200) 2014; 3 Kraus (CR221) 2004; 9 Fava (CR232) 2005; 7 Harnett, Bernier, Ahn, Morikawa (CR65) 2009; 62 Fan, Boston, Kesterson, Hruby, Cone (CR198) 1997; 385 Fortin, Roitman (CR235) 2017; 176 Gosnell, Levine (CR80) 2009; 33 Nair, Adams-Deutsch, Epstein, Shaham (CR64) 2009; 89 Vicente, Galvao-Ferreira, Tecuapetla, Costa (CR48) 2016; 26 Adams (CR88) 2015; 42 Stice, Spoor, Bohon, Veldhuizen, Small (CR125) 2008; 117 Kiefer (CR204) 2001; 49 Hommel (CR180) 2006; 51 Reddy (CR236) 2016; 6 Saddoris, Cacciapaglia, Wightman, Carelli (CR32) 2015; 35 Yau, Potenza (CR138) 2013; 38 Colantuoni (CR133) 2002; 10 Wing (CR160) 2013; 6 Trifilieff (CR26) 2013; 18 Vallof (CR147) 2016; 21 Sun (CR61) 2014; 136 Wise (CR16) 2009; 32 Parsons, Hurd (CR10) 2015; 16 Tellez (CR91) 2013; 341 Zhou, Zhao, Zhou, Li (CR168) 2016; 40 King (CR150) 2012; 307 McClelland, Bozhilova, Campbell, Schmidt (CR164) 2013; 21 Steffen, Engel, Wonderlich, Pollert, Sondag (CR155) 2015; 23 Mancino, Mendonça-Netto, García, Maldonado (CR75) 2016; 22 Cabrera (CR234) 2016; 11 Atasoy, Betley, Su, Sternson (CR197) 2012; 488 Tang, Posner, Rothbart, Volkow (CR8) 2015; 19 von der Goltz (CR220) 2010; 35 Courtney, Schacht, Hutchison, Roche, Ray (CR124) 2016; 21 Keithley (CR58) 2011; 83 Huerta-Ocampo, Mena-Segovia, Bolam (CR38) 2014; 219 Fiorentini, Busi, Spano, Missale (CR43) 2010; 10 Ferre (CR42) 2015; 36 Borgland, Storm, Bonci (CR187) 2008; 28 Volkow, Koob, McLellan (CR97) 2016; 374 Kravitz, O'Neal, Friend (CR169) 2016; 10 Hahn, Swanson (CR184) 2010; 64 Sorensen, Caine, Thomsen (CR237) 2016; 40 Hillemacher (CR222) 2005; 10 Volkow, Wang, Tomasi, Baler (CR52) 2013; 23 Labouebe (CR182) 2013; 16 Wilcox (CR146) 2010; 35 Palmiter (CR13) 2008; 1129 Volkow (CR95) 2002; 44 Ball (CR85) 2016; 21 Gerfen, Surmeier (CR39) 2011; 34 Appelhans (CR6) 2011; 19 Graziane (CR70) 2016; 19 Nieh (CR186) 2016; 90 Engen, Green, Voigt, Forsyth, Keshavarzian (CR176) 2015; 37 Peciña, Cagniard, Berridge, Aldridge, Zhuang (CR11) 2003; 23 Lammel, Lim, Malenka (CR29) 2014; 76 Fetissov (CR212) 2017; 13 Volkow, Baler (CR3) 2015; 38 Aguiar-Nemer, Toffolo, da Silva, Laranjeira, Silva-Fonseca (CR205) 2013; 5 Tarter (CR99) 2003; 160 Guegan (CR77) 2013; 23 Karlsson (CR110) 2015; 35 de Witt Huberts, Evers, de Ridder (CR135) 2013; 28 Narayanaswami, Dwoskin (CR140) 2017; 170 Arenas (CR229) 2016; 233 Wang (CR102) 2001; 357 Corwin, Avena, Boggiano (CR9) 2011; 104 Kupchik (CR49) 2015; 18 Volkow, Wang, Fowler, Telang (CR5) 2008; 363 Wolf (CR217) 2010; 18 Nogueiras (CR79) 2012; 5 de Weijer (CR104) 2011; 1 Wang (CR115) 2014; 9 Parvaz, Alia-Klein, Woicik, Volkow, Goldstein (CR120) 2011; 22 Szczypka (CR94) 2001; 30 Collins, Gerak, Javors, France (CR141) 2016; 356 Small, Zatorre, Dagher, Evans, Jones-Gotman (CR60) 2001; 124 Martinez (CR111) 2009; 34 Tomasi, Volkow (CR114) 2013; 48 Carlucci, Petrof, Allen-Vercoe (CR174) 2016; 13 Marcellino, Kehr, Agnati, Fuxe (CR21) 2012; 66 Wang (CR36) 2011; 72 Kiefer (CR219) 2005; 39 Engel, Jerlhag (CR208) 2014; 28 Floresco, West, Ash, Moore, Grace (CR35) 2003; 6 Volkow (CR123) 2012; 32 Chen (CR170) 2017; 641 Vanderschuren, Di Ciano, Everitt (CR71) 2005; 25 Zhu, Ottenheimer, DiLeone (CR92) 2016; 10 Valenta (CR230) 2013; 228 Tomasi (CR4) 2015; 36 Danjo, Yoshimi, Funabiki, Yawata, Nakanishi (CR24) 2014; 111 Hamid (CR56) 2016; 19 Kern, Albarran-Zeckler, Walsh, Smith (CR211) 2012; 73 al'Absi (CR218) 2011; 97 Marinelli, McCutcheon (CR31) 2014; 282 Sotak, Hnasko, Robinson, Kremer, Palmiter (CR12) 2005; 1061 Volkow, Morales (CR53) 2015; 162 Schultz (CR1) 1998; 80 Kravitz, Tye, Kreitzer (CR44) 2012; 15 Drazen, Vahl, D'Alessio, Seeley, Woods (CR224) 2006; 147 Chen, Papies, Barsalou (CR54) 2016; 110 Kempadoo (CR189) 2013; 33 Proctor, Thiennimitr, Chattipakorn, Chattipakorn (CR214) 2017; 32 Neelakantan (CR142) 2017; 8 Steele (CR105) 2010; 20 Jauch-Chara (CR158) 2014; 100 Robinson, Zitzman, Williams (CR33) 2011; 2 Volkow (CR101) 2006; 63 Conrad (CR73) 2008; 454 Volkow (CR108) 2001; 158 Aboujaoude, Salame (CR233) 2016; 30 Wise (CR7) 2004; 5 Parsons, Justice (CR57) 1992; 58 Jiang, Betancourt, Smith (CR210) 2006; 20 Nakanishi, Hikida, Yawata (CR47) 2014; 282 Namburi, Al-Hasani, Calhoon, Bruchas, Tye (CR40) 2016; 41 Baver (CR199) 2014; 34 Koob (CR132) 2014; 76 You (CR202) 2016; 41 Muller (CR166) 2016; 49 Terraneo (CR162) 2016; 26 You, Wang, Zitzman, Wise (CR68) 2008; 28 Richfield, Penney, Young (CR22) 1989; 30 Wang (CR178) 2015; 12 Everitt (CR93) 2008; 363 Harris, Aston-Jones (CR190) 2006; 29 Grace, Floresco, Goto, Lodge (CR37) 2007; 30 Day, Jones, Wightman, Carelli (CR55) 2010; 68 Volkow (CR118) 2014; 19 Sakurai (CR192) 1998; 92 Calabresi, Picconi, Tozzi, Ghiglieri, Di Filippo (CR50) 2014; 17 Sheng, Santiago, Thomas, Routh (CR193) 2014; 62 Parkes, Bradfield, Balleine (CR18) 2015; 35 Gutierrez-Cuesta (CR76) 2014; 39 Volkow, Fowler (CR100) 2000; 10 Schultz (CR34) 2013; 23 Dreyer, Herrik, Berg, Hounsgaard (CR25) 2010; 30 Koob, Le Moal (CR129) 2005; 8 Cone (CR194) 2005; 8 Ascher (CR231) 1995; 56 Howell, Cunningham (CR144) 2015; 67 Volkow (CR122) 2011; 16 Burgess, Hassmen, Pumpa (CR167) 2017; 7 Cui (CR46) 2013; 494 Zheng (CR215) 2016; 21 Volkow (CR106) 2008; 42 Hikida, Kimura, Wada, Funabiki, Nakanishi (CR45) 2010; 66 Han (CR87) 2016; 23 CR82 Raebel (CR152) 2013; 310 Voorn, Vanderschuren, Groenewegen, Robbins, Pennartz (CR20) 2004; 27 Luo, Volkow, Heintz, Pan, Du (CR41) 2011; 31 Figlewicz, Evans, Murphy, Hoen, Baskin (CR181) 2003; 964 Pandit (CR195) 2016; 41 Baimel (CR191) 2015; 172 Volkow (CR126) 2010; 68 Ball, Best, Luo, Miller (CR83) 2017; 319 Polston (CR153) 2013; 8 Schiffer (CR228) 2001; 42 Park, Volkow, Pan, Du (CR74) 2013; 33 Garcia-Garcia (CR121) 2013; 66 Childs, DeLeon, Nickel, Kroener (CR159) 2017; 24 Garris, Ciolkowski, Pastore, Wightman (CR28) 1994; 14 Calabresi, Centonze, Gubellini, Marfia, Bernardi (CR69) 1999; 19 Kauer, Malenka (CR72) 2007; 8 Ferrario (CR179) 2016; 36 Morales, Margolis (CR30) 2017; 18 Fink-Jensen, Vilsboll (CR238) 2016; 70 Parylak, Koob, Zorrilla (CR134) 2011; 104 Hill, Weaver, Blundell (CR136) 1991; 17 Leinninger (CR188) 2011; 14 Stice, Yokum, Blum, Bohon (CR117) 2010; 30 Bolloni (CR156) 2016; 7 Moffitt (CR98) 2011; 108 Biegler, Freet, Horvath, Rogers, Hajnal (CR154) 2016; 123 Ceccanti (CR161) 2015; 93 Tremaroli, Backhed (CR213) 2012; 489 Reddy, Stanwood, Galli (CR206) 2014; 73 Cahill, Ussher (CR148) 2011; 3 van de Giessen (CR90) 2013; 37 Wilhelm (CR223) 2011; 35 ND Volkow (BFnrn2017130_CR107) 1993; 14 I Garcia-Garcia (BFnrn2017130_CR121) 2013; 66 C Cansell (BFnrn2017130_CR196) 2012; 3 DL Drazen (BFnrn2017130_CR224) 2006; 147 KE Steele (BFnrn2017130_CR105) 2010; 20 M Marinelli (BFnrn2017130_CR31) 2014; 282 AM Vicente (BFnrn2017130_CR48) 2016; 26 EA Cabrera (BFnrn2017130_CR234) 2016; 11 W Schultz (BFnrn2017130_CR1) 1998; 80 C Colantuoni (BFnrn2017130_CR133) 2002; 10 SL Parylak (BFnrn2017130_CR134) 2011; 104 E van de Giessen (BFnrn2017130_CR90) 2013; 37 GD Stuber (BFnrn2017130_CR2) 2005; 46 Z Luo (BFnrn2017130_CR41) 2011; 31 D Marcellino (BFnrn2017130_CR21) 2012; 66 PM Johnson (BFnrn2017130_CR89) 2010; 13 P Voorn (BFnrn2017130_CR20) 2004; 27 JA Engel (BFnrn2017130_CR208) 2014; 28 KL Conrad (BFnrn2017130_CR73) 2008; 454 E Burgess (BFnrn2017130_CR167) 2017; 7 K Vo (BFnrn2017130_CR19) 2014; 137 IA Reddy (BFnrn2017130_CR206) 2014; 73 ND Volkow (BFnrn2017130_CR171) 2012; 32 GT Collins (BFnrn2017130_CR141) 2016; 356 UJ Muller (BFnrn2017130_CR166) 2016; 49 P Zheng (BFnrn2017130_CR215) 2016; 21 RD Palmiter (BFnrn2017130_CR13) 2008; 1129 T Kraus (BFnrn2017130_CR221) 2004; 9 AJ Hill (BFnrn2017130_CR136) 1991; 17 KP Cosgrove (BFnrn2017130_CR116) 2015; 69 E Stice (BFnrn2017130_CR117) 2010; 30 ND Volkow (BFnrn2017130_CR52) 2013; 23 P Bonnavion (BFnrn2017130_CR185) 2016; 594 S Mancino (BFnrn2017130_CR75) 2016; 22 ND Volkow (BFnrn2017130_CR3) 2015; 38 ND Volkow (BFnrn2017130_CR126) 2010; 68 JD Hommel (BFnrn2017130_CR180) 2006; 51 BA Gosnell (BFnrn2017130_CR80) 2009; 33 KE Courtney (BFnrn2017130_CR124) 2016; 21 JA Ascher (BFnrn2017130_CR231) 1995; 56 JP Dunn (BFnrn2017130_CR109) 2012; 35 LM Yager (BFnrn2017130_CR15) 2015; 301 SB Floresco (BFnrn2017130_CR35) 2003; 6 CR Ferrario (BFnrn2017130_CR179) 2016; 36 W Schultz (BFnrn2017130_CR34) 2013; 23 M Verwey (BFnrn2017130_CR172) 2016; 5 MC Arenas (BFnrn2017130_CR229) 2016; 233 A Madhavan (BFnrn2017130_CR66) 2013; 33 ND Volkow (BFnrn2017130_CR100) 2000; 10 M al'Absi (BFnrn2017130_CR209) 2014; 49 J Wilhelm (BFnrn2017130_CR223) 2011; 35 ND Volkow (BFnrn2017130_CR97) 2016; 374 T Sakurai (BFnrn2017130_CR192) 1998; 92 Z Justinova (BFnrn2017130_CR149) 2009; 1 R Pandit (BFnrn2017130_CR195) 2016; 41 GJ Wang (BFnrn2017130_CR115) 2014; 9 CD Howard (BFnrn2017130_CR17) 2017; 93 D Tomasi (BFnrn2017130_CR114) 2013; 48 R Sinha (BFnrn2017130_CR112) 2007; 26 ND Volkow (BFnrn2017130_CR118) 2014; 19 W Chen (BFnrn2017130_CR170) 2017; 641 JJ Day (BFnrn2017130_CR55) 2010; 68 W Han (BFnrn2017130_CR87) 2016; 23 G Labouebe (BFnrn2017130_CR182) 2013; 16 SL Borgland (BFnrn2017130_CR187) 2008; 28 GF Koob (BFnrn2017130_CR51) 2008 T Guegan (BFnrn2017130_CR77) 2013; 23 SL Parkes (BFnrn2017130_CR18) 2015; 35 SO Fetissov (BFnrn2017130_CR212) 2017; 13 SI Hong (BFnrn2017130_CR225) 2016; 233 JP Valenta (BFnrn2017130_CR230) 2013; 228 XF Wang (BFnrn2017130_CR178) 2015; 12 ND Volkow (BFnrn2017130_CR95) 2002; 44 D Atasoy (BFnrn2017130_CR197) 2012; 488 JM Biegler (BFnrn2017130_CR154) 2016; 123 S Ferre (BFnrn2017130_CR42) 2015; 36 IA Reddy (BFnrn2017130_CR236) 2016; 6 T Hikida (BFnrn2017130_CR45) 2010; 66 SE Hyman (BFnrn2017130_CR63) 2005; 162 EH Nieh (BFnrn2017130_CR186) 2016; 90 D Gilbert-Diamond (BFnrn2017130_CR127) 2017; 41 Y Zhou (BFnrn2017130_CR168) 2016; 40 VC Wing (BFnrn2017130_CR160) 2013; 6 LJ Vanderschuren (BFnrn2017130_CR71) 2005; 25 ND Volkow (BFnrn2017130_CR106) 2008; 42 TS Hnasko (BFnrn2017130_CR14) 2007; 27 MP Saddoris (BFnrn2017130_CR32) 2015; 35 C Bolloni (BFnrn2017130_CR156) 2016; 7 CS Wilcox (BFnrn2017130_CR146) 2010; 35 MA Parvaz (BFnrn2017130_CR120) 2011; 22 RA Wise (BFnrn2017130_CR62) 1995; 120 JK Dreyer (BFnrn2017130_CR25) 2010; 30 RE Tarter (BFnrn2017130_CR99) 2003; 160 GA Higgins (BFnrn2017130_CR227) 2013; 34 KA Kempadoo (BFnrn2017130_CR189) 2013; 33 PA Svensson (BFnrn2017130_CR151) 2013; 21 GF Koob (BFnrn2017130_CR129) 2005; 8 PA Engen (BFnrn2017130_CR176) 2015; 37 RA Wise (BFnrn2017130_CR16) 2009; 32 LP Wang (BFnrn2017130_CR36) 2011; 72 C Gramsch (BFnrn2017130_CR130) 1977; 44 F Kiefer (BFnrn2017130_CR204) 2001; 49 K Befort (BFnrn2017130_CR81) 2015; 6 J Chen (BFnrn2017130_CR54) 2016; 110 P Calabresi (BFnrn2017130_CR69) 1999; 19 E Stice (BFnrn2017130_CR125) 2008; 117 BN Sotak (BFnrn2017130_CR12) 2005; 1061 Z Ren (BFnrn2017130_CR78) 2010; 168 J Pfaffly (BFnrn2017130_CR203) 2010; 64 SG Nair (BFnrn2017130_CR64) 2009; 89 LH Parsons (BFnrn2017130_CR57) 1992; 58 ME Mooney (BFnrn2017130_CR145) 2016; 100 IE de Araujo (BFnrn2017130_CR139) 2008; 57 P Trifilieff (BFnrn2017130_CR26) 2013; 18 JE Polston (BFnrn2017130_CR153) 2013; 8 WK Schiffer (BFnrn2017130_CR228) 2001; 42 X Sun (BFnrn2017130_CR61) 2014; 136 RM Carelli (BFnrn2017130_CR119) 2014; 76 S Nakanishi (BFnrn2017130_CR47) 2014; 282 BM Appelhans (BFnrn2017130_CR6) 2011; 19 RB Keithley (BFnrn2017130_CR58) 2011; 83 KT Ball (BFnrn2017130_CR84) 2011; 222 M Morales (BFnrn2017130_CR30) 2017; 18 S Peciña (BFnrn2017130_CR11) 2003; 23 C Proctor (BFnrn2017130_CR214) 2017; 32 LA Tellez (BFnrn2017130_CR91) 2013; 341 GJ Wang (BFnrn2017130_CR131) 1997; 16 EK Richfield (BFnrn2017130_CR22) 1989; 30 GJ Wang (BFnrn2017130_CR102) 2001; 357 R Nogueiras (BFnrn2017130_CR79) 2012; 5 DP Figlewicz (BFnrn2017130_CR181) 2003; 964 X Zhu (BFnrn2017130_CR92) 2016; 10 K Park (BFnrn2017130_CR74) 2013; 33 MS Szczypka (BFnrn2017130_CR94) 2001; 30 LH Parsons (BFnrn2017130_CR10) 2015; 16 KT Ball (BFnrn2017130_CR85) 2016; 21 TN Jayasinghe (BFnrn2017130_CR175) 2016; 6 WC King (BFnrn2017130_CR150) 2012; 307 W Fan (BFnrn2017130_CR198) 1997; 385 T Hillemacher (BFnrn2017130_CR222) 2005; 10 R Sinha (BFnrn2017130_CR137) 2013; 73 AA Hamid (BFnrn2017130_CR56) 2016; 19 I Huerta-Ocampo (BFnrn2017130_CR38) 2014; 219 JD Hahn (BFnrn2017130_CR184) 2010; 64 ZB You (BFnrn2017130_CR68) 2008; 28 KJ Steffen (BFnrn2017130_CR155) 2015; 23 ND Volkow (BFnrn2017130_CR123) 2012; 32 DM Small (BFnrn2017130_CR60) 2001; 124 RL Corwin (BFnrn2017130_CR9) 2011; 104 SK Billes (BFnrn2017130_CR86) 2012; 1 H Jiang (BFnrn2017130_CR210) 2006; 20 ME Wolf (BFnrn2017130_CR217) 2010; 18 LS Zweifel (BFnrn2017130_CR27) 2009; 106 BA de Weijer (BFnrn2017130_CR104) 2011; 1 DL Robinson (BFnrn2017130_CR33) 2011; 2 D Val-Laillet (BFnrn2017130_CR157) 2015; 8 ZB You (BFnrn2017130_CR202) 2016; 41 D Martinez (BFnrn2017130_CR111) 2009; 34 P Namburi (BFnrn2017130_CR40) 2016; 41 C von der Goltz (BFnrn2017130_CR220) 2010; 35 G Cui (BFnrn2017130_CR46) 2013; 494 D Vallof (BFnrn2017130_CR147) 2016; 21 S Lammel (BFnrn2017130_CR29) 2014; 76 M Ceccanti (BFnrn2017130_CR161) 2015; 93 AS Aguiar-Nemer (BFnrn2017130_CR205) 2013; 5 D Tomasi (BFnrn2017130_CR4) 2015; 36 J McClelland (BFnrn2017130_CR164) 2013; 21 F Kiefer (BFnrn2017130_CR219) 2005; 39 DD Kiraly (BFnrn2017130_CR177) 2016; 6 YM Kupchik (BFnrn2017130_CR49) 2015; 18 SM Fortin (BFnrn2017130_CR235) 2017; 176 K Cahill (BFnrn2017130_CR148) 2011; 3 R Franco (BFnrn2017130_CR163) 2016; 6 Q Wang (BFnrn2017130_CR200) 2014; 3 A Terraneo (BFnrn2017130_CR162) 2016; 26 WK Adams (BFnrn2017130_CR88) 2015; 42 G Sorensen (BFnrn2017130_CR237) 2016; 40 JA Kauer (BFnrn2017130_CR72) 2007; 8 E van de Giessen (BFnrn2017130_CR103) 2014; 28 AA Grace (BFnrn2017130_CR37) 2007; 30 BJ Everitt (BFnrn2017130_CR93) 2008; 363 LL Howell (BFnrn2017130_CR144) 2015; 67 C Fiorentini (BFnrn2017130_CR43) 2010; 10 NM Graziane (BFnrn2017130_CR70) 2016; 19 E Aboujaoude (BFnrn2017130_CR233) 2016; 30 PA Garris (BFnrn2017130_CR28) 1994; 14 M Fava (BFnrn2017130_CR232) 2005; 7 T Danjo (BFnrn2017130_CR24) 2014; 111 JE Childs (BFnrn2017130_CR159) 2017; 24 K Jauch-Chara (BFnrn2017130_CR158) 2014; 100 AV Kravitz (BFnrn2017130_CR44) 2012; 15 KM Rapuano (BFnrn2017130_CR128) 2017; 114 ND Volkow (BFnrn2017130_CR122) 2011; 16 RA Wise (BFnrn2017130_CR7) 2004; 5 ES Epel (BFnrn2017130_CR96) 2014; 9 C Baimel (BFnrn2017130_CR191) 2015; 172 Z Sheng (BFnrn2017130_CR193) 2014; 62 MT Harnett (BFnrn2017130_CR65) 2009; 62 M Weygandt (BFnrn2017130_CR113) 2015; 109 GF Koob (BFnrn2017130_CR132) 2014; 76 D Guiraud (BFnrn2017130_CR165) 2016; 13 ND Volkow (BFnrn2017130_CR53) 2015; 162 V Narayanaswami (BFnrn2017130_CR140) 2017; 170 M Shen (BFnrn2017130_CR201) 2016; 6 AV Kravitz (BFnrn2017130_CR169) 2016; 10 C Carlucci (BFnrn2017130_CR174) 2016; 13 G Sorensen (BFnrn2017130_CR207) 2015; 149 KP Skibicka (BFnrn2017130_CR183) 2011; 180 CR Gerfen (BFnrn2017130_CR39) 2011; 34 ND Volkow (BFnrn2017130_CR108) 2001; 158 MA Raebel (BFnrn2017130_CR152) 2013; 310 MK Lobo (BFnrn2017130_CR216) 2010; 330 RB Rothman (BFnrn2017130_CR226) 1998; 844 JC de Witt Huberts (BFnrn2017130_CR135) 2013; 28 BFnrn2017130_CR82 RD Cone (BFnrn2017130_CR194) 2005; 8 B Wang (BFnrn2017130_CR67) 2005; 25 GC Harris (BFnrn2017130_CR190) 2006; 29 V Tremaroli (BFnrn2017130_CR213) 2012; 489 TE Moffitt (BFnrn2017130_CR98) 2011; 108 GA Higgins (BFnrn2017130_CR143) 2012; 37 YH Yau (BFnrn2017130_CR138) 2013; 38 M al'Absi (BFnrn2017130_CR218) 2011; 97 A Fink-Jensen (BFnrn2017130_CR238) 2016; 70 YY Tang (BFnrn2017130_CR8) 2015; 19 ES Bromberg-Martin (BFnrn2017130_CR23) 2010; 68 A Kern (BFnrn2017130_CR211) 2012; 73 CE Wiers (BFnrn2017130_CR173) 2016; 6 GM Leinninger (BFnrn2017130_CR188) 2011; 14 ND Volkow (BFnrn2017130_CR101) 2006; 63 ND Volkow (BFnrn2017130_CR5) 2008; 363 RM Wightman (BFnrn2017130_CR59) 2002; 82 J Gutierrez-Cuesta (BFnrn2017130_CR76) 2014; 39 SB Baver (BFnrn2017130_CR199) 2014; 34 HK Karlsson (BFnrn2017130_CR110) 2015; 35 H Neelakantan (BFnrn2017130_CR142) 2017; 8 P Calabresi (BFnrn2017130_CR50) 2014; 17 KT Ball (BFnrn2017130_CR83) 2017; 319 26110109 - Neuroimage Clin. 2015 Mar 24;8:1-31 21473572 - Anal Chem. 2011 May 1;83(9):3563-71 18768696 - J Neurosci. 2008 Sep 3;28(36):9021-9 24140429 - Neurochem Int. 2014 Jul;73:49-55 19177067 - Neuropsychopharmacology. 2009 Jun;34(7):1774-82 12055324 - Obes Res. 2002 Jun;10(6):478-88 23832596 - Brain Struct Funct. 2014 Sep;219(5):1787-800 26954979 - Transl Psychiatry. 2016 Mar 08;6:e752 22809824 - Brain Stimul. 2013 May;6(3):221-30 24769227 - Neuroscience. 2014 Dec 12;282:49-59 25740524 - J Neurosci. 2015 Mar 4;35(9):3959-65 27401883 - CNS Drugs. 2016 Aug;30(8):719-33 27151395 - Nord J Psychiatry. 2016 Nov;70(8):561-2 18640910 - Philos Trans R Soc Lond B Biol Sci. 2008 Oct 12;363(1507):3125-35 2528080 - Neuroscience. 1989;30(3):767-77 11729018 - Am J Psychiatry. 2001 Dec;158(12 ):2015-21 22647302 - Obes Facts. 2012;5(2):196-207 23884939 - J Neurosci. 2013 Jul 24;33(30):12329-36 27980074 - Learn Mem. 2016 Dec 15;24(1):35-42 21104390 - Curr Top Behav Neurosci. 2009;1:309-46 24567905 - Mol Metab. 2013 Oct 17;3(1):64-72 18591467 - Ann N Y Acad Sci. 2008;1129:35-46 10407046 - J Neurosci. 1999 Jul 15;19(14):6102-10 27187231 - Transl Psychiatry. 2016 May 17;6:e809 28107783 - ACS Chem Neurosci. 2017 May 17;8(5):1065-1073 23103690 - Neuroimage. 2013 Feb 1;66:232-9 18640912 - Philos Trans R Soc Lond B Biol Sci. 2008 Oct 12;363(1507):3191-200 19555651 - Neuron. 2009 Jun 25;62(6):826-38 27709426 - Metab Brain Dis. 2017 Feb;32(1):1-17 26214370 - Nat Neurosci. 2015 Sep;18(9):1230-2 21907138 - Cell Metab. 2011 Sep 7;14(3):313-23 25099550 - Am J Clin Nutr. 2014 Oct;100(4):1003-9 25664726 - Synapse. 2015 Apr;69(4):195-202 25084048 - Neuroscience. 2014 Dec 12;282:176-97 9668665 - Ann N Y Acad Sci. 1998 May 30;844:59-74 22868829 - Int J Obes (Lond). 2013 May;37(5):754-7 27101941 - Addict Biol. 2017 Sep;22(5):1179-1190 22573693 - J Neurosci. 2012 May 9;32(19):6711-7 27616451 - Nat Rev Endocrinol. 2017 Jan;13(1):11-25 24912491 - Mol Psychiatry. 2014 Sep;19(9):1037-43 12897785 - Nat Neurosci. 2003 Sep;6(9):968-73 18003826 - J Neurosci. 2007 Nov 14;27(46):12484-8 14561867 - J Neurosci. 2003 Oct 15;23(28):9395-402 26852738 - Neuropsychopharmacology. 2016 Aug;41(9):2241-51 25142207 - Hum Brain Mapp. 2015 Jan;36(1):120-36 22284186 - Neuron. 2012 Jan 26;73(2):317-32 24979216 - PLoS One. 2014 Jun 30;9(6):e101350 20170674 - Brain Res Rev. 2010 Sep;64(1):14-103 20452572 - Biol Psychiatry. 2010 Aug 1;68(3):306-9 26243270 - Neuropsychopharmacology. 2016 Mar;41(4):1024-33 23293630 - Front Endocrinol (Lausanne). 2012 Dec 27;3:169 20947769 - Science. 2010 Oct 15;330(6002):385-90 25698968 - Front Pharmacol. 2015 Feb 05;6:6 7480530 - Psychopharmacology (Berl). 1995 Jul;120(1):10-20 27790107 - Front Hum Neurosci. 2016 Oct 14;10 :514 21469956 - Annu Rev Neurosci. 2011;34:441-66 15511715 - Addict Biol. 2004 Sep-Dec;9(3-4):213-9 22214469 - EJNMMI Res. 2011 Dec 16;1(1):37 11331086 - Biol Psychiatry. 2001 May 1;49(9):782-7 21549136 - Physiol Behav. 2011 Jul 25;104(1):87-97 27213949 - Clin Pharmacol Ther. 2016 Oct;100(4):344-52 16904760 - Trends Neurosci. 2006 Oct;29(10):571-7 28130186 - Neurosci Lett. 2017 Feb 22;641:56-61 22034017 - Synapse. 2012 Mar;66(3):196-203 24391816 - PLoS One. 2013 Dec 31;8(12):e83741 20962248 - J Neurosci. 2010 Oct 20;30(42):14273-83 26816013 - N Engl J Med. 2016 Jan 28;374(4):363-71 15271494 - Trends Neurosci. 2004 Aug;27(8):468-74 10731226 - Cereb Cortex. 2000 Mar;10(3):318-25 25904797 - J Neurosci. 2015 Apr 22;35(16):6464-71 27302606 - J Physiol. 2016 Nov 15;594(22):6443-6462 27067014 - Mol Psychiatry. 2016 Jun;21(6):786-96 25000285 - PLoS One. 2014 Jul 07;9(7):e101585 27994159 - Proc Natl Acad Sci U S A. 2017 Jan 3;114(1):160-165 24943644 - Neuropsychopharmacology. 2014 Dec;39(13):2974-88 19758714 - Trends Neurosci. 2009 Oct;32(10):517-24 27773782 - Pharmacol Ther. 2017 Feb;170:116-147 18367093 - Neuron. 2008 Mar 27;57(6):930-41 23711983 - Mol Psychiatry. 2013 Sep;18(9):1025-33 15944133 - Neuron. 2005 May 19;46(4):661-9 16953002 - Arch Gen Psychiatry. 2006 Sep;63(9):999-1008 8990120 - Nature. 1997 Jan 9;385(6612):165-8 27238864 - Neuron. 2016 Jun 15;90(6):1286-1298 25065439 - Nat Neurosci. 2014 Aug;17(8):1022-30 23541000 - Biol Psychiatry. 2013 May 1;73(9):827-35 19902317 - Obes Surg. 2010 Mar;20(3):369-74 21144997 - Neuron. 2010 Dec 9;68(5):815-34 8101394 - Synapse. 1993 Jun;14 (2):169-77 24741039 - J Neurosci. 2014 Apr 16;34(16):5486-96 15856065 - Nat Neurosci. 2005 May;8(5):571-8 15152198 - Nat Rev Neurosci. 2004 Jun;5(6):483-94 24024122 - Mol Metab. 2012 Jul 27;1(1-2):86-93 26595651 - Nat Neurosci. 2016 Jan;19(1):117-26 11210998 - Lancet. 2001 Feb 3;357(9253):354-7 23173916 - Crit Rev Biochem Mol Biol. 2013 Jan-Feb;48(1):1-19 26435524 - Addict Biol. 2016 Jan;21(1):3-22 22801496 - Nature. 2012 Aug 9;488(7410):172-7 17400299 - Trends Neurosci. 2007 May;30(5):220-7 23520203 - Obesity (Silver Spring). 2013 Dec;21(12):2444-51 12777265 - Am J Psychiatry. 2003 Jun;160(6):1078-85 26647973 - Neuropsychopharmacology. 2016 Jun;41(7):1697-715 20856250 - Mol Psychiatry. 2011 Nov;16(11):1147-54 23267662 - Curr Opin Neurobiol. 2013 Apr;23(2):229-38 16027765 - Prim Care Companion J Clin Psychiatry. 2005;7(3):106-13 16226228 - Brain Res. 2005 Nov 9;1061(2):88-96 26303264 - Addict Biol. 2016 Mar;21(2):422-37 27635233 - F1000Res. 2016 Aug 24;5:null 21475139 - Obesity (Silver Spring). 2011 Nov;19(11):2175-82 27145161 - Pharmacopsychiatry. 2016 Jul;49(4):170-3 26655188 - Eur Neuropsychopharmacol. 2016 Jan;26(1):37-44 22432117 - Diabetes Care. 2012 May;35(5):1105-11 26527415 - Eur J Neurosci. 2015 Dec;42(12 ):3095-104 16601073 - Mol Endocrinol. 2006 Aug;20(8):1772-85 21121933 - Alcohol Clin Exp Res. 2011 Feb;35(2):235-9 26072178 - Physiol Behav. 2015 Oct 1;149:262-8 27579999 - Alcohol Clin Exp Res. 2016 Oct;40(10 ):2247-2252 16982424 - Neuron. 2006 Sep 21;51(6):801-10 21262822 - Proc Natl Acad Sci U S A. 2011 Feb 15;108(7):2693-8 12573518 - Brain Res. 2003 Feb 21;964(1):107-15 11522575 - Brain. 2001 Sep;124(Pt 9):1720-33 20888455 - Biol Psychiatry. 2010 Oct 15;68(8):685-6 26290234 - J Neurosci. 2015 Aug 19;35(33):11572-82 27845229 - Behav Brain Res. 2017 Feb 15;319:1-8 26235449 - Trends Cogn Sci. 2015 Aug;19(8):439-44 11430814 - Neuron. 2001 Jun;30(3):819-28 16318955 - Addict Biol. 2005 Dec;10(4):337-43 23671541 - J Clin Med Res. 2013 Jun;5(3):164-7 22710289 - JAMA. 2012 Jun 20;307(23):2516-25 23434063 - Curr Opin Neurobiol. 2013 Aug;23(4):639-48 20881128 - J Neurosci. 2010 Sep 29;30(39):13105-9 28285820 - Neuron. 2017 Mar 22;93(6):1436-1450.e8 22117165 - Rev Neurosci. 2011;22(6):609-24 19828259 - Psychoneuroendocrinology. 2010 May;35(4):570-7 21412887 - Cochrane Database Syst Rev. 2011 Mar 16;(3):CD005353 26925392 - Front Cell Infect Microbiol. 2016 Feb 19;6:15 15930388 - J Neurosci. 2005 Jun 1;25(22):5389-96 27911750 - J Neurosci. 2016 Nov 9;36(45):11469-11481 18598772 - Neuroimage. 2008 Oct 1;42(4):1537-43 23578393 - Neuropharmacology. 2014 Jan;76 Pt B:351-9 19528981 - Int J Obes (Lond). 2009 Jun;33 Suppl 2:S54-8 25505168 - Pharmacol Rev. 2015;67(1):176-97 560969 - Eur J Pharmacol. 1977 Aug 1;44(3):231-40 19926400 - Addict Behav. 2010 Mar;35(3):229-34 27147989 - Front Behav Neurosci. 2016 Apr 12;10:66 22262882 - J Neurosci. 2012 Jan 18;32(3):841-9 27438859 - Brain Sci. 2016 Jul 18;6(3):null 9491897 - Cell. 1998 Feb 20;92(4):573-85 16251985 - Nat Neurosci. 2005 Nov;8(11):1442-4 25730614 - Can J Physiol Pharmacol. 2015 Apr;93(4):283-90 27184387 - J Neuroimmune Pharmacol. 2016 Sep;11(3):408-33 22196339 - Neuron. 2011 Dec 22;72(6):1055-66 28315693 - Physiol Behav. 2017 Jul 1;176:17-25 21629844 - Front Psychiatry. 2011 May 09;2:23 27239940 - Nat Neurosci. 2016 Jul;19(7):915-25 25107627 - Mol Cell Neurosci. 2014 Sep;62:30-41 27654143 - Int J Obes (Lond). 2017 Jan;41(1):23-29 26304761 - Brain Res Bull. 2016 May;123:47-52 1727431 - J Neurochem. 1992 Jan;58(1):212-8 21917801 - J Neurosci. 2011 Sep 14;31(37):13180-90 25704194 - Trends Pharmacol Sci. 2015 Mar;36(3):145-52 23503684 - Psychopharmacology (Berl). 2013 Aug;228(3):389-400 21557958 - Physiol Behav. 2011 Jul 25;104(1):149-56 27156016 - Brain Cogn. 2016 Dec;110:20-42 26116518 - Neuroscience. 2015 Aug 20;301:529-41 25127083 - Psychoneuroendocrinology. 2014 Nov;49:253-9 12358778 - J Neurochem. 2002 Aug;82(4):721-35 26212334 - Cell Rep. 2015 Aug 4;12(5):726-33 26534942 - J Pharmacol Exp Ther. 2016 Jan;356(1):85-95 26887589 - Psychopharmacology (Berl). 2016 Apr;233(8):1405-13 18500330 - Nature. 2008 Jul 3;454(7200):118-21 27351347 - J Neural Eng. 2016 Aug;13(4):041002 22580057 - Eur Neuropsychopharmacol. 2013 Mar;23(3):240-52 27551268 - Front Psychiatry. 2016 Aug 08;7:133 24641197 - Br J Pharmacol. 2015 Jan;172(2):334-48 28053327 - Nat Rev Neurosci. 2017 Feb;18(2):73-85 23639430 - Neuropharmacology. 2014 Jan;76 Pt B:360-9 23747571 - Neuropharmacology. 2014 Jan;76 Pt B:370-82 24089490 - J Neurosci. 2013 Oct 2;33(40):15827-36 17364833 - Drug Alcohol Rev. 2007 Jan;26(1):25-31 24041919 - Trends Pharmacol Sci. 2013 Oct;34(10):560-70 24126546 - Minerva Endocrinol. 2013 Sep;38(3):255-67 18793323 - Eur J Neurosci. 2008 Oct;28(8):1545-56 7665537 - J Clin Psychiatry. 1995 Sep;56(9):395-401 20348917 - Nat Neurosci. 2010 May;13(5):635-41 19837631 - Curr Opin Pharmacol. 2010 Feb;10(1):87-92 26182835 - Front Neuroendocrinol. 2016 Jan;40:24-41 9015800 - Neuropsychopharmacology. 1997 Feb;16(2):174-82 27720396 - EBioMedicine. 2016 Nov;13:37-45 1799281 - Appetite. 1991 Dec;17(3):187-97 28296261 - Clin Obes. 2017 Jun;7(3):123-135 19497349 - Prog Neurobiol. 2009 Sep;89(1):18-45 22189292 - Neuropsychopharmacology. 2012 Apr;37(5):1177-91 23950538 - Science. 2013 Aug 16;341(6147):800-2 28653666 - Neuropsychopharmacology. 2017 Jun 27;:null 23637156 - J Neurosci. 2013 May 1;33(18):7618-26 26698915 - Cell Metab. 2016 Jan 12;23 (1):103-12 19342487 - Proc Natl Acad Sci U S A. 2009 May 5;106(18):7281-8 16177034 - J Neurosci. 2005 Sep 21;25(38):8665-70 20361291 - Neurotox Res. 2010 Nov;18(3-4):393-409 25273995 - Brain. 2014 Dec;137(Pt 12):3129-35 16055762 - Am J Psychiatry. 2005 Aug;162(8):1414-22 19025237 - J Abnorm Psychol. 2008 Nov;117(4):924-35 25576647 - Neuroimage. 2015 Apr 1;109:318-27 27922639 - Transl Psychia
References_xml	– volume: 27 start-page: 12484 year: 2007 end-page: 12488 ident: CR14 article-title: Cocaine-conditioned place preference by dopamine-deficient mice is mediated by serotonin publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.3133-07.2007 – volume: 6 start-page: 221 year: 2013 end-page: 230 ident: CR160 article-title: Brain stimulation methods to treat tobacco addiction publication-title: Brain Stimul. doi: 10.1016/j.brs.2012.06.008 – volume: 228 start-page: 389 year: 2013 end-page: 400 ident: CR230 article-title: μ-Opioid receptors in the stimulation of mesolimbic dopamine activity by ethanol and morphine in Long-Evans rats: a delayed effect of ethanol publication-title: Psychopharmacology doi: 10.1007/s00213-013-3041-9 – volume: 49 start-page: 170 year: 2016 end-page: 173 ident: CR166 article-title: Nucleus accumbens deep brain stimulation for alcohol addiction — safety and clinical long-term results of a pilot trial publication-title: Pharmacopsychiatry doi: 10.1055/s-0036-1582055 – volume: 23 start-page: 229 year: 2013 end-page: 238 ident: CR34 article-title: Updating dopamine reward signals publication-title: Curr. Opin. Neurobiol. doi: 10.1016/j.conb.2012.11.012 – volume: 22 start-page: 1179 year: 2016 end-page: 1190 ident: CR75 article-title: Role of DOR in neuronal plasticity changes promoted by food-seeking behaviour publication-title: Addict. Biol. doi: 10.1111/adb.12401 – volume: 8 start-page: 1442 year: 2005 end-page: 1444 ident: CR129 article-title: Plasticity of reward neurocircuitry and the 'dark side' of drug addiction publication-title: Nat. Neurosci. doi: 10.1038/nn1105-1442 – volume: 3 start-page: 64 year: 2014 end-page: 72 ident: CR200 article-title: Arcuate AgRP neurons mediate orexigenic and glucoregulatory actions of ghrelin publication-title: Mol. Metab. doi: 10.1016/j.molmet.2013.10.001 – volume: 160 start-page: 1078 year: 2003 end-page: 1085 ident: CR99 article-title: Neurobehavioral disinhibition in childhood predicts early age at onset of substance use disorder publication-title: Am. J. Psychiatry doi: 10.1176/appi.ajp.160.6.1078 – volume: 37 start-page: 223 year: 2015 end-page: 236 ident: CR176 article-title: The gastrointestinal microbiome: alcohol effects on the composition of intestinal microbiota publication-title: Alcohol Res. – volume: 282 start-page: 49 year: 2014 end-page: 59 ident: CR47 article-title: Distinct dopaminergic control of the direct and indirect pathways in reward-based and avoidance learning behaviors publication-title: Neuroscience doi: 10.1016/j.neuroscience.2014.04.026 – volume: 233 start-page: 3849 year: 2016 end-page: 3859 ident: CR229 article-title: Topiramate increases the rewarding properties of cocaine in young-adult mice limiting its clinical usefulness publication-title: Psychopharmacology doi: 10.1007/s00213-016-4409-4 – volume: 42 start-page: 3095 year: 2015 end-page: 3104 ident: CR88 article-title: Long-term, calorie-restricted intake of a high-fat diet in rats reduces impulse control and ventral striatal D2 receptor signalling — two markers of addiction vulnerability publication-title: Eur. J. Neurosci. doi: 10.1111/ejn.13117 – volume: 28 start-page: 9021 year: 2008 end-page: 9029 ident: CR68 article-title: Acetylcholine release in the mesocorticolimbic dopamine system during cocaine seeking: conditioned and unconditioned contributions to reward and motivation publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.0694-08.2008 – volume: 10 start-page: 337 year: 2005 end-page: 343 ident: CR222 article-title: Alteration of prolactin serum levels during alcohol withdrawal correlates with craving in female patients publication-title: Addict. Biol. doi: 10.1080/13556210500314527 – volume: 41 start-page: 2241 year: 2016 end-page: 2251 ident: CR195 article-title: Melanocortin 3 receptor signaling in midbrain dopamine neurons increases the motivation for food reward publication-title: Neuropsychopharmacology doi: 10.1038/npp.2016.19 – volume: 6 start-page: 968 year: 2003 end-page: 973 ident: CR35 article-title: Afferent modulation of dopamine neuron firing differentially regulates tonic and phasic dopamine transmission publication-title: Nat. Neurosci. doi: 10.1038/nn1103 – volume: 1 start-page: 37 year: 2011 ident: CR104 article-title: Lower striatal dopamine D receptor availability in obese compared with non-obese subjects publication-title: EJNMMI Res. doi: 10.1186/2191-219X-1-37 – volume: 7 start-page: 123 year: 2017 end-page: 135 ident: CR167 article-title: Determinants of adherence to lifestyle intervention in adults with obesity: a systematic review publication-title: Clin. Obes. doi: 10.1111/cob.12183 – volume: 33 start-page: 7618 year: 2013 end-page: 7626 ident: CR189 article-title: Hypothalamic neurotensin projections promote reward by enhancing glutamate transmission in the VTA publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.2588-12.2013 – volume: 35 start-page: 11572 year: 2015 end-page: 11582 ident: CR32 article-title: Differential dopamine release dynamics in the nucleus accumbens core and shell reveal complementary signals for error prediction and incentive motivation publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.2344-15.2015 – volume: 21 start-page: 786 year: 2016 end-page: 796 ident: CR215 article-title: Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host's metabolism publication-title: Mol. Psychiatry doi: 10.1038/mp.2016.44 – volume: 1 start-page: 309 year: 2009 end-page: 346 ident: CR149 article-title: Drug addiction publication-title: Curr. Top. Behav. Neurosci. doi: 10.1007/978-3-540-88955-7_13 – volume: 44 start-page: 231 year: 1977 end-page: 240 ident: CR130 article-title: Changes in striatal dopamine metabolism during precipitated morphine withdrawal publication-title: Eur. J. Pharmacol. doi: 10.1016/0014-2999(77)90070-X – volume: 30 start-page: 220 year: 2007 end-page: 227 ident: CR37 article-title: Regulation of firing of dopaminergic neurons and control of goal-directed behaviors publication-title: Trends Neurosci. doi: 10.1016/j.tins.2007.03.003 – volume: 39 start-page: 2974 year: 2014 end-page: 2988 ident: CR76 article-title: Effects of genetic deletion of endogenous opioid system components on the reinstatement of cocaine-seeking behavior in mice publication-title: Neuropsychopharmacology doi: 10.1038/npp.2014.149 – volume: 69 start-page: 195 year: 2015 end-page: 202 ident: CR116 article-title: Opposing relationships of BMI with BOLD and dopamine D2/3 receptor binding potential in the dorsal striatum publication-title: Synapse doi: 10.1002/syn.21809 – volume: 17 start-page: 187 year: 1991 end-page: 197 ident: CR136 article-title: Food craving, dietary restraint and mood publication-title: Appetite doi: 10.1016/0195-6663(91)90021-J – volume: 58 start-page: 212 year: 1992 end-page: 218 ident: CR57 article-title: Extracellular concentration and recovery of dopamine in the nucleus accumbens using microdialysis publication-title: J. Neurochem. doi: 10.1111/j.1471-4159.1992.tb09298.x – volume: 76 start-page: 360 year: 2014 end-page: 369 ident: CR119 article-title: When a good taste turns bad: neural mechanisms underlying the emergence of negative affect and associated natural reward devaluation by cocaine publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2013.04.025 – volume: 57 start-page: 930 year: 2008 end-page: 941 ident: CR139 article-title: Food reward in the absence of taste receptor signaling publication-title: Neuron doi: 10.1016/j.neuron.2008.01.032 – volume: 19 start-page: 117 year: 2016 end-page: 126 ident: CR56 article-title: Mesolimbic dopamine signals the value of work publication-title: Nat. Neurosci. doi: 10.1038/nn.4173 – volume: 282 start-page: 176 year: 2014 end-page: 197 ident: CR31 article-title: Heterogeneity of dopamine neuron activity across traits and states publication-title: Neuroscience doi: 10.1016/j.neuroscience.2014.07.034 – volume: 9 start-page: 213 year: 2004 end-page: 219 ident: CR221 article-title: Leptin is associated with craving in females with alcoholism publication-title: Addict. Biol. doi: 10.1111/j.1369-1600.2004.tb00535.x – volume: 33 start-page: S54 issue: Suppl. 2 year: 2009 end-page: S58 ident: CR80 article-title: Reward systems and food intake: role of opioids publication-title: Int. J. Obes. doi: 10.1038/ijo.2009.73 – volume: 16 start-page: 174 year: 1997 end-page: 182 ident: CR131 article-title: Dopamine D2 receptor availability in opiate-dependent subjects before and after naloxone-precipitated withdrawal publication-title: Neuropsychopharmacology doi: 10.1016/S0893-133X(96)00184-4 – volume: 28 start-page: 686 year: 2013 end-page: 700 ident: CR135 article-title: Double trouble: restrained eaters do not eat less and feel worse publication-title: Psychol. Health doi: 10.1080/08870446.2012.751106 – volume: 964 start-page: 107 year: 2003 end-page: 115 ident: CR181 article-title: Expression of receptors for insulin and leptin in the ventral tegmental area/substantia nigra (VTA/SN) of the rat publication-title: Brain Res. doi: 10.1016/S0006-8993(02)04087-8 – volume: 51 start-page: 801 year: 2006 end-page: 810 ident: CR180 article-title: Leptin receptor signaling in midbrain dopamine neurons regulates feeding publication-title: Neuron doi: 10.1016/j.neuron.2006.08.023 – volume: 68 start-page: 306 year: 2010 end-page: 309 ident: CR55 article-title: Phasic nucleus accumbens dopamine release encodes effort- and delay-related costs publication-title: Biol. Psychiatry doi: 10.1016/j.biopsych.2010.03.026 – volume: 90 start-page: 1286 year: 2016 end-page: 1298 ident: CR186 article-title: Inhibitory input from the lateral hypothalamus to the ventral tegmental area disinhibits dopamine neurons and promotes behavioral activation publication-title: Neuron doi: 10.1016/j.neuron.2016.04.035 – volume: 33 start-page: 12329 year: 2013 end-page: 12336 ident: CR66 article-title: Loss of D2 dopamine receptor function modulates cocaine-induced glutamatergic synaptic potentiation in the ventral tegmental area publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.0809-13.2013 – volume: 844 start-page: 59 year: 1998 end-page: 74 ident: CR226 article-title: Phentermine and fenfluramine. Preclinical studies in animal models of cocaine addiction publication-title: Ann. NY Acad. Sci. doi: 10.1111/j.1749-6632.1998.tb08222.x – volume: 34 start-page: 441 year: 2011 end-page: 466 ident: CR39 article-title: Modulation of striatal projection systems by dopamine publication-title: Annu. Rev. Neurosci. doi: 10.1146/annurev-neuro-061010-113641 – volume: 26 start-page: 37 year: 2016 end-page: 44 ident: CR162 article-title: Transcranial magnetic stimulation of dorsolateral prefrontal cortex reduces cocaine use: a pilot study publication-title: Eur. Neuropsychopharmacol. doi: 10.1016/j.euroneuro.2015.11.011 – volume: 109 start-page: 318 year: 2015 end-page: 327 ident: CR113 article-title: Impulse control in the dorsolateral prefrontal cortex counteracts post-diet weight regain in obesity publication-title: Neuroimage doi: 10.1016/j.neuroimage.2014.12.073 – volume: 23 start-page: 9395 year: 2003 end-page: 9402 ident: CR11 article-title: Hyperdopaminergic mutant mice have higher “wanting” but not “liking” for sweet rewards publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.23-28-09395.2003 – volume: 108 start-page: 2693 year: 2011 end-page: 2698 ident: CR98 article-title: A gradient of childhood self-control predicts health, wealth, and public safety publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1010076108 – volume: 341 start-page: 800 year: 2013 end-page: 802 ident: CR91 article-title: A gut lipid messenger links excess dietary fat to dopamine deficiency publication-title: Science doi: 10.1126/science.1239275 – volume: 28 start-page: 866 year: 2014 end-page: 873 ident: CR103 article-title: Dopamine D receptor availability and amphetamine-induced dopamine release in obesity publication-title: J. Psychopharmacol. doi: 10.1177/0269881114531664 – volume: 319 start-page: 1 year: 2017 end-page: 8 ident: CR83 article-title: Chronic restraint stress causes a delayed increase in responding for palatable food cues during forced abstinence via a dopamine D -like receptor-mediated mechanism publication-title: Behav. Brain Res. doi: 10.1016/j.bbr.2016.11.020 – volume: 136 start-page: 63 year: 2014 end-page: 73 ident: CR61 article-title: The neural signature of satiation is associated with ghrelin response and triglyceride metabolism publication-title: Physiol. Behav. doi: 10.1016/j.physbeh.2014.04.017 – volume: 158 start-page: 2015 year: 2001 end-page: 2021 ident: CR108 article-title: Low level of brain dopamine D receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex publication-title: Am. J. Psychiatry doi: 10.1176/appi.ajp.158.12.2015 – volume: 13 start-page: 635 year: 2010 end-page: 641 ident: CR89 article-title: Dopamine D2 receptors in addiction-like reward dysfunction and compulsive eating in obese rats publication-title: Nat. Neurosci. doi: 10.1038/nn.2519 – volume: 1061 start-page: 88 year: 2005 end-page: 96 ident: CR12 article-title: Dysregulation of dopamine signaling in the dorsal striatum inhibits feeding publication-title: Brain Res. doi: 10.1016/j.brainres.2005.08.053 – volume: 37 start-page: 1177 year: 2012 end-page: 1191 ident: CR143 article-title: The 5-HT receptor agonist lorcaserin reduces nicotine self-administration, discrimination, and reinstatement: relationship to feeding behavior and impulse control publication-title: Neuropsychopharmacology doi: 10.1038/npp.2011.303 – volume: 219 start-page: 1787 year: 2014 end-page: 1800 ident: CR38 article-title: Convergence of cortical and thalamic input to direct and indirect pathway medium spiny neurons in the striatum publication-title: Brain Struct. Function doi: 10.1007/s00429-013-0601-z – volume: 5 start-page: 164 year: 2013 end-page: 167 ident: CR205 article-title: Leptin influence in craving and relapse of alcoholics and smokers publication-title: J. Clin. Med. Res. – volume: 34 start-page: 1774 year: 2009 end-page: 1782 ident: CR111 article-title: Dopamine D1 receptors in cocaine dependence measured with PET and the choice to self-administer cocaine publication-title: Neuropsychopharmacology doi: 10.1038/npp.2008.235 – volume: 8 start-page: 1065 year: 2017 end-page: 1073 ident: CR142 article-title: Lorcaserin suppresses oxycodone self-administration and relapse vulnerability in rats publication-title: ACS Chem. Neurosci. doi: 10.1021/acschemneuro.6b00413 – volume: 124 start-page: 1720 year: 2001 end-page: 1733 ident: CR60 article-title: Changes in brain activity related to eating chocolate: from pleasure to aversion publication-title: Brain doi: 10.1093/brain/124.9.1720 – volume: 13 start-page: 37 year: 2016 end-page: 45 ident: CR174 article-title: Fecal microbiota-based therapeutics for recurrent infection, ulcerative colitis and obesity publication-title: EBioMedicine doi: 10.1016/j.ebiom.2016.09.029 – volume: 100 start-page: 344 year: 2016 end-page: 352 ident: CR145 article-title: Bupropion and naltrexone for smoking cessation: a double-blind randomized placebo-controlled clinical trial publication-title: Clin. Pharmacol. Ther. doi: 10.1002/cpt.402 – volume: 15 start-page: 816 year: 2012 end-page: 818 ident: CR44 article-title: Distinct roles for direct and indirect pathway striatal neurons in reinforcement publication-title: Nat. Neurosci. doi: 10.1038/nn.3100 – volume: 641 start-page: 56 year: 2017 end-page: 61 ident: CR170 article-title: Moderate intensity treadmill exercise alters food preference via dopaminergic plasticity of ventral tegmental area-nucleus accumbens in obese mice publication-title: Neurosci. Lett. doi: 10.1016/j.neulet.2017.01.055 – volume: 2 start-page: 23 year: 2011 ident: CR33 article-title: Mesolimbic dopamine transients in motivated behaviors: focus on maternal behavior publication-title: Front. Psychiatry doi: 10.3389/fpsyt.2011.00023 – volume: 35 start-page: 229 year: 2010 end-page: 234 ident: CR146 article-title: An open-label study of naltrexone and bupropion combination therapy for smoking cessation in overweight and obese subjects publication-title: Addict. Behav. doi: 10.1016/j.addbeh.2009.10.017 – volume: 36 start-page: 145 year: 2015 end-page: 152 ident: CR42 article-title: The GPCR heterotetramer: challenging classical pharmacology publication-title: Trends Pharmacol Sci. doi: 10.1016/j.tips.2015.01.002 – volume: 23 start-page: 639 year: 2013 end-page: 648 ident: CR52 article-title: Unbalanced neuronal circuits in addiction publication-title: Curr. Opin. Neurobiol. doi: 10.1016/j.conb.2013.01.002 – volume: 5 start-page: 2062 year: 2016 ident: CR172 article-title: Circadian influences on dopamine circuits of the brain: regulation of striatal rhythms of clock gene expression and implications for psychopathology and disease publication-title: F1000Res doi: 10.12688/f1000research.9180.1 – volume: 24 start-page: 35 year: 2017 end-page: 42 ident: CR159 article-title: Vagus nerve stimulation reduces cocaine seeking and alters plasticity in the extinction network publication-title: Learn. Mem. doi: 10.1101/lm.043539.116 – volume: 30 start-page: 14273 year: 2010 end-page: 14283 ident: CR25 article-title: Influence of phasic and tonic dopamine release on receptor activation publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.1894-10.2010 – volume: 18 start-page: 1230 year: 2015 end-page: 1232 ident: CR49 article-title: Coding the direct/indirect pathways by D1 and D2 receptors is not valid for accumbens projections publication-title: Nat. Neurosci. doi: 10.1038/nn.4068 – volume: 80 start-page: 1 year: 1998 end-page: 27 ident: CR1 article-title: Predictive reward signal of dopamine neurons publication-title: J. Neurophysiol. doi: 10.1152/jn.1998.80.1.1 – volume: 7 start-page: 133 year: 2016 ident: CR156 article-title: Bilateral transcranial magnetic stimulation of the prefrontal cortex reduces cocaine intake: a pilot study publication-title: Front. Psychiatry doi: 10.3389/fpsyt.2016.00133 – volume: 63 start-page: 999 year: 2006 end-page: 1008 ident: CR101 article-title: High levels of dopamine D2 receptors in unaffected members of alcoholic families: possible protective factors publication-title: Arch. Gen. Psychiatry doi: 10.1001/archpsyc.63.9.999 – volume: 117 start-page: 924 year: 2008 end-page: 935 ident: CR125 article-title: Relation of reward from food intake and anticipated food intake to obesity: a functional magnetic resonance imaging study publication-title: J. Abnorm. Psychol. doi: 10.1037/a0013600 – volume: 6 start-page: 35455 year: 2016 ident: CR177 article-title: Alterations of the host microbiome affect behavioral responses to cocaine publication-title: Sci. Rep. doi: 10.1038/srep35455 – volume: 21 start-page: 436 year: 2013 end-page: 455 ident: CR164 article-title: A systematic review of the effects of neuromodulation on eating and body weight: evidence from human and animal studies publication-title: Eur. Eat Disord. Rev. doi: 10.1002/erv.2256 – volume: 233 start-page: 1405 year: 2016 end-page: 1413 ident: CR225 article-title: Phentermine induces conditioned rewarding effects via activation of the PI3K/Akt signaling pathway in the nucleus accumbens publication-title: Psychopharmacology doi: 10.1007/s00213-016-4231-z – volume: 22 start-page: 609 year: 2011 end-page: 624 ident: CR120 article-title: Neuroimaging for drug addiction and related behaviors publication-title: Rev. Neurosci. doi: 10.1515/RNS.2011.055 – volume: 76 start-page: 351 year: 2014 end-page: 359 ident: CR29 article-title: Reward and aversion in a heterogeneous midbrain dopamine system publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2013.03.019 – volume: 18 start-page: 1025 year: 2013 end-page: 1033 ident: CR26 article-title: Increasing dopamine D2 receptor expression in the adult nucleus accumbens enhances motivation publication-title: Mol. Psychiatry doi: 10.1038/mp.2013.57 – volume: 49 start-page: 782 year: 2001 end-page: 787 ident: CR204 article-title: Leptin: a modulator of alcohol craving? publication-title: Biol. Psychiatry doi: 10.1016/S0006-3223(01)01081-2 – volume: 66 start-page: 896 year: 2010 end-page: 907 ident: CR45 article-title: Distinct roles of synaptic transmission in direct and indirect striatal pathways to reward and aversive behavior publication-title: Neuron doi: 10.1016/j.neuron.2010.05.011 – volume: 8 start-page: 844 year: 2007 end-page: 858 ident: CR72 article-title: Synaptic plasticity and addiction publication-title: Nat. Rev. Neurosci. doi: 10.1038/nrn2234 – volume: 6 start-page: 6 year: 2015 ident: CR81 article-title: Interactions of the opioid and cannabinoid systems in reward: Insights from knockout studies publication-title: Front. Pharmacol. – volume: 114 start-page: 160 year: 2017 end-page: 165 ident: CR128 article-title: Genetic risk for obesity predicts nucleus accumbens size and responsivity to real-world food cues publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1605548113 – volume: 176 start-page: 17 year: 2017 end-page: 25 ident: CR235 article-title: Central GLP-1 receptor activation modulates cocaine-evoked phasic dopamine signaling in the nucleus accumbens core publication-title: Physiol. Behav. doi: 10.1016/j.physbeh.2017.03.019 – volume: 10 start-page: 514 year: 2016 ident: CR169 article-title: Do dopaminergic impairments underlie physical inactivity in people with obesity? publication-title: Front. Hum. Neurosci. doi: 10.3389/fnhum.2016.00514 – volume: 310 start-page: 1369 year: 2013 end-page: 1376 ident: CR152 article-title: Chronic use of opioid medications before and after bariatric surgery publication-title: JAMA doi: 10.1001/jama.2013.278344 – volume: 594 start-page: 6443 year: 2016 end-page: 6462 ident: CR185 article-title: Hubs and spokes of the lateral hypothalamus: cell types, circuits and behaviour publication-title: J. Physiol. doi: 10.1113/JP271946 – volume: 35 start-page: 6464 year: 2015 end-page: 6471 ident: CR18 article-title: Interaction of insular cortex and ventral striatum mediates the effect of incentive memory on choice between goal-directed actions publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.4153-14.2015 – ident: CR82 – volume: 41 start-page: 1024 year: 2016 end-page: 1033 ident: CR202 article-title: Reciprocal inhibitory interactions between the reward-related effects of leptin and cocaine publication-title: Neuropsychopharmacology doi: 10.1038/npp.2015.230 – volume: 73 start-page: 827 year: 2013 end-page: 835 ident: CR137 article-title: Stress as a common risk factor for obesity and addiction publication-title: Biol. Psychiatry doi: 10.1016/j.biopsych.2013.01.032 – volume: 147 start-page: 23 year: 2006 end-page: 30 ident: CR224 article-title: Effects of a fixed meal pattern on ghrelin secretion: evidence for a learned response independent of nutrient status publication-title: Endocrinology doi: 10.1210/en.2005-0973 – volume: 172 start-page: 334 year: 2015 end-page: 348 ident: CR191 article-title: Orexin/hypocretin role in reward: implications for opioid and other addictions publication-title: Br. J. Pharmacol. doi: 10.1111/bph.12639 – volume: 62 start-page: 826 year: 2009 end-page: 838 ident: CR65 article-title: Burst-timing-dependent plasticity of NMDA receptor-mediated transmission in midbrain dopamine neurons publication-title: Neuron doi: 10.1016/j.neuron.2009.05.011 – volume: 41 start-page: 23 year: 2017 end-page: 29 ident: CR127 article-title: Television food advertisement exposure and FTO rs9939609 genotype in relation to excess consumption in children publication-title: Int. J. Obes. doi: 10.1038/ijo.2016.163 – volume: 25 start-page: 5389 year: 2005 end-page: 5396 ident: CR67 article-title: Cocaine experience establishes control of midbrain glutamate and dopamine by corticotropin-releasing factor: a role in stress-induced relapse to drug seeking publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.0955-05.2005 – volume: 23 start-page: 240 year: 2013 end-page: 252 ident: CR77 article-title: Operant behavior to obtain palatable food modifies ERK activity in the brain reward circuit publication-title: Eur. Neuropsychopharmacol. doi: 10.1016/j.euroneuro.2012.04.009 – volume: 21 start-page: 2444 year: 2013 end-page: 2451 ident: CR151 article-title: Alcohol consumption and alcohol problems after bariatric surgery in the Swedish obese subjects study publication-title: Obesity doi: 10.1002/oby.20397 – volume: 21 start-page: 3 year: 2016 end-page: 22 ident: CR124 article-title: Neural substrates of cue reactivity: association with treatment outcomes and relapse publication-title: Addict. Biol. doi: 10.1111/adb.12314 – volume: 32 start-page: 1 year: 2017 end-page: 17 ident: CR214 article-title: Diet, gut microbiota and cognition publication-title: Metab. Brain Dis. doi: 10.1007/s11011-016-9917-8 – volume: 35 start-page: 570 year: 2010 end-page: 577 ident: CR220 article-title: Orexin and leptin are associated with nicotine craving: a link between smoking, appetite and reward publication-title: Psychoneuroendocrinology doi: 10.1016/j.psyneuen.2009.09.005 – volume: 40 start-page: 2247 year: 2016 end-page: 2252 ident: CR237 article-title: Effects of the GLP-1 agonist exendin-4 on intravenous ethanol self-administration in mice publication-title: Alcohol. Clin. Exp. Res. doi: 10.1111/acer.13199 – volume: 301 start-page: 529 year: 2015 end-page: 541 ident: CR15 article-title: The ins and outs of the striatum: role in drug addiction publication-title: Neuroscience doi: 10.1016/j.neuroscience.2015.06.033 – volume: 14 start-page: 313 year: 2011 end-page: 323 ident: CR188 article-title: Leptin action via neurotensin neurons controls orexin, the mesolimbic dopamine system and energy balance publication-title: Cell Metab. doi: 10.1016/j.cmet.2011.06.016 – volume: 120 start-page: 10 year: 1995 end-page: 20 ident: CR62 article-title: Fluctuations in nucleus accumbens dopamine concentration during intravenous cocaine self-administration in rats publication-title: Psychopharmacology doi: 10.1007/BF02246140 – volume: 104 start-page: 87 year: 2011 end-page: 97 ident: CR9 article-title: Feeding and reward: perspectives from three rat models of binge eating publication-title: Physiol. Behav. doi: 10.1016/j.physbeh.2011.04.041 – volume: 168 start-page: 48 year: 2010 end-page: 60 ident: CR78 article-title: Dopamine D1 and N-methyl-D-aspartate receptors and extracellular signal-regulated kinase mediate neuronal morphological changes induced by repeated cocaine administration publication-title: Neuroscience doi: 10.1016/j.neuroscience.2010.03.034 – volume: 19 start-page: 6102 year: 1999 end-page: 6110 ident: CR69 article-title: Glutamate-triggered events inducing corticostriatal long-term depression publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.19-14-06102.1999 – volume: 180 start-page: 129 year: 2011 end-page: 137 ident: CR183 article-title: Ghrelin directly targets the ventral tegmental area to increase food motivation publication-title: Neuroscience doi: 10.1016/j.neuroscience.2011.02.016 – volume: 49 start-page: 253 year: 2014 end-page: 259 ident: CR209 article-title: Peptide YY and ghrelin predict craving and risk for relapse in abstinent smokers publication-title: Psychoneuroendocrinology doi: 10.1016/j.psyneuen.2014.07.018 – volume: 68 start-page: 815 year: 2010 end-page: 834 ident: CR23 article-title: Dopamine in motivational control: rewarding, aversive, and alerting publication-title: Neuron doi: 10.1016/j.neuron.2010.11.022 – volume: 10 start-page: 87 year: 2010 end-page: 92 ident: CR43 article-title: Dimerization of dopamine D1 and D3 receptors in the regulation of striatal function publication-title: Curr. Opin. Pharmacol. doi: 10.1016/j.coph.2009.09.008 – volume: 13 start-page: 041002 year: 2016 ident: CR165 article-title: Vagus nerve stimulation: state of the art of stimulation and recording strategies to address autonomic function neuromodulation publication-title: J. Neural Eng. doi: 10.1088/1741-2560/13/4/041002 – volume: 488 start-page: 172 year: 2012 end-page: 177 ident: CR197 article-title: Deconstruction of a neural circuit for hunger publication-title: Nature doi: 10.1038/nature11270 – volume: 19 start-page: 1037 year: 2014 end-page: 1043 ident: CR118 article-title: Stimulant-induced dopamine increases are markedly blunted in active cocaine abusers publication-title: Mol. Psychiatry doi: 10.1038/mp.2014.58 – volume: 3 start-page: CD005353 year: 2011 ident: CR148 article-title: Cannabinoid type 1 receptor antagonists for smoking cessation publication-title: Cochrane Database Syst. Rev. – volume: 356 start-page: 85 year: 2016 end-page: 95 ident: CR141 article-title: Lorcaserin reduces the discriminative stimulus and reinforcing effects of cocaine in rhesus monkeys publication-title: J. Pharmacol. Exp. Ther. doi: 10.1124/jpet.115.228833 – volume: 35 start-page: 235 year: 2011 end-page: 239 ident: CR223 article-title: Prolactin serum levels during alcohol withdrawal are associated with the severity of alcohol dependence and withdrawal symptoms publication-title: Alcohol. Clin. Exp. Res. doi: 10.1111/j.1530-0277.2010.01339.x – volume: 82 start-page: 721 year: 2002 end-page: 735 ident: CR59 article-title: Transient changes in mesolimbic dopamine and their association with 'reward' publication-title: J. Neurochem. doi: 10.1046/j.1471-4159.2002.01005.x – volume: 19 start-page: 439 year: 2015 end-page: 444 ident: CR8 article-title: Circuitry of self-control and its role in reducing addiction publication-title: Trends Cogn. Sci. doi: 10.1016/j.tics.2015.06.007 – volume: 489 start-page: 242 year: 2012 end-page: 249 ident: CR213 article-title: Functional interactions between the gut microbiota and host metabolism publication-title: Nature doi: 10.1038/nature11552 – volume: 36 start-page: 11469 year: 2016 end-page: 11481 ident: CR179 article-title: Homeostasis meets motivation in the battle to control food intake publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.2338-16.2016 – volume: 170 start-page: 116 year: 2017 end-page: 147 ident: CR140 article-title: Obesity: current and potential pharmacotherapeutics and targets publication-title: Pharmacol. Ther. doi: 10.1016/j.pharmthera.2016.10.015 – volume: 21 start-page: 422 year: 2016 end-page: 437 ident: CR147 article-title: The glucagon-like peptide 1 receptor agonist liraglutide attenuates the reinforcing properties of alcohol in rodents publication-title: Addict. Biol. doi: 10.1111/adb.12295 – volume: 16 start-page: 300 year: 2013 end-page: 308 ident: CR182 article-title: Insulin induces long-term depression of ventral tegmental area dopamine neurons via endocannabinoids publication-title: Nat. Neurosci. doi: 10.1038/nn.3321 – volume: 137 start-page: 3129 year: 2014 end-page: 3135 ident: CR19 article-title: Dorsal striatum is necessary for stimulus-value but not action-value learning in humans publication-title: Brain doi: 10.1093/brain/awu277 – volume: 6 start-page: e752 year: 2016 ident: CR173 article-title: Reduced sleep duration mediates decreases in striatal D2/D3 receptor availability in cocaine abusers publication-title: Transl Psychiatry doi: 10.1038/tp.2016.14 – volume: 18 start-page: 73 year: 2017 end-page: 85 ident: CR30 article-title: Ventral tegmental area: cellular heterogeneity, connectivity and behaviour publication-title: Nat. Rev. Neurosci. doi: 10.1038/nrn.2016.165 – volume: 64 start-page: 503 year: 2010 end-page: 510 ident: CR203 article-title: Leptin increases striatal dopamine D2 receptor binding in leptin-deficient obese (ob/ob) mice publication-title: Synapse doi: 10.1002/syn.20755 – volume: 494 start-page: 238 year: 2013 end-page: 242 ident: CR46 article-title: Concurrent activation of striatal direct and indirect pathways during action initiation publication-title: Nature doi: 10.1038/nature11846 – volume: 30 start-page: 819 year: 2001 end-page: 828 ident: CR94 article-title: Dopamine production in the caudate putamen restores feeding in dopamine-deficient mice publication-title: Neuron doi: 10.1016/S0896-6273(01)00319-1 – volume: 32 start-page: 6711 year: 2012 end-page: 6717 ident: CR171 article-title: Evidence that sleep deprivation downregulates dopamine D2R in ventral striatum in the human brain publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.0045-12.2012 – volume: 20 start-page: 1772 year: 2006 end-page: 1785 ident: CR210 article-title: Ghrelin amplifies dopamine signaling by cross talk involving formation of growth hormone secretagogue receptor/dopamine receptor subtype 1 heterodimers publication-title: Mol. Endocrinol. doi: 10.1210/me.2005-0084 – volume: 8 start-page: e83741 year: 2013 ident: CR153 article-title: Roux-en-Y gastric bypass increases intravenous ethanol self-administration in dietary obese rats publication-title: PLoS ONE doi: 10.1371/journal.pone.0083741 – volume: 72 start-page: 1055 year: 2011 end-page: 1066 ident: CR36 article-title: NMDA receptors in dopaminergic neurons are crucial for habit learning publication-title: Neuron doi: 10.1016/j.neuron.2011.10.019 – volume: 28 start-page: 1545 year: 2008 end-page: 1556 ident: CR187 article-title: Orexin B/hypocretin 2 increases glutamatergic transmission to ventral tegmental area neurons publication-title: Eur. J. Neurosci. doi: 10.1111/j.1460-9568.2008.06397.x – volume: 23 start-page: 442 year: 2015 end-page: 450 ident: CR155 article-title: Alcohol and other addictive disorders following bariatric surgery: prevalence, risk factors and possible etiologies publication-title: Eur. Eat Disord. Rev. doi: 10.1002/erv.2399 – volume: 62 start-page: 30 year: 2014 end-page: 41 ident: CR193 article-title: Metabolic regulation of lateral hypothalamic glucose-inhibited orexin neurons may influence midbrain reward neurocircuitry publication-title: Mol. Cell Neurosci. doi: 10.1016/j.mcn.2014.08.001 – volume: 374 start-page: 363 year: 2016 end-page: 371 ident: CR97 article-title: Neurobiologic advances from the brain disease model of addiction publication-title: N. Engl. J. Med. doi: 10.1056/NEJMra1511480 – volume: 330 start-page: 385 year: 2010 end-page: 390 ident: CR216 article-title: Cell type-specific loss of BDNF signaling mimics optogenetic control of cocaine reward publication-title: Science doi: 10.1126/science.1188472 – volume: 97 start-page: 509 year: 2011 end-page: 513 ident: CR218 article-title: Circulating leptin levels are associated with increased craving to smoke in abstinent smokers publication-title: Pharmacol. Biochem. Behav. doi: 10.1016/j.pbb.2010.10.004 – volume: 42 start-page: 1537 year: 2008 end-page: 1543 ident: CR106 article-title: Low dopamine striatal D2 receptors are associated with prefrontal metabolism in obese subjects: possible contributing factors publication-title: Neuroimage doi: 10.1016/j.neuroimage.2008.06.002 – volume: 10 start-page: 478 year: 2002 end-page: 488 ident: CR133 article-title: Evidence that intermittent, excessive sugar intake causes endogenous opioid dependence publication-title: Obes. Res. doi: 10.1038/oby.2002.66 – volume: 5 start-page: 196 year: 2012 end-page: 207 ident: CR79 article-title: The opioid system and food intake: homeostatic and hedonic mechanisms publication-title: Obes. Facts doi: 10.1159/000338163 – volume: 92 start-page: 573 year: 1998 end-page: 585 ident: CR192 article-title: Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior publication-title: Cell doi: 10.1016/S0092-8674(00)80949-6 – volume: 76 start-page: 370 year: 2014 end-page: 382 ident: CR132 article-title: Addiction as a stress surfeit disorder publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2013.05.024 – volume: 123 start-page: 47 year: 2016 end-page: 52 ident: CR154 article-title: Increased intravenous morphine self-administration following Roux-en-Y gastric bypass in dietary obese rats publication-title: Brain Res. Bull. doi: 10.1016/j.brainresbull.2015.08.003 – volume: 7 start-page: 106 year: 2005 end-page: 113 ident: CR232 article-title: 15 years of clinical experience with bupropion HCl: from bupropion to bupropion SR to bupropion XL publication-title: Prim. Care Companion J. Clin. Psychiatry doi: 10.4088/PCC.v07n0305 – volume: 83 start-page: 3563 year: 2011 end-page: 3571 ident: CR58 article-title: Higher sensitivity dopamine measurements with faster-scan cyclic voltammetry publication-title: Anal. Chem. doi: 10.1021/ac200143v – volume: 363 start-page: 3191 year: 2008 end-page: 3200 ident: CR5 article-title: Overlapping neuronal circuits in addiction and obesity: evidence of systems pathology publication-title: Philos. Trans. R. Soc. Lond. B Biol. Sci. doi: 10.1098/rstb.2008.0107 – volume: 27 start-page: 468 year: 2004 end-page: 474 ident: CR20 article-title: Putting a spin on the dorsal-ventral divide of the striatum publication-title: Trends Neurosci. doi: 10.1016/j.tins.2004.06.006 – volume: 32 start-page: 517 year: 2009 end-page: 524 ident: CR16 article-title: Roles for nigrostriatal — not just mesocorticolimbic — dopamine in reward and addiction publication-title: Trends Neurosci. doi: 10.1016/j.tins.2009.06.004 – volume: 25 start-page: 8665 year: 2005 end-page: 8670 ident: CR71 article-title: Involvement of the dorsal striatum in cue-controlled cocaine seeking publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.0925-05.2005 – volume: 14 start-page: 6084 year: 1994 end-page: 6093 ident: CR28 article-title: Efflux of dopamine from the synaptic cleft in the nucleus accumbens of the rat brain publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.14-10-06084.1994 – volume: 110 start-page: 20 year: 2016 end-page: 42 ident: CR54 article-title: A core eating network and its modulations underlie diverse eating phenomena publication-title: Brain Cogn. doi: 10.1016/j.bandc.2016.04.004 – start-page: 987 year: 2008 end-page: 1016 ident: CR51 publication-title: Fundamental Neuroscience – volume: 66 start-page: 232 year: 2013 end-page: 239 ident: CR121 article-title: Functional connectivity in obesity during reward processing publication-title: Neuroimage doi: 10.1016/j.neuroimage.2012.10.035 – volume: 14 start-page: 169 year: 1993 end-page: 177 ident: CR107 article-title: Decreased dopamine D receptor availability is associated with reduced frontal metabolism in cocaine abusers publication-title: Synapse doi: 10.1002/syn.890140210 – volume: 149 start-page: 262 year: 2015 end-page: 268 ident: CR207 article-title: The glucagon-like peptide 1 (GLP-1) receptor agonist exendin-4 reduces cocaine self-administration in mice publication-title: Physiol. Behav. doi: 10.1016/j.physbeh.2015.06.013 – volume: 68 start-page: 685 year: 2010 end-page: 686 ident: CR126 article-title: Opioid-dopamine interactions: implications for substance use disorders and their treatment publication-title: Biol. Psychiatry doi: 10.1016/j.biopsych.2010.08.002 – volume: 46 start-page: 661 year: 2005 end-page: 669 ident: CR2 article-title: Extinction of cocaine self-administration reveals functionally and temporally distinct dopaminergic signals in the nucleus accumbens publication-title: Neuron doi: 10.1016/j.neuron.2005.04.036 – volume: 28 start-page: 875 year: 2014 end-page: 886 ident: CR208 article-title: Role of appetite-regulating peptides in the pathophysiology of addiction: implications for pharmacotherapy publication-title: CNS Drugs doi: 10.1007/s40263-014-0178-y – volume: 66 start-page: 196 year: 2012 end-page: 203 ident: CR21 article-title: Increased affinity of dopamine for D -like versus D -like receptors. Relevance for volume transmission in interpreting PET findings publication-title: Synapse doi: 10.1002/syn.21501 – volume: 104 start-page: 149 year: 2011 end-page: 156 ident: CR134 article-title: The dark side of food addiction publication-title: Physiol. Behav. doi: 10.1016/j.physbeh.2011.04.063 – volume: 8 start-page: 1 year: 2015 end-page: 31 ident: CR157 article-title: Neuroimaging and neuromodulation approaches to study eating behavior and prevent and treat eating disorders and obesity publication-title: Neuroimage Clin. doi: 10.1016/j.nicl.2015.03.016 – volume: 73 start-page: 317 year: 2012 end-page: 332 ident: CR211 article-title: Apo-ghrelin receptor forms heteromers with DRD2 in hypothalamic neurons and is essential for anorexigenic effects of DRD2 agonism publication-title: Neuron doi: 10.1016/j.neuron.2011.10.038 – volume: 20 start-page: 369 year: 2010 end-page: 374 ident: CR105 article-title: Alterations of central dopamine receptors before and after gastric bypass surgery publication-title: Obes. Surg. doi: 10.1007/s11695-009-0015-4 – volume: 10 start-page: 318 year: 2000 end-page: 325 ident: CR100 article-title: Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex publication-title: Cereb. Cortex doi: 10.1093/cercor/10.3.318 – volume: 11 start-page: 408 year: 2016 end-page: 433 ident: CR234 article-title: Neuroimaging the effectiveness of substance use disorder treatments publication-title: J. Neuroimmune Pharmacol. doi: 10.1007/s11481-016-9680-y – volume: 1129 start-page: 35 year: 2008 end-page: 46 ident: CR13 article-title: Dopamine signaling in the dorsal striatum is essential for motivated behaviors: lessons from dopamine-deficient mice publication-title: Ann. NY Acad. Sci. doi: 10.1196/annals.1417.003 – volume: 222 start-page: 390 year: 2011 end-page: 393 ident: CR84 article-title: Opposing roles for dopamine D - and D -like receptors in discrete cue-induced reinstatement of food seeking publication-title: Behav. Brain Res. doi: 10.1016/j.bbr.2011.03.064 – volume: 1 start-page: 86 year: 2012 end-page: 93 ident: CR86 article-title: Leptin reduces food intake via a dopamine D2 receptor-dependent mechanism publication-title: Mol. Metab. doi: 10.1016/j.molmet.2012.07.003 – volume: 34 start-page: 5486 year: 2014 end-page: 5496 ident: CR199 article-title: Leptin modulates the intrinsic excitability of AgRP/NPY neurons in the arcuate nucleus of the hypothalamus publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.4861-12.2014 – volume: 8 start-page: 571 year: 2005 end-page: 578 ident: CR194 article-title: Anatomy and regulation of the central melanocortin system publication-title: Nat. Neurosci. doi: 10.1038/nn1455 – volume: 357 start-page: 354 year: 2001 end-page: 357 ident: CR102 article-title: Brain dopamine and obesity publication-title: Lancet doi: 10.1016/S0140-6736(00)03643-6 – volume: 9 start-page: e101350 year: 2014 ident: CR96 article-title: The reward-based eating drive scale: a self-report index of reward-based eating publication-title: PLoS ONE doi: 10.1371/journal.pone.0101350 – volume: 41 start-page: 1697 year: 2016 end-page: 1715 ident: CR40 article-title: Architectural representation of valence in the limbic system publication-title: Neuropsychopharmacology doi: 10.1038/npp.2015.358 – volume: 26 start-page: 25 year: 2007 end-page: 31 ident: CR112 article-title: Imaging stress- and cue-induced drug and alcohol craving: association with relapse and clinical implications publication-title: Drug Alcohol Rev. doi: 10.1080/09595230601036960 – volume: 93 start-page: 1436 year: 2017 end-page: 1450.e8 ident: CR17 article-title: Dynamic nigrostriatal dopamine biases action selection publication-title: Neuron doi: 10.1016/j.neuron.2017.02.029 – volume: 3 start-page: 169 year: 2012 ident: CR196 article-title: Arcuate AgRP neurons and the regulation of energy balance publication-title: Front. Endocrinol. doi: 10.3389/fendo.2012.00169 – volume: 70 start-page: 561 year: 2016 end-page: 562 ident: CR238 article-title: Glucagon-like peptide-1 (GLP-1) analogues: a potential new treatment for alcohol use disorder? publication-title: Nord. J. Psychiatry doi: 10.1080/08039488.2016.1176252 – volume: 17 start-page: 1022 year: 2014 end-page: 1030 ident: CR50 article-title: Direct and indirect pathways of basal ganglia: a critical reappraisal publication-title: Nat. Neurosci. doi: 10.1038/nn.3743 – volume: 454 start-page: 118 year: 2008 end-page: 121 ident: CR73 article-title: Formation of accumbens GluR2-lacking AMPA receptors mediates incubation of cocaine craving publication-title: Nature doi: 10.1038/nature06995 – volume: 111 start-page: 6455 year: 2014 end-page: 6460 ident: CR24 article-title: Aversive behavior induced by optogenetic inactivation of ventral tegmental area dopamine neurons is mediated by dopamine D2 receptors in the nucleus accumbens publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1404323111 – volume: 38 start-page: 255 year: 2013 end-page: 267 ident: CR138 article-title: Stress and eating behaviors publication-title: Minerva Endocrinol. – volume: 31 start-page: 13180 year: 2011 end-page: 13190 ident: CR41 article-title: Acute cocaine induces fast activation of D1 receptor and progressive deactivation of D2 receptor striatal neurons: optical microprobe [Ca ] imaging publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.2369-11.2011 – volume: 162 start-page: 1414 year: 2005 end-page: 1422 ident: CR63 article-title: Addiction: a disease of learning and memory publication-title: Am. J. Psychiatry doi: 10.1176/appi.ajp.162.8.1414 – volume: 385 start-page: 165 year: 1997 end-page: 168 ident: CR198 article-title: Role of melanocortinergic neurons in feeding and the agouti obesity syndrome publication-title: Nature doi: 10.1038/385165a0 – volume: 162 start-page: 712 year: 2015 end-page: 725 ident: CR53 article-title: The brain on drugs: from reward to addiction publication-title: Cell doi: 10.1016/j.cell.2015.07.046 – volume: 23 start-page: 103 year: 2016 end-page: 112 ident: CR87 article-title: Striatal dopamine links gastrointestinal rerouting to altered sweet appetite publication-title: Cell Metab. doi: 10.1016/j.cmet.2015.10.009 – volume: 29 start-page: 571 year: 2006 end-page: 577 ident: CR190 article-title: Arousal and reward: a dichotomy in orexin function publication-title: Trends Neurosci. doi: 10.1016/j.tins.2006.08.002 – volume: 40 start-page: 24 year: 2016 end-page: 41 ident: CR168 article-title: Sex differences in drug addiction and response to exercise intervention: from human to animal studies publication-title: Front. Neuroendocrinol. doi: 10.1016/j.yfrne.2015.07.001 – volume: 26 start-page: R267 year: 2016 end-page: R269 ident: CR48 article-title: Direct and indirect dorsolateral striatum pathways reinforce different action strategies publication-title: Curr. Biol. doi: 10.1016/j.cub.2016.02.036 – volume: 32 start-page: 841 year: 2012 end-page: 849 ident: CR123 article-title: Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.4461-11.2012 – volume: 100 start-page: 1003 year: 2014 end-page: 1009 ident: CR158 article-title: Repetitive electric brain stimulation reduces food intake in humans publication-title: Am. J. Clin. Nutr. doi: 10.3945/ajcn.113.075481 – volume: 21 start-page: 1140 year: 2016 end-page: 1150 ident: CR85 article-title: Effects of repeated yohimbine administration on reinstatement of palatable food seeking: involvement of dopamine D -like receptors and food-associated cues publication-title: Addict. Biol. doi: 10.1111/adb.12287 – volume: 42 start-page: 196 year: 2001 end-page: 198 ident: CR228 article-title: Topiramate selectively attenuates nicotine-induced increases in monoamine release publication-title: Synapse doi: 10.1002/syn.10000 – volume: 6 start-page: e972 year: 2016 ident: CR201 article-title: Mesolimbic leptin signaling negatively regulates cocaine-conditioned reward publication-title: Transl Psychiatry doi: 10.1038/tp.2016.223 – volume: 13 start-page: 11 year: 2017 end-page: 25 ident: CR212 article-title: Role of the gut microbiota in host appetite control: bacterial growth to animal feeding behaviour publication-title: Nat. Rev. Endocrinol. doi: 10.1038/nrendo.2016.150 – volume: 34 start-page: 560 year: 2013 end-page: 570 ident: CR227 article-title: From obesity to substance abuse: therapeutic opportunities for 5-HT receptor agonists publication-title: Trends Pharmacol. Sci. doi: 10.1016/j.tips.2013.08.001 – volume: 30 start-page: 719 year: 2016 end-page: 733 ident: CR233 article-title: Naltrexone: a pan-addiction treatment? publication-title: CNS Drugs doi: 10.1007/s40263-016-0373-0 – volume: 9 start-page: e101585 year: 2014 ident: CR115 article-title: BMI modulates calorie-dependent dopamine changes in accumbens from glucose intake publication-title: PLoS ONE doi: 10.1371/journal.pone.0101585 – volume: 18 start-page: 393 year: 2010 end-page: 409 ident: CR217 article-title: Regulation of AMPA receptor trafficking in the nucleus accumbens by dopamine and cocaine publication-title: Neurotox. Res. doi: 10.1007/s12640-010-9176-0 – volume: 93 start-page: 283 year: 2015 end-page: 290 ident: CR161 article-title: Deep TMS on alcoholics: effects on cortisolemia and dopamine pathway modulation. A pilot study publication-title: Can. J. Physiol. Pharmacol. doi: 10.1139/cjpp-2014-0188 – volume: 37 start-page: 754 year: 2013 end-page: 757 ident: CR90 article-title: High fat/carbohydrate ratio but not total energy intake induces lower striatal dopamine D receptor availability in diet-induced obesity publication-title: Int. J. Obes. doi: 10.1038/ijo.2012.128 – volume: 6 start-page: 21 year: 2016 ident: CR163 article-title: DBS for obesity publication-title: Brain Sci. doi: 10.3390/brainsci6030021 – volume: 12 start-page: 726 year: 2015 end-page: 733 ident: CR178 article-title: Endogenous glucagon-like peptide-1 suppresses high-fat food intake by reducing synaptic drive onto mesolimbic dopamine neurons publication-title: Cell Rep. doi: 10.1016/j.celrep.2015.06.062 – volume: 44 start-page: 175 year: 2002 end-page: 180 ident: CR95 article-title: “Nonhedonic” food motivation in humans involves dopamine in the dorsal striatum and methylphenidate amplifies this effect publication-title: Synapse doi: 10.1002/syn.10075 – volume: 36 start-page: 120 year: 2015 end-page: 136 ident: CR4 article-title: Overlapping patterns of brain activation to food and cocaine cues in cocaine abusers: association to striatal D2/D3 receptors publication-title: Hum. Brain Mapp. doi: 10.1002/hbm.22617 – volume: 33 start-page: 15827 year: 2013 end-page: 15836 ident: CR74 article-title: Chronic cocaine dampens dopamine signaling during cocaine intoxication and unbalances D over D receptor signaling publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.1935-13.2013 – volume: 5 start-page: 483 year: 2004 end-page: 494 ident: CR7 article-title: Dopamine, learning and motivation publication-title: Nat. Rev. Neurosci. doi: 10.1038/nrn1406 – volume: 35 start-page: 3959 year: 2015 end-page: 3965 ident: CR110 article-title: Obesity is associated with decreased μ-opioid but unaltered dopamine D receptor availability in the brain publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.4744-14.2015 – volume: 30 start-page: 13105 year: 2010 end-page: 13109 ident: CR117 article-title: Weight gain is associated with reduced striatal response to palatable food publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.2105-10.2010 – volume: 19 start-page: 2175 year: 2011 end-page: 2182 ident: CR6 article-title: Inhibiting food reward: delay discounting, food reward sensitivity, and palatable food intake in overweight and obese women publication-title: Obesity doi: 10.1038/oby.2011.57 – volume: 307 start-page: 2516 year: 2012 end-page: 2525 ident: CR150 article-title: Prevalence of alcohol use disorders before and after bariatric surgery publication-title: JAMA doi: 10.1001/jama.2012.6147 – volume: 16 start-page: 1147 year: 2011 end-page: 1154 ident: CR122 article-title: Motivation deficit in ADHD is associated with dysfunction of the dopamine reward pathway publication-title: Mol. Psychiatry doi: 10.1038/mp.2010.97 – volume: 10 start-page: 66 year: 2016 ident: CR92 article-title: Activity of D1/2 receptor expressing neurons in the nucleus accumbens regulates running, locomotion, and food intake publication-title: Front. Behav. Neurosci. doi: 10.3389/fnbeh.2016.00066 – volume: 67 start-page: 176 year: 2015 end-page: 197 ident: CR144 article-title: Serotonin 5-HT receptor interactions with dopamine function: implications for therapeutics in cocaine use disorder publication-title: Pharmacol Rev. doi: 10.1124/pr.114.009514 – volume: 30 start-page: 767 year: 1989 end-page: 777 ident: CR22 article-title: Anatomical and affinity state comparisons between dopamine D1 and D2 receptors in the rat central nervous system publication-title: Neuroscience doi: 10.1016/0306-4522(89)90168-1 – volume: 106 start-page: 7281 year: 2009 end-page: 7288 ident: CR27 article-title: Disruption of NMDAR-dependent burst firing by dopamine neurons provides selective assessment of phasic dopamine-dependent behavior publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.0813415106 – volume: 64 start-page: 14 year: 2010 end-page: 103 ident: CR184 article-title: Distinct patterns of neuronal inputs and outputs of the juxtaparaventricular and suprafornical regions of the lateral hypothalamic area in the male rat publication-title: Brain Res. Rev. doi: 10.1016/j.brainresrev.2010.02.002 – volume: 363 start-page: 3125 year: 2008 end-page: 3135 ident: CR93 article-title: Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addiction publication-title: Philos. Trans. R. Soc. Lond. B Biol. Sci. doi: 10.1098/rstb.2008.0089 – volume: 39 start-page: 545 year: 2005 end-page: 551 ident: CR219 article-title: Increasing leptin precedes craving and relapse during pharmacological abstinence maintenance treatment of alcoholism publication-title: J. Psychiatr. Res. doi: 10.1016/j.jpsychires.2004.11.005 – volume: 6 start-page: 15 year: 2016 ident: CR175 article-title: The new era of treatment for obesity and metabolic disorders: evidence and expectations for gut microbiome transplantation publication-title: Front. Cell. Infect. Microbiol. doi: 10.3389/fcimb.2016.00015 – volume: 6 start-page: e809 year: 2016 ident: CR236 article-title: Glucagon-like peptide 1 receptor activation regulates cocaine actions and dopamine homeostasis in the lateral septum by decreasing arachidonic acid levels publication-title: Transl Psychiatry doi: 10.1038/tp.2016.86 – volume: 19 start-page: 915 year: 2016 end-page: 925 ident: CR70 article-title: Opposing mechanisms mediate morphine- and cocaine-induced generation of silent synapses publication-title: Nat. Neurosci. doi: 10.1038/nn.4313 – volume: 48 start-page: 1 year: 2013 end-page: 19 ident: CR114 article-title: Striatocortical pathway dysfunctionin addiction and obesity: differences and similarities publication-title: Crit. Rev. Biochem. Mol. Biol. doi: 10.3109/10409238.2012.735642 – volume: 73 start-page: 49 year: 2014 end-page: 55 ident: CR206 article-title: Moving beyond energy homeostasis: new roles for glucagon-like peptide-1 in food and drug reward publication-title: Neurochem. Int. doi: 10.1016/j.neuint.2013.10.003 – volume: 89 start-page: 18 year: 2009 end-page: 45 ident: CR64 article-title: The neuropharmacology of relapse to food seeking: methodology, main findings, and comparison with relapse to drug seeking publication-title: Prog. Neurobiol. doi: 10.1016/j.pneurobio.2009.05.003 – volume: 38 start-page: 345 year: 2015 end-page: 352 ident: CR3 article-title: NOW versus LATER brain circuits: implications for obesity and addiction publication-title: Trends Neurosci. doi: 10.1016/j.tins.2015.04.002 – volume: 35 start-page: 1105 year: 2012 end-page: 1111 ident: CR109 article-title: Relationship of dopamine type 2 receptor binding potential with fasting neuroendocrine hormones and insulin sensitivity in human obesity publication-title: Diabetes Care doi: 10.2337/dc11-2250 – volume: 16 start-page: 579 year: 2015 end-page: 594 ident: CR10 article-title: Endocannabinoid signalling in reward and addiction publication-title: Nat. Rev. Neurosci. doi: 10.1038/nrn4004 – volume: 56 start-page: 395 year: 1995 end-page: 401 ident: CR231 article-title: Bupropion: a review of its mechanism of antidepressant activity publication-title: J. Clin. Psychiatry – volume: 39 start-page: 545 year: 2005 ident: BFnrn2017130_CR219 publication-title: J. Psychiatr. Res. doi: 10.1016/j.jpsychires.2004.11.005 – volume: 147 start-page: 23 year: 2006 ident: BFnrn2017130_CR224 publication-title: Endocrinology doi: 10.1210/en.2005-0973 – volume: 310 start-page: 1369 year: 2013 ident: BFnrn2017130_CR152 publication-title: JAMA doi: 10.1001/jama.2013.278344 – volume: 35 start-page: 570 year: 2010 ident: BFnrn2017130_CR220 publication-title: Psychoneuroendocrinology doi: 10.1016/j.psyneuen.2009.09.005 – volume: 109 start-page: 318 year: 2015 ident: BFnrn2017130_CR113 publication-title: Neuroimage doi: 10.1016/j.neuroimage.2014.12.073 – volume: 83 start-page: 3563 year: 2011 ident: BFnrn2017130_CR58 publication-title: Anal. Chem. doi: 10.1021/ac200143v – volume: 3 start-page: CD005353 year: 2011 ident: BFnrn2017130_CR148 publication-title: Cochrane Database Syst. Rev. – volume: 76 start-page: 351 year: 2014 ident: BFnrn2017130_CR29 publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2013.03.019 – volume: 70 start-page: 561 year: 2016 ident: BFnrn2017130_CR238 publication-title: Nord. J. Psychiatry doi: 10.1080/08039488.2016.1176252 – volume: 100 start-page: 1003 year: 2014 ident: BFnrn2017130_CR158 publication-title: Am. J. Clin. Nutr. doi: 10.3945/ajcn.113.075481 – volume: 19 start-page: 6102 year: 1999 ident: BFnrn2017130_CR69 publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.19-14-06102.1999 – volume: 21 start-page: 786 year: 2016 ident: BFnrn2017130_CR215 publication-title: Mol. Psychiatry doi: 10.1038/mp.2016.44 – volume: 301 start-page: 529 year: 2015 ident: BFnrn2017130_CR15 publication-title: Neuroscience doi: 10.1016/j.neuroscience.2015.06.033 – volume: 7 start-page: 133 year: 2016 ident: BFnrn2017130_CR156 publication-title: Front. Psychiatry doi: 10.3389/fpsyt.2016.00133 – volume: 8 start-page: 844 year: 2007 ident: BFnrn2017130_CR72 publication-title: Nat. Rev. Neurosci. doi: 10.1038/nrn2234 – volume: 8 start-page: 571 year: 2005 ident: BFnrn2017130_CR194 publication-title: Nat. Neurosci. doi: 10.1038/nn1455 – volume: 63 start-page: 999 year: 2006 ident: BFnrn2017130_CR101 publication-title: Arch. Gen. Psychiatry doi: 10.1001/archpsyc.63.9.999 – volume: 149 start-page: 262 year: 2015 ident: BFnrn2017130_CR207 publication-title: Physiol. Behav. doi: 10.1016/j.physbeh.2015.06.013 – volume: 64 start-page: 14 year: 2010 ident: BFnrn2017130_CR184 publication-title: Brain Res. Rev. doi: 10.1016/j.brainresrev.2010.02.002 – volume: 16 start-page: 1147 year: 2011 ident: BFnrn2017130_CR122 publication-title: Mol. Psychiatry doi: 10.1038/mp.2010.97 – volume: 24 start-page: 35 year: 2017 ident: BFnrn2017130_CR159 publication-title: Learn. Mem. doi: 10.1101/lm.043539.116 – volume: 14 start-page: 6084 year: 1994 ident: BFnrn2017130_CR28 publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.14-10-06084.1994 – volume: 42 start-page: 1537 year: 2008 ident: BFnrn2017130_CR106 publication-title: Neuroimage doi: 10.1016/j.neuroimage.2008.06.002 – volume: 36 start-page: 120 year: 2015 ident: BFnrn2017130_CR4 publication-title: Hum. Brain Mapp. doi: 10.1002/hbm.22617 – volume: 69 start-page: 195 year: 2015 ident: BFnrn2017130_CR116 publication-title: Synapse doi: 10.1002/syn.21809 – volume: 33 start-page: 15827 year: 2013 ident: BFnrn2017130_CR74 publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.1935-13.2013 – volume: 48 start-page: 1 year: 2013 ident: BFnrn2017130_CR114 publication-title: Crit. Rev. Biochem. Mol. Biol. doi: 10.3109/10409238.2012.735642 – volume: 22 start-page: 609 year: 2011 ident: BFnrn2017130_CR120 publication-title: Rev. Neurosci. doi: 10.1515/RNS.2011.055 – volume: 36 start-page: 145 year: 2015 ident: BFnrn2017130_CR42 publication-title: Trends Pharmacol Sci. doi: 10.1016/j.tips.2015.01.002 – volume: 30 start-page: 819 year: 2001 ident: BFnrn2017130_CR94 publication-title: Neuron doi: 10.1016/S0896-6273(01)00319-1 – volume: 34 start-page: 441 year: 2011 ident: BFnrn2017130_CR39 publication-title: Annu. Rev. Neurosci. doi: 10.1146/annurev-neuro-061010-113641 – volume: 23 start-page: 240 year: 2013 ident: BFnrn2017130_CR77 publication-title: Eur. Neuropsychopharmacol. doi: 10.1016/j.euroneuro.2012.04.009 – volume: 21 start-page: 436 year: 2013 ident: BFnrn2017130_CR164 publication-title: Eur. Eat Disord. Rev. doi: 10.1002/erv.2256 – volume: 123 start-page: 47 year: 2016 ident: BFnrn2017130_CR154 publication-title: Brain Res. Bull. doi: 10.1016/j.brainresbull.2015.08.003 – volume: 13 start-page: 11 year: 2017 ident: BFnrn2017130_CR212 publication-title: Nat. Rev. Endocrinol. doi: 10.1038/nrendo.2016.150 – volume: 93 start-page: 1436 year: 2017 ident: BFnrn2017130_CR17 publication-title: Neuron doi: 10.1016/j.neuron.2017.02.029 – volume: 117 start-page: 924 year: 2008 ident: BFnrn2017130_CR125 publication-title: J. Abnorm. Psychol. doi: 10.1037/a0013600 – volume: 233 start-page: 1405 year: 2016 ident: BFnrn2017130_CR225 publication-title: Psychopharmacology doi: 10.1007/s00213-016-4231-z – volume: 6 start-page: 35455 year: 2016 ident: BFnrn2017130_CR177 publication-title: Sci. Rep. doi: 10.1038/srep35455 – volume: 30 start-page: 719 year: 2016 ident: BFnrn2017130_CR233 publication-title: CNS Drugs doi: 10.1007/s40263-016-0373-0 – volume: 374 start-page: 363 year: 2016 ident: BFnrn2017130_CR97 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMra1511480 – volume: 363 start-page: 3125 year: 2008 ident: BFnrn2017130_CR93 publication-title: Philos. Trans. R. Soc. Lond. B Biol. Sci. doi: 10.1098/rstb.2008.0089 – volume: 357 start-page: 354 year: 2001 ident: BFnrn2017130_CR102 publication-title: Lancet doi: 10.1016/S0140-6736(00)03643-6 – volume: 17 start-page: 187 year: 1991 ident: BFnrn2017130_CR136 publication-title: Appetite doi: 10.1016/0195-6663(91)90021-J – volume: 136 start-page: 63 year: 2014 ident: BFnrn2017130_CR61 publication-title: Physiol. Behav. doi: 10.1016/j.physbeh.2014.04.017 – volume: 20 start-page: 369 year: 2010 ident: BFnrn2017130_CR105 publication-title: Obes. Surg. doi: 10.1007/s11695-009-0015-4 – volume: 23 start-page: 442 year: 2015 ident: BFnrn2017130_CR155 publication-title: Eur. Eat Disord. Rev. doi: 10.1002/erv.2399 – volume: 37 start-page: 1177 year: 2012 ident: BFnrn2017130_CR143 publication-title: Neuropsychopharmacology doi: 10.1038/npp.2011.303 – volume: 41 start-page: 1024 year: 2016 ident: BFnrn2017130_CR202 publication-title: Neuropsychopharmacology doi: 10.1038/npp.2015.230 – volume: 19 start-page: 2175 year: 2011 ident: BFnrn2017130_CR6 publication-title: Obesity doi: 10.1038/oby.2011.57 – volume: 58 start-page: 212 year: 1992 ident: BFnrn2017130_CR57 publication-title: J. Neurochem. doi: 10.1111/j.1471-4159.1992.tb09298.x – volume: 10 start-page: 478 year: 2002 ident: BFnrn2017130_CR133 publication-title: Obes. Res. doi: 10.1038/oby.2002.66 – volume: 307 start-page: 2516 year: 2012 ident: BFnrn2017130_CR150 publication-title: JAMA doi: 10.1001/jama.2012.6147 – volume: 6 start-page: 968 year: 2003 ident: BFnrn2017130_CR35 publication-title: Nat. Neurosci. doi: 10.1038/nn1103 – volume: 38 start-page: 345 year: 2015 ident: BFnrn2017130_CR3 publication-title: Trends Neurosci. doi: 10.1016/j.tins.2015.04.002 – volume: 19 start-page: 439 year: 2015 ident: BFnrn2017130_CR8 publication-title: Trends Cogn. Sci. doi: 10.1016/j.tics.2015.06.007 – volume: 341 start-page: 800 year: 2013 ident: BFnrn2017130_CR91 publication-title: Science doi: 10.1126/science.1239275 – volume: 35 start-page: 3959 year: 2015 ident: BFnrn2017130_CR110 publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.4744-14.2015 – volume: 46 start-page: 661 year: 2005 ident: BFnrn2017130_CR2 publication-title: Neuron doi: 10.1016/j.neuron.2005.04.036 – volume: 44 start-page: 175 year: 2002 ident: BFnrn2017130_CR95 publication-title: Synapse doi: 10.1002/syn.10075 – volume: 6 start-page: e972 year: 2016 ident: BFnrn2017130_CR201 publication-title: Transl Psychiatry doi: 10.1038/tp.2016.223 – volume: 233 start-page: 3849 year: 2016 ident: BFnrn2017130_CR229 publication-title: Psychopharmacology doi: 10.1007/s00213-016-4409-4 – volume: 106 start-page: 7281 year: 2009 ident: BFnrn2017130_CR27 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.0813415106 – volume: 8 start-page: e83741 year: 2013 ident: BFnrn2017130_CR153 publication-title: PLoS ONE doi: 10.1371/journal.pone.0083741 – volume: 73 start-page: 317 year: 2012 ident: BFnrn2017130_CR211 publication-title: Neuron doi: 10.1016/j.neuron.2011.10.038 – volume: 72 start-page: 1055 year: 2011 ident: BFnrn2017130_CR36 publication-title: Neuron doi: 10.1016/j.neuron.2011.10.019 – volume: 16 start-page: 300 year: 2013 ident: BFnrn2017130_CR182 publication-title: Nat. Neurosci. doi: 10.1038/nn.3321 – volume: 14 start-page: 313 year: 2011 ident: BFnrn2017130_CR188 publication-title: Cell Metab. doi: 10.1016/j.cmet.2011.06.016 – volume: 66 start-page: 196 year: 2012 ident: BFnrn2017130_CR21 publication-title: Synapse doi: 10.1002/syn.21501 – volume: 93 start-page: 283 year: 2015 ident: BFnrn2017130_CR161 publication-title: Can. J. Physiol. Pharmacol. doi: 10.1139/cjpp-2014-0188 – volume: 21 start-page: 3 year: 2016 ident: BFnrn2017130_CR124 publication-title: Addict. Biol. doi: 10.1111/adb.12314 – volume: 18 start-page: 73 year: 2017 ident: BFnrn2017130_CR30 publication-title: Nat. Rev. Neurosci. doi: 10.1038/nrn.2016.165 – volume: 494 start-page: 238 year: 2013 ident: BFnrn2017130_CR46 publication-title: Nature doi: 10.1038/nature11846 – volume: 319 start-page: 1 year: 2017 ident: BFnrn2017130_CR83 publication-title: Behav. Brain Res. doi: 10.1016/j.bbr.2016.11.020 – volume: 25 start-page: 8665 year: 2005 ident: BFnrn2017130_CR71 publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.0925-05.2005 – volume: 26 start-page: 37 year: 2016 ident: BFnrn2017130_CR162 publication-title: Eur. Neuropsychopharmacol. doi: 10.1016/j.euroneuro.2015.11.011 – volume: 37 start-page: 223 year: 2015 ident: BFnrn2017130_CR176 publication-title: Alcohol Res. – volume: 488 start-page: 172 year: 2012 ident: BFnrn2017130_CR197 publication-title: Nature doi: 10.1038/nature11270 – volume: 80 start-page: 1 year: 1998 ident: BFnrn2017130_CR1 publication-title: J. Neurophysiol. doi: 10.1152/jn.1998.80.1.1 – volume: 44 start-page: 231 year: 1977 ident: BFnrn2017130_CR130 publication-title: Eur. J. Pharmacol. doi: 10.1016/0014-2999(77)90070-X – volume: 23 start-page: 229 year: 2013 ident: BFnrn2017130_CR34 publication-title: Curr. Opin. Neurobiol. doi: 10.1016/j.conb.2012.11.012 – volume: 170 start-page: 116 year: 2017 ident: BFnrn2017130_CR140 publication-title: Pharmacol. Ther. doi: 10.1016/j.pharmthera.2016.10.015 – volume: 62 start-page: 826 year: 2009 ident: BFnrn2017130_CR65 publication-title: Neuron doi: 10.1016/j.neuron.2009.05.011 – ident: BFnrn2017130_CR82 doi: 10.1038/npp.2017.126 – volume: 32 start-page: 1 year: 2017 ident: BFnrn2017130_CR214 publication-title: Metab. Brain Dis. doi: 10.1007/s11011-016-9917-8 – volume: 1129 start-page: 35 year: 2008 ident: BFnrn2017130_CR13 publication-title: Ann. NY Acad. Sci. doi: 10.1196/annals.1417.003 – volume: 42 start-page: 3095 year: 2015 ident: BFnrn2017130_CR88 publication-title: Eur. J. Neurosci. doi: 10.1111/ejn.13117 – volume: 6 start-page: e752 year: 2016 ident: BFnrn2017130_CR173 publication-title: Transl Psychiatry doi: 10.1038/tp.2016.14 – volume: 33 start-page: 12329 year: 2013 ident: BFnrn2017130_CR66 publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.0809-13.2013 – volume: 90 start-page: 1286 year: 2016 ident: BFnrn2017130_CR186 publication-title: Neuron doi: 10.1016/j.neuron.2016.04.035 – volume: 27 start-page: 12484 year: 2007 ident: BFnrn2017130_CR14 publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.3133-07.2007 – volume: 19 start-page: 915 year: 2016 ident: BFnrn2017130_CR70 publication-title: Nat. Neurosci. doi: 10.1038/nn.4313 – volume: 13 start-page: 635 year: 2010 ident: BFnrn2017130_CR89 publication-title: Nat. Neurosci. doi: 10.1038/nn.2519 – volume: 35 start-page: 229 year: 2010 ident: BFnrn2017130_CR146 publication-title: Addict. Behav. doi: 10.1016/j.addbeh.2009.10.017 – volume: 6 start-page: 221 year: 2013 ident: BFnrn2017130_CR160 publication-title: Brain Stimul. doi: 10.1016/j.brs.2012.06.008 – volume: 13 start-page: 37 year: 2016 ident: BFnrn2017130_CR174 publication-title: EBioMedicine doi: 10.1016/j.ebiom.2016.09.029 – volume: 14 start-page: 169 year: 1993 ident: BFnrn2017130_CR107 publication-title: Synapse doi: 10.1002/syn.890140210 – volume: 31 start-page: 13180 year: 2011 ident: BFnrn2017130_CR41 publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.2369-11.2011 – volume: 33 start-page: S54 issue: Suppl. 2 year: 2009 ident: BFnrn2017130_CR80 publication-title: Int. J. Obes. doi: 10.1038/ijo.2009.73 – volume: 68 start-page: 815 year: 2010 ident: BFnrn2017130_CR23 publication-title: Neuron doi: 10.1016/j.neuron.2010.11.022 – volume: 64 start-page: 503 year: 2010 ident: BFnrn2017130_CR203 publication-title: Synapse doi: 10.1002/syn.20755 – volume: 9 start-page: e101350 year: 2014 ident: BFnrn2017130_CR96 publication-title: PLoS ONE doi: 10.1371/journal.pone.0101350 – volume: 1 start-page: 309 year: 2009 ident: BFnrn2017130_CR149 publication-title: Curr. Top. Behav. Neurosci. doi: 10.1007/978-3-540-88955-7_13 – volume: 73 start-page: 827 year: 2013 ident: BFnrn2017130_CR137 publication-title: Biol. Psychiatry doi: 10.1016/j.biopsych.2013.01.032 – volume: 5 start-page: 196 year: 2012 ident: BFnrn2017130_CR79 publication-title: Obes. Facts doi: 10.1159/000338163 – volume: 49 start-page: 253 year: 2014 ident: BFnrn2017130_CR209 publication-title: Psychoneuroendocrinology doi: 10.1016/j.psyneuen.2014.07.018 – volume: 228 start-page: 389 year: 2013 ident: BFnrn2017130_CR230 publication-title: Psychopharmacology doi: 10.1007/s00213-013-3041-9 – volume: 158 start-page: 2015 year: 2001 ident: BFnrn2017130_CR108 publication-title: Am. J. Psychiatry doi: 10.1176/appi.ajp.158.12.2015 – volume: 172 start-page: 334 year: 2015 ident: BFnrn2017130_CR191 publication-title: Br. J. Pharmacol. doi: 10.1111/bph.12639 – volume: 28 start-page: 866 year: 2014 ident: BFnrn2017130_CR103 publication-title: J. Psychopharmacol. doi: 10.1177/0269881114531664 – volume: 37 start-page: 754 year: 2013 ident: BFnrn2017130_CR90 publication-title: Int. J. Obes. doi: 10.1038/ijo.2012.128 – volume: 89 start-page: 18 year: 2009 ident: BFnrn2017130_CR64 publication-title: Prog. Neurobiol. doi: 10.1016/j.pneurobio.2009.05.003 – volume: 41 start-page: 23 year: 2017 ident: BFnrn2017130_CR127 publication-title: Int. J. Obes. doi: 10.1038/ijo.2016.163 – volume: 27 start-page: 468 year: 2004 ident: BFnrn2017130_CR20 publication-title: Trends Neurosci. doi: 10.1016/j.tins.2004.06.006 – volume: 18 start-page: 1230 year: 2015 ident: BFnrn2017130_CR49 publication-title: Nat. Neurosci. doi: 10.1038/nn.4068 – volume: 162 start-page: 712 year: 2015 ident: BFnrn2017130_CR53 publication-title: Cell doi: 10.1016/j.cell.2015.07.046 – volume: 19 start-page: 1037 year: 2014 ident: BFnrn2017130_CR118 publication-title: Mol. Psychiatry doi: 10.1038/mp.2014.58 – volume: 40 start-page: 24 year: 2016 ident: BFnrn2017130_CR168 publication-title: Front. Neuroendocrinol. doi: 10.1016/j.yfrne.2015.07.001 – volume: 66 start-page: 896 year: 2010 ident: BFnrn2017130_CR45 publication-title: Neuron doi: 10.1016/j.neuron.2010.05.011 – volume: 9 start-page: 213 year: 2004 ident: BFnrn2017130_CR221 publication-title: Addict. Biol. doi: 10.1111/j.1369-1600.2004.tb00535.x – volume: 594 start-page: 6443 year: 2016 ident: BFnrn2017130_CR185 publication-title: J. Physiol. doi: 10.1113/JP271946 – volume: 92 start-page: 573 year: 1998 ident: BFnrn2017130_CR192 publication-title: Cell doi: 10.1016/S0092-8674(00)80949-6 – volume: 6 start-page: 15 year: 2016 ident: BFnrn2017130_CR175 publication-title: Front. Cell. Infect. Microbiol. doi: 10.3389/fcimb.2016.00015 – volume: 17 start-page: 1022 year: 2014 ident: BFnrn2017130_CR50 publication-title: Nat. Neurosci. doi: 10.1038/nn.3743 – volume: 22 start-page: 1179 year: 2016 ident: BFnrn2017130_CR75 publication-title: Addict. Biol. doi: 10.1111/adb.12401 – volume: 1 start-page: 37 year: 2011 ident: BFnrn2017130_CR104 publication-title: EJNMMI Res. doi: 10.1186/2191-219X-1-37 – volume: 67 start-page: 176 year: 2015 ident: BFnrn2017130_CR144 publication-title: Pharmacol Rev. doi: 10.1124/pr.114.009514 – volume: 35 start-page: 1105 year: 2012 ident: BFnrn2017130_CR109 publication-title: Diabetes Care doi: 10.2337/dc11-2250 – volume: 2 start-page: 23 year: 2011 ident: BFnrn2017130_CR33 publication-title: Front. Psychiatry doi: 10.3389/fpsyt.2011.00023 – volume: 10 start-page: 66 year: 2016 ident: BFnrn2017130_CR92 publication-title: Front. Behav. Neurosci. doi: 10.3389/fnbeh.2016.00066 – volume: 34 start-page: 5486 year: 2014 ident: BFnrn2017130_CR199 publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.4861-12.2014 – volume: 20 start-page: 1772 year: 2006 ident: BFnrn2017130_CR210 publication-title: Mol. Endocrinol. doi: 10.1210/me.2005-0084 – volume: 282 start-page: 176 year: 2014 ident: BFnrn2017130_CR31 publication-title: Neuroscience doi: 10.1016/j.neuroscience.2014.07.034 – volume: 104 start-page: 149 year: 2011 ident: BFnrn2017130_CR134 publication-title: Physiol. Behav. doi: 10.1016/j.physbeh.2011.04.063 – volume: 1 start-page: 86 year: 2012 ident: BFnrn2017130_CR86 publication-title: Mol. Metab. doi: 10.1016/j.molmet.2012.07.003 – volume: 385 start-page: 165 year: 1997 ident: BFnrn2017130_CR198 publication-title: Nature doi: 10.1038/385165a0 – volume: 1061 start-page: 88 year: 2005 ident: BFnrn2017130_CR12 publication-title: Brain Res. doi: 10.1016/j.brainres.2005.08.053 – volume: 120 start-page: 10 year: 1995 ident: BFnrn2017130_CR62 publication-title: Psychopharmacology doi: 10.1007/BF02246140 – volume: 35 start-page: 235 year: 2011 ident: BFnrn2017130_CR223 publication-title: Alcohol. Clin. Exp. Res. doi: 10.1111/j.1530-0277.2010.01339.x – volume: 964 start-page: 107 year: 2003 ident: BFnrn2017130_CR181 publication-title: Brain Res. doi: 10.1016/S0006-8993(02)04087-8 – volume: 111 start-page: 6455 year: 2014 ident: BFnrn2017130_CR24 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1404323111 – volume: 32 start-page: 517 year: 2009 ident: BFnrn2017130_CR16 publication-title: Trends Neurosci. doi: 10.1016/j.tins.2009.06.004 – volume: 454 start-page: 118 year: 2008 ident: BFnrn2017130_CR73 publication-title: Nature doi: 10.1038/nature06995 – volume: 10 start-page: 87 year: 2010 ident: BFnrn2017130_CR43 publication-title: Curr. Opin. Pharmacol. doi: 10.1016/j.coph.2009.09.008 – volume: 30 start-page: 14273 year: 2010 ident: BFnrn2017130_CR25 publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.1894-10.2010 – volume: 100 start-page: 344 year: 2016 ident: BFnrn2017130_CR145 publication-title: Clin. Pharmacol. Ther. doi: 10.1002/cpt.402 – volume: 7 start-page: 123 year: 2017 ident: BFnrn2017130_CR167 publication-title: Clin. Obes. doi: 10.1111/cob.12183 – volume: 9 start-page: e101585 year: 2014 ident: BFnrn2017130_CR115 publication-title: PLoS ONE doi: 10.1371/journal.pone.0101585 – volume: 41 start-page: 2241 year: 2016 ident: BFnrn2017130_CR195 publication-title: Neuropsychopharmacology doi: 10.1038/npp.2016.19 – volume: 30 start-page: 13105 year: 2010 ident: BFnrn2017130_CR117 publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.2105-10.2010 – volume: 330 start-page: 385 year: 2010 ident: BFnrn2017130_CR216 publication-title: Science doi: 10.1126/science.1188472 – volume: 7 start-page: 106 year: 2005 ident: BFnrn2017130_CR232 publication-title: Prim. Care Companion J. Clin. Psychiatry doi: 10.4088/PCC.v07n0305 – volume: 28 start-page: 1545 year: 2008 ident: BFnrn2017130_CR187 publication-title: Eur. J. Neurosci. doi: 10.1111/j.1460-9568.2008.06397.x – volume: 23 start-page: 639 year: 2013 ident: BFnrn2017130_CR52 publication-title: Curr. Opin. Neurobiol. doi: 10.1016/j.conb.2013.01.002 – volume: 10 start-page: 318 year: 2000 ident: BFnrn2017130_CR100 publication-title: Cereb. Cortex doi: 10.1093/cercor/10.3.318 – volume: 6 start-page: 6 year: 2015 ident: BFnrn2017130_CR81 publication-title: Front. Pharmacol. – volume: 51 start-page: 801 year: 2006 ident: BFnrn2017130_CR180 publication-title: Neuron doi: 10.1016/j.neuron.2006.08.023 – volume: 41 start-page: 1697 year: 2016 ident: BFnrn2017130_CR40 publication-title: Neuropsychopharmacology doi: 10.1038/npp.2015.358 – volume: 76 start-page: 370 year: 2014 ident: BFnrn2017130_CR132 publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2013.05.024 – volume: 16 start-page: 579 year: 2015 ident: BFnrn2017130_CR10 publication-title: Nat. Rev. Neurosci. doi: 10.1038/nrn4004 – volume: 30 start-page: 220 year: 2007 ident: BFnrn2017130_CR37 publication-title: Trends Neurosci. doi: 10.1016/j.tins.2007.03.003 – volume: 8 start-page: 1442 year: 2005 ident: BFnrn2017130_CR129 publication-title: Nat. Neurosci. doi: 10.1038/nn1105-1442 – start-page: 987 volume-title: Fundamental Neuroscience year: 2008 ident: BFnrn2017130_CR51 – volume: 12 start-page: 726 year: 2015 ident: BFnrn2017130_CR178 publication-title: Cell Rep. doi: 10.1016/j.celrep.2015.06.062 – volume: 176 start-page: 17 year: 2017 ident: BFnrn2017130_CR235 publication-title: Physiol. Behav. doi: 10.1016/j.physbeh.2017.03.019 – volume: 108 start-page: 2693 year: 2011 ident: BFnrn2017130_CR98 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1010076108 – volume: 110 start-page: 20 year: 2016 ident: BFnrn2017130_CR54 publication-title: Brain Cogn. doi: 10.1016/j.bandc.2016.04.004 – volume: 42 start-page: 196 year: 2001 ident: BFnrn2017130_CR228 publication-title: Synapse doi: 10.1002/syn.10000 – volume: 21 start-page: 1140 year: 2016 ident: BFnrn2017130_CR85 publication-title: Addict. Biol. doi: 10.1111/adb.12287 – volume: 21 start-page: 422 year: 2016 ident: BFnrn2017130_CR147 publication-title: Addict. Biol. doi: 10.1111/adb.12295 – volume: 28 start-page: 875 year: 2014 ident: BFnrn2017130_CR208 publication-title: CNS Drugs doi: 10.1007/s40263-014-0178-y – volume: 16 start-page: 174 year: 1997 ident: BFnrn2017130_CR131 publication-title: Neuropsychopharmacology doi: 10.1016/S0893-133X(96)00184-4 – volume: 29 start-page: 571 year: 2006 ident: BFnrn2017130_CR190 publication-title: Trends Neurosci. doi: 10.1016/j.tins.2006.08.002 – volume: 57 start-page: 930 year: 2008 ident: BFnrn2017130_CR139 publication-title: Neuron doi: 10.1016/j.neuron.2008.01.032 – volume: 3 start-page: 64 year: 2014 ident: BFnrn2017130_CR200 publication-title: Mol. Metab. doi: 10.1016/j.molmet.2013.10.001 – volume: 23 start-page: 103 year: 2016 ident: BFnrn2017130_CR87 publication-title: Cell Metab. doi: 10.1016/j.cmet.2015.10.009 – volume: 219 start-page: 1787 year: 2014 ident: BFnrn2017130_CR38 publication-title: Brain Struct. Function doi: 10.1007/s00429-013-0601-z – volume: 356 start-page: 85 year: 2016 ident: BFnrn2017130_CR141 publication-title: J. Pharmacol. Exp. Ther. doi: 10.1124/jpet.115.228833 – volume: 33 start-page: 7618 year: 2013 ident: BFnrn2017130_CR189 publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.2588-12.2013 – volume: 38 start-page: 255 year: 2013 ident: BFnrn2017130_CR138 publication-title: Minerva Endocrinol. – volume: 68 start-page: 306 year: 2010 ident: BFnrn2017130_CR55 publication-title: Biol. Psychiatry doi: 10.1016/j.biopsych.2010.03.026 – volume: 114 start-page: 160 year: 2017 ident: BFnrn2017130_CR128 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1605548113 – volume: 160 start-page: 1078 year: 2003 ident: BFnrn2017130_CR99 publication-title: Am. J. Psychiatry doi: 10.1176/appi.ajp.160.6.1078 – volume: 97 start-page: 509 year: 2011 ident: BFnrn2017130_CR218 publication-title: Pharmacol. Biochem. Behav. doi: 10.1016/j.pbb.2010.10.004 – volume: 844 start-page: 59 year: 1998 ident: BFnrn2017130_CR226 publication-title: Ann. NY Acad. Sci. doi: 10.1111/j.1749-6632.1998.tb08222.x – volume: 124 start-page: 1720 year: 2001 ident: BFnrn2017130_CR60 publication-title: Brain doi: 10.1093/brain/124.9.1720 – volume: 10 start-page: 514 year: 2016 ident: BFnrn2017130_CR169 publication-title: Front. Hum. Neurosci. doi: 10.3389/fnhum.2016.00514 – volume: 34 start-page: 1774 year: 2009 ident: BFnrn2017130_CR111 publication-title: Neuropsychopharmacology doi: 10.1038/npp.2008.235 – volume: 222 start-page: 390 year: 2011 ident: BFnrn2017130_CR84 publication-title: Behav. Brain Res. doi: 10.1016/j.bbr.2011.03.064 – volume: 36 start-page: 11469 year: 2016 ident: BFnrn2017130_CR179 publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.2338-16.2016 – volume: 49 start-page: 170 year: 2016 ident: BFnrn2017130_CR166 publication-title: Pharmacopsychiatry doi: 10.1055/s-0036-1582055 – volume: 35 start-page: 6464 year: 2015 ident: BFnrn2017130_CR18 publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.4153-14.2015 – volume: 73 start-page: 49 year: 2014 ident: BFnrn2017130_CR206 publication-title: Neurochem. Int. doi: 10.1016/j.neuint.2013.10.003 – volume: 363 start-page: 3191 year: 2008 ident: BFnrn2017130_CR5 publication-title: Philos. Trans. R. Soc. Lond. B Biol. Sci. doi: 10.1098/rstb.2008.0107 – volume: 18 start-page: 1025 year: 2013 ident: BFnrn2017130_CR26 publication-title: Mol. Psychiatry doi: 10.1038/mp.2013.57 – volume: 28 start-page: 686 year: 2013 ident: BFnrn2017130_CR135 publication-title: Psychol. Health doi: 10.1080/08870446.2012.751106 – volume: 8 start-page: 1 year: 2015 ident: BFnrn2017130_CR157 publication-title: Neuroimage Clin. doi: 10.1016/j.nicl.2015.03.016 – volume: 35 start-page: 11572 year: 2015 ident: BFnrn2017130_CR32 publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.2344-15.2015 – volume: 162 start-page: 1414 year: 2005 ident: BFnrn2017130_CR63 publication-title: Am. J. Psychiatry doi: 10.1176/appi.ajp.162.8.1414 – volume: 26 start-page: R267 year: 2016 ident: BFnrn2017130_CR48 publication-title: Curr. Biol. doi: 10.1016/j.cub.2016.02.036 – volume: 282 start-page: 49 year: 2014 ident: BFnrn2017130_CR47 publication-title: Neuroscience doi: 10.1016/j.neuroscience.2014.04.026 – volume: 23 start-page: 9395 year: 2003 ident: BFnrn2017130_CR11 publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.23-28-09395.2003 – volume: 82 start-page: 721 year: 2002 ident: BFnrn2017130_CR59 publication-title: J. Neurochem. doi: 10.1046/j.1471-4159.2002.01005.x – volume: 28 start-page: 9021 year: 2008 ident: BFnrn2017130_CR68 publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.0694-08.2008 – volume: 137 start-page: 3129 year: 2014 ident: BFnrn2017130_CR19 publication-title: Brain doi: 10.1093/brain/awu277 – volume: 25 start-page: 5389 year: 2005 ident: BFnrn2017130_CR67 publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.0955-05.2005 – volume: 19 start-page: 117 year: 2016 ident: BFnrn2017130_CR56 publication-title: Nat. Neurosci. doi: 10.1038/nn.4173 – volume: 3 start-page: 169 year: 2012 ident: BFnrn2017130_CR196 publication-title: Front. Endocrinol. doi: 10.3389/fendo.2012.00169 – volume: 5 start-page: 164 year: 2013 ident: BFnrn2017130_CR205 publication-title: J. Clin. Med. Res. – volume: 489 start-page: 242 year: 2012 ident: BFnrn2017130_CR213 publication-title: Nature doi: 10.1038/nature11552 – volume: 66 start-page: 232 year: 2013 ident: BFnrn2017130_CR121 publication-title: Neuroimage doi: 10.1016/j.neuroimage.2012.10.035 – volume: 68 start-page: 685 year: 2010 ident: BFnrn2017130_CR126 publication-title: Biol. Psychiatry doi: 10.1016/j.biopsych.2010.08.002 – volume: 32 start-page: 6711 year: 2012 ident: BFnrn2017130_CR171 publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.0045-12.2012 – volume: 180 start-page: 129 year: 2011 ident: BFnrn2017130_CR183 publication-title: Neuroscience doi: 10.1016/j.neuroscience.2011.02.016 – volume: 5 start-page: 483 year: 2004 ident: BFnrn2017130_CR7 publication-title: Nat. Rev. Neurosci. doi: 10.1038/nrn1406 – volume: 8 start-page: 1065 year: 2017 ident: BFnrn2017130_CR142 publication-title: ACS Chem. Neurosci. doi: 10.1021/acschemneuro.6b00413 – volume: 104 start-page: 87 year: 2011 ident: BFnrn2017130_CR9 publication-title: Physiol. Behav. doi: 10.1016/j.physbeh.2011.04.041 – volume: 30 start-page: 767 year: 1989 ident: BFnrn2017130_CR22 publication-title: Neuroscience doi: 10.1016/0306-4522(89)90168-1 – volume: 10 start-page: 337 year: 2005 ident: BFnrn2017130_CR222 publication-title: Addict. Biol. doi: 10.1080/13556210500314527 – volume: 18 start-page: 393 year: 2010 ident: BFnrn2017130_CR217 publication-title: Neurotox. Res. doi: 10.1007/s12640-010-9176-0 – volume: 21 start-page: 2444 year: 2013 ident: BFnrn2017130_CR151 publication-title: Obesity doi: 10.1002/oby.20397 – volume: 641 start-page: 56 year: 2017 ident: BFnrn2017130_CR170 publication-title: Neurosci. Lett. doi: 10.1016/j.neulet.2017.01.055 – volume: 49 start-page: 782 year: 2001 ident: BFnrn2017130_CR204 publication-title: Biol. Psychiatry doi: 10.1016/S0006-3223(01)01081-2 – volume: 13 start-page: 041002 year: 2016 ident: BFnrn2017130_CR165 publication-title: J. Neural Eng. doi: 10.1088/1741-2560/13/4/041002 – volume: 15 start-page: 816 year: 2012 ident: BFnrn2017130_CR44 publication-title: Nat. Neurosci. doi: 10.1038/nn.3100 – volume: 34 start-page: 560 year: 2013 ident: BFnrn2017130_CR227 publication-title: Trends Pharmacol. Sci. doi: 10.1016/j.tips.2013.08.001 – volume: 11 start-page: 408 year: 2016 ident: BFnrn2017130_CR234 publication-title: J. Neuroimmune Pharmacol. doi: 10.1007/s11481-016-9680-y – volume: 32 start-page: 841 year: 2012 ident: BFnrn2017130_CR123 publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.4461-11.2012 – volume: 40 start-page: 2247 year: 2016 ident: BFnrn2017130_CR237 publication-title: Alcohol. Clin. Exp. Res. doi: 10.1111/acer.13199 – volume: 39 start-page: 2974 year: 2014 ident: BFnrn2017130_CR76 publication-title: Neuropsychopharmacology doi: 10.1038/npp.2014.149 – volume: 56 start-page: 395 year: 1995 ident: BFnrn2017130_CR231 publication-title: J. Clin. Psychiatry – volume: 76 start-page: 360 year: 2014 ident: BFnrn2017130_CR119 publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2013.04.025 – volume: 6 start-page: e809 year: 2016 ident: BFnrn2017130_CR236 publication-title: Transl Psychiatry doi: 10.1038/tp.2016.86 – volume: 6 start-page: 21 year: 2016 ident: BFnrn2017130_CR163 publication-title: Brain Sci. doi: 10.3390/brainsci6030021 – volume: 168 start-page: 48 year: 2010 ident: BFnrn2017130_CR78 publication-title: Neuroscience doi: 10.1016/j.neuroscience.2010.03.034 – volume: 26 start-page: 25 year: 2007 ident: BFnrn2017130_CR112 publication-title: Drug Alcohol Rev. doi: 10.1080/09595230601036960 – volume: 5 start-page: 2062 year: 2016 ident: BFnrn2017130_CR172 publication-title: F1000Res doi: 10.12688/f1000research.9180.1 – volume: 62 start-page: 30 year: 2014 ident: BFnrn2017130_CR193 publication-title: Mol. Cell Neurosci. doi: 10.1016/j.mcn.2014.08.001 – reference: 27151395 - Nord J Psychiatry. 2016 Nov;70(8):561-2 – reference: 2528080 - Neuroscience. 1989;30(3):767-77 – reference: 26435524 - Addict Biol. 2016 Jan;21(1):3-22 – reference: 23832596 - Brain Struct Funct. 2014 Sep;219(5):1787-800 – reference: 24979216 - PLoS One. 2014 Jun 30;9(6):e101350 – reference: 24769227 - Neuroscience. 2014 Dec 12;282:49-59 – reference: 25084048 - Neuroscience. 2014 Dec 12;282:176-97 – reference: 15511715 - Addict Biol. 2004 Sep-Dec;9(3-4):213-9 – reference: 25959611 - Trends Neurosci. 2015 Jun;38(6):345-52 – reference: 21473572 - Anal Chem. 2011 May 1;83(9):3563-71 – reference: 26182835 - Front Neuroendocrinol. 2016 Jan;40:24-41 – reference: 27911750 - J Neurosci. 2016 Nov 9;36(45):11469-11481 – reference: 23103690 - Neuroimage. 2013 Feb 1;66:232-9 – reference: 26534942 - J Pharmacol Exp Ther. 2016 Jan;356(1):85-95 – reference: 26212334 - Cell Rep. 2015 Aug 4;12(5):726-33 – reference: 12777265 - Am J Psychiatry. 2003 Jun;160(6):1078-85 – reference: 24089490 - J Neurosci. 2013 Oct 2;33(40):15827-36 – reference: 18640912 - Philos Trans R Soc Lond B Biol Sci. 2008 Oct 12;363(1507):3191-200 – reference: 27752130 - Sci Rep. 2016 Oct 18;6:35455 – reference: 23520203 - Obesity (Silver Spring). 2013 Dec;21(12):2444-51 – reference: 19555651 - Neuron. 2009 Jun 25;62(6):826-38 – reference: 22868829 - Int J Obes (Lond). 2013 May;37(5):754-7 – reference: 16226228 - Brain Res. 2005 Nov 9;1061(2):88-96 – reference: 20452572 - Biol Psychiatry. 2010 Aug 1;68(3):306-9 – reference: 26655188 - Eur Neuropsychopharmacol. 2016 Jan;26(1):37-44 – reference: 15944133 - Neuron. 2005 May 19;46(4):661-9 – reference: 20170674 - Brain Res Rev. 2010 Sep;64(1):14-103 – reference: 16318955 - Addict Biol. 2005 Dec;10(4):337-43 – reference: 26925392 - Front Cell Infect Microbiol. 2016 Feb 19;6:15 – reference: 27187231 - Transl Psychiatry. 2016 May 17;6:e809 – reference: 26954979 - Transl Psychiatry. 2016 Mar 08;6:e752 – reference: 22573693 - J Neurosci. 2012 May 9;32(19):6711-7 – reference: 20881128 - J Neurosci. 2010 Sep 29;30(39):13105-9 – reference: 22647302 - Obes Facts. 2012;5(2):196-207 – reference: 14561867 - J Neurosci. 2003 Oct 15;23(28):9395-402 – reference: 15271494 - Trends Neurosci. 2004 Aug;27(8):468-74 – reference: 19837631 - Curr Opin Pharmacol. 2010 Feb;10(1):87-92 – reference: 24912491 - Mol Psychiatry. 2014 Sep;19(9):1037-43 – reference: 26223161 - Addict Biol. 2016 Nov;21(6):1140-1150 – reference: 24024122 - Mol Metab. 2012 Jul 27;1(1-2):86-93 – reference: 22809824 - Brain Stimul. 2013 May;6(3):221-30 – reference: 26110109 - Neuroimage Clin. 2015 Mar 24;8:1-31 – reference: 24785761 - J Psychopharmacol. 2014 Sep;28(9):866-73 – reference: 28130186 - Neurosci Lett. 2017 Feb 22;641:56-61 – reference: 26647973 - Neuropsychopharmacology. 2016 Jun;41(7):1697-715 – reference: 27184387 - J Neuroimmune Pharmacol. 2016 Sep;11(3):408-33 – reference: 26303264 - Addict Biol. 2016 Mar;21(2):422-37 – reference: 25664726 - Synapse. 2015 Apr;69(4):195-202 – reference: 16904760 - Trends Neurosci. 2006 Oct;29(10):571-7 – reference: 26290234 - J Neurosci. 2015 Aug 19;35(33):11572-82 – reference: 16055762 - Am J Psychiatry. 2005 Aug;162(8):1414-22 – reference: 21549136 - Physiol Behav. 2011 Jul 25;104(1):87-97 – reference: 26235449 - Trends Cogn Sci. 2015 Aug;19(8):439-44 – reference: 22214469 - EJNMMI Res. 2011 Dec 16;1(1):37 – reference: 22432117 - Diabetes Care. 2012 May;35(5):1105-11 – reference: 27213949 - Clin Pharmacol Ther. 2016 Oct;100(4):344-52 – reference: 20348917 - Nat Neurosci. 2010 May;13(5):635-41 – reference: 24732416 - Physiol Behav. 2014 Sep;136:63-73 – reference: 17948030 - Nat Rev Neurosci. 2007 Nov;8(11):844-58 – reference: 15856065 - Nat Neurosci. 2005 May;8(5):571-8 – reference: 21412887 - Cochrane Database Syst Rev. 2011 Mar 16;(3):CD005353 – reference: 24140429 - Neurochem Int. 2014 Jul;73:49-55 – reference: 25142207 - Hum Brain Mapp. 2015 Jan;36(1):120-36 – reference: 25273995 - Brain. 2014 Dec;137(Pt 12):3129-35 – reference: 22972297 - Nature. 2012 Sep 13;489(7415):242-9 – reference: 7931564 - J Neurosci. 1994 Oct;14(10):6084-93 – reference: 9491897 - Cell. 1998 Feb 20;92(4):573-85 – reference: 16027765 - Prim Care Companion J Clin Psychiatry. 2005;7(3):106-13 – reference: 17400299 - Trends Neurosci. 2007 May;30(5):220-7 – reference: 26214370 - Nat Neurosci. 2015 Sep;18(9):1230-2 – reference: 25065439 - Nat Neurosci. 2014 Aug;17(8):1022-30 – reference: 23293630 - Front Endocrinol (Lausanne). 2012 Dec 27;3:169 – reference: 23541000 - Biol Psychiatry. 2013 May 1;73(9):827-35 – reference: 9015800 - Neuropsychopharmacology. 1997 Feb;16(2):174-82 – reference: 16982424 - Neuron. 2006 Sep 21;51(6):801-10 – reference: 11430814 - Neuron. 2001 Jun;30(3):819-28 – reference: 28653666 - Neuropsychopharmacology. 2017 Jun 27;:null – reference: 27101941 - Addict Biol. 2017 Sep;22(5):1179-1190 – reference: 27351347 - J Neural Eng. 2016 Aug;13(4):041002 – reference: 22196339 - Neuron. 2011 Dec 22;72(6):1055-66 – reference: 27596289 - Psychopharmacology (Berl). 2016 Dec;233(23-24):3849-3859 – reference: 25107627 - Mol Cell Neurosci. 2014 Sep;62:30-41 – reference: 27238864 - Neuron. 2016 Jun 15;90(6):1286-1298 – reference: 27709426 - Metab Brain Dis. 2017 Feb;32(1):1-17 – reference: 23884939 - J Neurosci. 2013 Jul 24;33(30):12329-36 – reference: 28296261 - Clin Obes. 2017 Jun;7(3):123-135 – reference: 26116518 - Neuroscience. 2015 Aug 20;301:529-41 – reference: 23267662 - Curr Opin Neurobiol. 2013 Apr;23(2):229-38 – reference: 26887589 - Psychopharmacology (Berl). 2016 Apr;233(8):1405-13 – reference: 21917801 - J Neurosci. 2011 Sep 14;31(37):13180-90 – reference: 24126546 - Minerva Endocrinol. 2013 Sep;38(3):255-67 – reference: 20620875 - Neuron. 2010 Jun 24;66(6):896-907 – reference: 22801496 - Nature. 2012 Aug 9;488(7410):172-7 – reference: 10407046 - J Neurosci. 1999 Jul 15;19(14):6102-10 – reference: 27720396 - EBioMedicine. 2016 Nov;13:37-45 – reference: 27994159 - Proc Natl Acad Sci U S A. 2017 Jan 3;114(1):160-165 – reference: 18003826 - J Neurosci. 2007 Nov 14;27(46):12484-8 – reference: 25904797 - J Neurosci. 2015 Apr 22;35(16):6464-71 – reference: 27046807 - Curr Biol. 2016 Apr 4;26(7):R267-9 – reference: 26304761 - Brain Res Bull. 2016 May;123:47-52 – reference: 21907138 - Cell Metab. 2011 Sep 7;14(3):313-23 – reference: 27579999 - Alcohol Clin Exp Res. 2016 Oct;40(10 ):2247-2252 – reference: 20947769 - Science. 2010 Oct 15;330(6002):385-90 – reference: 25099550 - Am J Clin Nutr. 2014 Oct;100(4):1003-9 – reference: 16179409 - Endocrinology. 2006 Jan;147(1):23-30 – reference: 23434063 - Curr Opin Neurobiol. 2013 Aug;23(4):639-48 – reference: 11210998 - Lancet. 2001 Feb 3;357(9253):354-7 – reference: 26816013 - N Engl J Med. 2016 Jan 28;374(4):363-71 – reference: 27790107 - Front Hum Neurosci. 2016 Oct 14;10 :514 – reference: 24155246 - Eur Eat Disord Rev. 2013 Nov;21(6):436-55 – reference: 23637156 - J Neurosci. 2013 May 1;33(18):7618-26 – reference: 21497172 - Behav Brain Res. 2011 Sep 23;222(2):390-3 – reference: 24084922 - JAMA. 2013 Oct 2;310(13):1369-76 – reference: 8990120 - Nature. 1997 Jan 9;385(6612):165-8 – reference: 11729018 - Am J Psychiatry. 2001 Dec;158(12 ):2015-21 – reference: 24737889 - Proc Natl Acad Sci U S A. 2014 Apr 29;111(17):6455-60 – reference: 27654143 - Int J Obes (Lond). 2017 Jan;41(1):23-29 – reference: 27438859 - Brain Sci. 2016 Jul 18;6(3):null – reference: 24943644 - Neuropsychopharmacology. 2014 Dec;39(13):2974-88 – reference: 19902317 - Obes Surg. 2010 Mar;20(3):369-74 – reference: 26276628 - Cell. 2015 Aug 13;162(4):712-25 – reference: 18598772 - Neuroimage. 2008 Oct 1;42(4):1537-43 – reference: 28285820 - Neuron. 2017 Mar 22;93(6):1436-1450.e8 – reference: 15930388 - J Neurosci. 2005 Jun 1;25(22):5389-96 – reference: 23711983 - Mol Psychiatry. 2013 Sep;18(9):1025-33 – reference: 26243270 - Neuropsychopharmacology. 2016 Mar;41(4):1024-33 – reference: 24041919 - Trends Pharmacol Sci. 2013 Oct;34(10):560-70 – reference: 23639430 - Neuropharmacology. 2014 Jan;76 Pt B:360-9 – reference: 21469956 - Annu Rev Neurosci. 2011;34:441-66 – reference: 19758714 - Trends Neurosci. 2009 Oct;32(10):517-24 – reference: 24641197 - Br J Pharmacol. 2015 Jan;172(2):334-48 – reference: 26072178 - Physiol Behav. 2015 Oct 1;149:262-8 – reference: 27616451 - Nat Rev Endocrinol. 2017 Jan;13(1):11-25 – reference: 26698915 - Cell Metab. 2016 Jan 12;23 (1):103-12 – reference: 25740524 - J Neurosci. 2015 Mar 4;35(9):3959-65 – reference: 9658025 - J Neurophysiol. 1998 Jul;80(1):1-27 – reference: 26852738 - Neuropsychopharmacology. 2016 Aug;41(9):2241-51 – reference: 10731226 - Cereb Cortex. 2000 Mar;10(3):318-25 – reference: 20962248 - J Neurosci. 2010 Oct 20;30(42):14273-83 – reference: 18591467 - Ann N Y Acad Sci. 2008;1129:35-46 – reference: 1799281 - Appetite. 1991 Dec;17(3):187-97 – reference: 19828259 - Psychoneuroendocrinology. 2010 May;35(4):570-7 – reference: 7665537 - J Clin Psychiatry. 1995 Sep;56(9):395-401 – reference: 26449524 - Eur Eat Disord Rev. 2015 Nov;23(6):442-50 – reference: 27239940 - Nat Neurosci. 2016 Jul;19(7):915-25 – reference: 27067014 - Mol Psychiatry. 2016 Jun;21(6):786-96 – reference: 27980074 - Learn Mem. 2016 Dec 15;24(1):35-42 – reference: 16177034 - J Neurosci. 2005 Sep 21;25(38):8665-70 – reference: 27145161 - Pharmacopsychiatry. 2016 Jul;49(4):170-3 – reference: 27845229 - Behav Brain Res. 2017 Feb 15;319:1-8 – reference: 25000285 - PLoS One. 2014 Jul 07;9(7):e101585 – reference: 19528981 - Int J Obes (Lond). 2009 Jun;33 Suppl 2:S54-8 – reference: 22117165 - Rev Neurosci. 2011;22(6):609-24 – reference: 19926400 - Addict Behav. 2010 Mar;35(3):229-34 – reference: 23671541 - J Clin Med Res. 2013 Jun;5(3):164-7 – reference: 21557958 - Physiol Behav. 2011 Jul 25;104(1):149-56 – reference: 19342487 - Proc Natl Acad Sci U S A. 2009 May 5;106(18):7281-8 – reference: 19177067 - Neuropsychopharmacology. 2009 Jun;34(7):1774-82 – reference: 20361291 - Neurotox Res. 2010 Nov;18(3-4):393-409 – reference: 12573518 - Brain Res. 2003 Feb 21;964(1):107-15 – reference: 18768696 - J Neurosci. 2008 Sep 3;28(36):9021-9 – reference: 25127083 - Psychoneuroendocrinology. 2014 Nov;49:253-9 – reference: 7480530 - Psychopharmacology (Berl). 1995 Jul;120(1):10-20 – reference: 9668665 - Ann N Y Acad Sci. 1998 May 30;844:59-74 – reference: 22580057 - Eur Neuropsychopharmacol. 2013 Mar;23(3):240-52 – reference: 15992564 - J Psychiatr Res. 2005 Sep;39(5):545-51 – reference: 24741039 - J Neurosci. 2014 Apr 16;34(16):5486-96 – reference: 23578393 - Neuropharmacology. 2014 Jan;76 Pt B:351-9 – reference: 19497349 - Prog Neurobiol. 2009 Sep;89(1):18-45 – reference: 18367093 - Neuron. 2008 Mar 27;57(6):930-41 – reference: 28315693 - Physiol Behav. 2017 Jul 1;176:17-25 – reference: 12358778 - J Neurochem. 2002 Aug;82(4):721-35 – reference: 1727431 - J Neurochem. 1992 Jan;58(1):212-8 – reference: 20175225 - Synapse. 2010 Jul;64(7):503-10 – reference: 20856250 - Mol Psychiatry. 2011 Nov;16(11):1147-54 – reference: 16251985 - Nat Neurosci. 2005 Nov;8(11):1442-4 – reference: 26527415 - Eur J Neurosci. 2015 Dec;42(12 ):3095-104 – reference: 20951159 - Pharmacol Biochem Behav. 2011 Jan;97(3):509-13 – reference: 23173916 - Crit Rev Biochem Mol Biol. 2013 Jan-Feb;48(1):1-19 – reference: 25704194 - Trends Pharmacol Sci. 2015 Mar;36(3):145-52 – reference: 26373473 - Nat Rev Neurosci. 2015 Oct;16(10 ):579-94 – reference: 27922639 - Transl Psychiatry. 2016 Dec 6;6(12 ):e972 – reference: 20888455 - Biol Psychiatry. 2010 Oct 15;68(8):685-6 – reference: 23244741 - Psychol Health. 2013;28(6):686-700 – reference: 25505168 - Pharmacol Rev. 2015;67(1):176-97 – reference: 560969 - Eur J Pharmacol. 1977 Aug 1;44(3):231-40 – reference: 23354329 - Nat Neurosci. 2013 Mar;16(3):300-8 – reference: 26595651 - Nat Neurosci. 2016 Jan;19(1):117-26 – reference: 18793323 - Eur J Neurosci. 2008 Oct;28(8):1545-56 – reference: 23503684 - Psychopharmacology (Berl). 2013 Aug;228(3):389-400 – reference: 22034017 - Synapse. 2012 Mar;66(3):196-203 – reference: 21121933 - Alcohol Clin Exp Res. 2011 Feb;35(2):235-9 – reference: 18640910 - Philos Trans R Soc Lond B Biol Sci. 2008 Oct 12;363(1507):3125-35 – reference: 11954049 - Synapse. 2002 Jun 1;44(3):175-80 – reference: 28107783 - ACS Chem Neurosci. 2017 May 17;8(5):1065-1073 – reference: 11522575 - Brain. 2001 Sep;124(Pt 9):1720-33 – reference: 17364833 - Drug Alcohol Rev. 2007 Jan;26(1):25-31 – reference: 25576647 - Neuroimage. 2015 Apr 1;109:318-27 – reference: 27302606 - J Physiol. 2016 Nov 15;594(22):6443-6462 – reference: 21144997 - Neuron. 2010 Dec 9;68(5):815-34 – reference: 22189292 - Neuropsychopharmacology. 2012 Apr;37(5):1177-91 – reference: 27773782 - Pharmacol Ther. 2017 Feb;170:116-147 – reference: 23950538 - Science. 2013 Aug 16;341(6147):800-2 – reference: 11331086 - Biol Psychiatry. 2001 May 1;49(9):782-7 – reference: 24958205 - CNS Drugs. 2014 Oct;28(10):875-86 – reference: 18500330 - Nature. 2008 Jul 3;454(7200):118-21 – reference: 16601073 - Mol Endocrinol. 2006 Aug;20(8):1772-85 – reference: 21629844 - Front Psychiatry. 2011 May 09;2:23 – reference: 22284186 - Neuron. 2012 Jan 26;73(2):317-32 – reference: 27147989 - Front Behav Neurosci. 2016 Apr 12;10:66 – reference: 12897785 - Nat Neurosci. 2003 Sep;6(9):968-73 – reference: 25698968 - Front Pharmacol. 2015 Feb 05;6:6 – reference: 27156016 - Brain Cogn. 2016 Dec;110:20-42 – reference: 25730614 - Can J Physiol Pharmacol. 2015 Apr;93(4):283-90 – reference: 21104390 - Curr Top Behav Neurosci. 2009;1:309-46 – reference: 12055324 - Obes Res. 2002 Jun;10(6):478-88 – reference: 11746717 - Synapse. 2001 Dec 1;42(3):196-8 – reference: 24391816 - PLoS One. 2013 Dec 31;8(12):e83741 – reference: 27401883 - CNS Drugs. 2016 Aug;30(8):719-33 – reference: 28053327 - Nat Rev Neurosci. 2017 Feb;18(2):73-85 – reference: 23747571 - Neuropharmacology. 2014 Jan;76 Pt B:370-82 – reference: 24567905 - Mol Metab. 2013 Oct 17;3(1):64-72 – reference: 22262882 - J Neurosci. 2012 Jan 18;32(3):841-9 – reference: 8101394 - Synapse. 1993 Jun;14 (2):169-77 – reference: 15152198 - Nat Rev Neurosci. 2004 Jun;5(6):483-94 – reference: 22710289 - JAMA. 2012 Jun 20;307(23):2516-25 – reference: 21475139 - Obesity (Silver Spring). 2011 Nov;19(11):2175-82 – reference: 27635233 - F1000Res. 2016 Aug 24;5:null – reference: 16953002 - Arch Gen Psychiatry. 2006 Sep;63(9):999-1008 – reference: 20346392 - Neuroscience. 2010 Jun 16;168(1):48-60 – reference: 19025237 - J Abnorm Psychol. 2008 Nov;117(4):924-35 – reference: 27551268 - Front Psychiatry. 2016 Aug 08;7:133 – reference: 21262822 - Proc Natl Acad Sci U S A. 2011 Feb 15;108(7):2693-8
SSID	ssj0016176
Score	2.6813283
SecondaryResourceType	review_article
Snippet	Key Points The motivation to eat, like the motivation to take addictive drugs, activates the forebrain dopamine systems. Excessive activation of this system... Behaviours such as eating, copulating, defending oneself or taking addictive drugs begin with a motivation to initiate the behaviour. Both this motivational...
SourceID	proquest gale pubmed crossref springer
SourceType	Aggregation Database Index Database Enrichment Source Publisher
StartPage	741
SubjectTerms	59/36 631/378/1488/393 631/378/1689/5 631/378/2629/1788 692/699/317 692/699/476/5 Addiction Addictions Analysis Animal Genetics and Genomics Animals Behavior, Addictive - drug therapy Behavior, Addictive - physiopathology Behavioral Sciences Biological Techniques Biomedicine Brain research Dopamine Dopamine - metabolism Dopamine - pharmacology Dopamine receptors Dopaminergic mechanisms Drug addiction Food Food Addiction - drug therapy Health aspects Humans Motivation Motivation (Psychology) Motivation - drug effects Neostriatum Neural Pathways - drug effects Neurobiology Neurosciences Obesity Psychological aspects Reinforcement (Psychology) review-article Risk factors
Title	The dopamine motive system: implications for drug and food addiction
URI	https://link.springer.com/article/10.1038/nrn.2017.130 https://www.ncbi.nlm.nih.gov/pubmed/29142296 https://www.proquest.com/docview/1978442581 https://www.proquest.com/docview/1965245065
Volume	18
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
link	http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR3ZSsQwcPAA8UW8rRcRPB6k2Ctp6ot4IoIiorBvJU1SEbS7rrt-vzNtdt0V9TFkEpKZJDOTuQB2ZVjKzAjpp8ZmflJq4WfKhL5VZZZGtoyLun7K7Z24fkpuWrzlPtw-nFvl4E2sH2rT1vRHfhSiupPgAZPhSefdp6pRZF11JTQmYZpSl5HylbaGCheJ7k10UYoqcxC3nON7EMujqkvJT8OUqiGPsaSfD_MIZ_phKq050NU8zDnRkZ02tF6ACVstwsytM44vwQWSnBlUgt-wycjJ7tOyJlPzMXsZ8RxnKKgy0-0_M1UZbLQNI7eiOsJhGZ6uLh_Pr31XJMHXCQ96PuIyiJQIdUwFxFSidKiDQMXcaqlLGxVprfag2lAaXUjkyNZwZWqLpVQoHKzAVNWu7BqwOORWBVoUUWKRt9lMFQHnpRA4LQVZe3A4wFOuXQZxKmTxmteW7FjmiNWcsEpGMg_2htCdJnPGH3AHhPKcLhTOppWLC8A1UWqq_BRFOo4cNI082ByDxIugx7sHRMvdRfzIv4-NBzvDbhpJzmWVbfcJRvAIkSlwh6sNsYcrjjL6JMuEB_sD6o9M_st21v9fxQbMEmTjELMJU71u326hWNMrtuuzuw3TZ5d39w9f1F30Pg
linkProvider	ProQuest
linkToHtml	http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR1dTxQxcEIgQV-M4tcqSk1EH8yGbnfb7ZoYQ0RyCMcTJPdWu23XkOAeHncY_5S_0Zn9OO8I-sbjph_bzkw7M50vgNc6qXThlY5zH4o4q5yKC-uTONiqyEWo0rKpnzI8VoPT7MtIjlbgdx8LQ26V_Z3YXNR-7OiNfCdBdSdDAtPJx4sfMVWNIutqX0KjJYvD8OsnqmyXHw72EL_bQux_Pvk0iLuqArHLJJ_G-HMurEpcShW3bGZd4ji3qQxOuyqIMm_0BJSzK-9KjSwseGl9Y-LTVlCiA7zy15DxcnIhzEdzBY9UhTaaKUcVnaejztGep3qnnlCy1SSn6stLLPA6I1jghNdMsw3H278P9zpRle22tPUAVkK9AevDzhj_EPaQxJhHpfs7fjJy6rsKrM0M_Z6dLXiqMxSMmZ_MvjFbe_wYe0ZuTE1ExSM4vRXwPYbVelyHp8DSRAbLnSpFFpCXhsKWXMpKKZyWgrojeNfDybguYzkVzjg3jeU81QahagiqZJSLYHve-6LN1PGPfm8J5IYOMM7mbBeHgGuiVFhmF0VIiRw7FxFsLvXEg-eWm3ukme7gX5q_ZBrBq3kzjSRntjqMZ9RHSYHAVLjDJy2y5ysWBT3KFSqCNz32Fya_YTvP_r-KLbgzOBkemaOD48PncJdGtc44m7A6nczCCxSppuXLho4ZfL3tg_MHGMsudA
linkToPdf	http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR1dTxQxcEIwIb4YBT9WEGoi-mA2t9vddrskhBDOC4gQHyS5t9ptu4QE9vC40_jX_HXM7MdxR9Q3Hpt-pJ3OdGY6XwDvVFyq3EkVZs7nYVpaGebGxaE3ZZ5xXyZFXT_l5FQenqWfh2K4BH-6WBhyq-zexPqhdiNLf-S9GNWdFBFMxb2ydYv42h_sXf8IqYIUWVq7choNihz7379QfbvZPerjXW9zPvj07eAwbCsMhDYV0STEjUTcyNgmVH3LpMbGNopMIrxVtvS8yGqdAWXu0tlCITvzThhXm_uU4ZT0AJ__R1mCbBNpKRvOlD1SG5rIpgzV9SgZtk73UaJ61ZgSr8YZVWJeYIf3mcIcV7xnpq253-ApPGnFVrbf4NkzWPLVKqyctIb5NegjujGHCvgVNhk5-P30rMkSvcMu5rzWGQrJzI2n58xUDhsjx8ilqY6ueA5nDwK-F7BcjSr_ClgSC28iKwueeuSrPjdFJEQpJS5LAd4BfOzgpG2bvZyKaFzq2oqeKI1Q1QRVMtAFsD0bfd1k7fjHuA8Eck3EjKtZ08Yk4J4oLZbeR3FSIPfOeAAbCyORCO1id3dpun0EbvQdygbwdtZNM8mxrfKjKY2RgiMwJZ7wZXPZsx3znD7ochnA--725xb_y3Fe_38XW7CCJKO_HJ0er8NjmtT45WzA8mQ89W9QupoUmzUaM_j-0HRzC1o3Mqo
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+dopamine+motive+system%3A+implications+for+drug+and+food+addiction&rft.jtitle=Nature+reviews.+Neuroscience&rft.au=Volkow%2C+Nora+D&rft.au=Wise%2C+Roy+A&rft.au=Baler%2C+Ruben&rft.date=2017-12-01&rft.eissn=1471-0048&rft.volume=18&rft.issue=12&rft.spage=741&rft_id=info:doi/10.1038%2Fnrn.2017.130&rft_id=info%3Apmid%2F29142296&rft.externalDocID=29142296
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-003X&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-003X&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-003X&client=summon